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Early Detection of Mental and Motor Symptoms
In the Wernicke-Korsakoff Syndrome
Jan Watze Wijnia
The clinical signs of Wernicke encephalopathy most often occur within hours to days before a subsequent 
hospital admission. Wernicke encephalopathy may be identified by the presence of a delirium in malnour-
ished alcoholic patients who have trouble walking. In these patients the delirium is usually due to vitamin 
B1 deficiency among other causes, which may be erroneously diagnosed as alcohol withdrawal delirium. In 
Wernicke delirium the possible loss-of-function mechanisms are proposed to come from microglial activa-
tion in the brain.
Other heralding symptoms of vitamin B1 deficiency are the serious infections that are likely to occur. Wer-
nicke-Korsakoff patients who suffered from an infection during the acute phase are at risk of worse neuro-
psychological outcomes on follow-up. Assessing the final Korsakoff syndrome diagnosis becomes relevant 
when the patient with suspected Korsakoff syndrome can walk independently again. In an attempt to fur-
ther understand the overall symptom profile, we proposed a neuropathological correlate for Korsakoff syn-
drome involving cerebellar neurocognition at brainstem level. The time course of mental symptoms and 
gait- and balance disturbances is described in more detail.
Muscle weakness in chronic alcoholism may be related to interdependent deficiencies of vitamin D, phos-
phate, and magnesium. Further research is needed to determine if vitamin D supplementation can improve 
muscle function in chronic alcoholic myopathy.
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Introduction
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The Slingedael Korsakoff Center in Rotterdam, the Netherlands, is a long-term care 
facility for patients with Korsakoff syndrome. Many of our patients are referred to us by 
general and psychiatric hospitals in the Rotterdam region. The Korsakoff Center offers 
day care, observation and diagnosis, and specialized nursing home care. Slingedael 
cooperates with other care facilities supporting similarly affected patients.
1.1. bacKgrounD
1.1.1. Wernicke-Korsakoff syndrome
Wernicke encephalopathy (WE) and Korsakoff syndrome are considered to be different 
stages of the same disorder following vitamin B1 (is thiamine) deficiency, which is called 
Wernicke-Korsakoff syndrome (WKS). There are excellent monographies on alcohol-
related Wernicke-Korsakoff syndrome by Arts (2007) and multidisciplinary guidelines 
on alcohol-related disorders by Thomson et al (2002) and by van den Brink and Jansen 
(2009). Yet, it remains to be seen how well we are doing in the diagnosis and manage-
ment of alcohol-related Wernicke-Korsakoff’s (Isenberg-Grzeda et al, 2014). Many cases 
of Wernicke encephalopathy are missed, despite existing literature and clinical knowl-
edge. This is in agreement with literature from the US and UK: “Over a century after the 
initial descriptions, Wernicke-Korsakoff syndrome remains diagnostically difficult. […]. 
Indeed, even in countries where national guidelines exist, thiamine is still underdosed” 
(Isenberg-Grzeda et al, 2012).1
1.1.2. general information
Wernicke encephalopathy is due to thiamine deficiency and is characterized ‘clas-
sically’ by clouding of consciousness,2 ocular signs,3 and ataxia (Cook et al, 1998). As 
Wernicke encephalopathy is essentially a clinical diagnosis warranting prompt treat-
ment, presumptive treatment should not be delayed pending the results of diagnostic 
procedures.4 Moreover, serum thiamine levels may be a poor measure of thiamine 
status (Davies et al, 2011) and results of brain magnetic resonance imaging (MRI) may 
be found to be normal in some cases of Wernicke encephalopathy (Manzo et al, 2014). 
If high-dose parenteral thiamine is not given urgently, the biochemical abnormalities 
that thiamine deficiency causes can lead to irreversible brain damage (Cook et al, 1998). 
Brain lesions in Wernicke encephalopathy are commonly found in the thalamus, mam-
millary bodies, subependymal structures (along the third and fourth ventricles and the 
1 Quotation marks (“ ”) are used to enclose words that are quoted from the original source.
2 Acute confusion/ delirium.
3 Nystagmus, ophthalmoplegia.
4 www.bestpractice.bmj.com/best-practice/monograph/405/diagnosis/step-by-step.html
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aqueduct), and the inferior olivary nuclei (Torvik, 1985). The brain damage may lead 
to death, with mortality rates of 17%−20% being reported, or in 85% of survivors, to 
the chronic Korsakoff syndrome, characterized by short-term memory loss, but with 
relative reservation of intellectual functions (Cook et al, 1998). In postmortem studies, 
Wernicke encephalopathy occurred in chronic alcoholics at a frequency of 12.5% (Torvik 
et al, 1982) and in the population as a whole, the figure is ~ 1.5%. However, Wernicke 
encephalopathy is widely underdiagnosed and so these figures are likely to represent an 
underestimate of the true prevalence (Cook et al, 1998). The work of Harper et al (1986) 
demonstrated that the diagnosis of Wernicke encephalopathy was only made clinically 
in 16% of cases prior to autopsy. In a further review of pathological studies, only 10% 
of patients with Wernicke encephalopathy had the full classical triad of clinical signs, 
23% had ataxia, 29% had ocular signs, and 82% presented with mental changes, i.e., 
confusion, drowsiness, obtundation, pre-coma, and coma (Harper et al, 1986).
1.1.3. before admission to Slingedael Korsakoff center
We visited patients in preparation for transferring them to Slingedael Korsakoff Cen-
ter. These hospital visits enable us to develop a better understanding of the patients’ 
initial circumstances and the course of Wernicke-Korsakoff syndrome. As we describe 
in Chapter 2, the managing of alcohol-related disorders includes a hazard of undertreat-
ment, even in patients already admitted to the hospital. Besides standard diagnostic and 
therapeutic procedures, whenever patients showing behavioral problems are admitted, 
circumstances of suboptimal medical care may occur, because the managing of these 
patients generally is no common practice for the admitting team.
The following brief case history is given to further introduce the topic of this thesis on 
‘Early detection of mental and motor symptoms in the Wernicke-Korsakoff syndrome’.
1.1.4. case history
A 55-year-old woman was referred to our Korsakoff Center under strong suspicion of 
having Wernicke-Korsakoff syndrome and alcohol withdrawal delirium. Treatment con-
sisted of intramuscularly thiamine 100 mg/day and clorazepate.
She expressed feelings of anxiety. Presenting symptoms had remained unchanged 
during the hospital admission. Alcohol abuse existed ever since her youth. The last 
months she had been secluding herself from her environment.
We examined the patient being in a constant state of anxiety and confusion. She 
was barefoot, wearing a nightgown. She was unable to walk. There was impairment of 
her consciousness with fluctuating drowsiness. Orientation of time and space was lost: 
she thought that she was in a train station, rather than in a hospital. Abnormalities of 
language included incoherent speech and dysarthria. She thought that she had been 
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caught by the police, attending nurses would be offending her, and danger was con-
stantly lurking round the corner. Furthermore, there were visual hallucinations.
The symptoms described, represented a delirium. On reexamination four months 
later signs had changed to a chronic Korsakoff syndrome with apathy, severe memory 
deficits, and confabulations.
1.2. rESEarch quEStIonS
1.2.1. Main questions
To clarify prevalence rates of delirium in the initial phase of Wernicke-Korsakoff syn-
drome in our Center, we systematically looked for reports on delirium that preceded the 
Korsakoff syndrome in our patient group. We sought to find support for the hypothesis 
that delirium in itself can be a primary presenting feature of Wernicke-Korsakoff syn-
drome and might be one of the key symptoms of an active Wernicke encephalopathy. 
Therefore, one of the main questions was:
(I) Are Wernicke encephalopathy and delirium synonymous conditions in malnourished 
alcoholic patients (Chapter 3 & 5)?
Furthermore, patients suffering from delirium of any cause may show impairments 
of gait during their delirium episode − however, in the literature no specific informa-
tion is available on this particular topic (Cf., Axer et al, 2010; Godfrey et al, 2009). As 
disease-related mobility disturbances are obvious in many clinical cases of Wernicke 
encephalopathy, we were especially interested in the motor symptoms in combination 
with the mental changes of the Wernicke-Korsakoff syndrome. Therefore, the second 
main research question was:
(II) Wernicke-Korsakoff syndrome is a ‘spectrum of disease’ resulting from thiamine defi-
ciency, but would it be possible to more specifically determine its temporal progression 
regarding the patients’ mobility and mental symptoms (Chapter 4)?
1.2.2. Subsidiary questions
When searching for information on Wernicke encephalopathy, our attention was caught 
by studies, which focused on prisoners on hunger strike (www.evertdorhoutmees.nl/
hongerstaking.html, 2005). In the hunger strikes, the prisoners who died, died of Wer-
nicke encephalopathy. Moreover, infections were pointed out as one of the most frequent 
triggers of death in these cases of Wernicke encephalopathy. Having an infection can 
increase the utilization of thiamine and may precipitate Wernicke encephalopathy in pa-
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tients with marginal thiamine reserves (Donnino et al, 2007; World Health Organization, 
1999). Although many studies described the transition of Wernicke encephalopathy to 
Korsakoff syndrome, the possible role of systemic infections in this transition is not clear.
In our group of end-stage Korsakoff patients, we subsequently made an inventory of the 
occurrence of infections during the acute Wernicke phase and investigated the effects 
of these initial infections on the ultimate cognitive outcomes of the Korsakoff syndrome.
The research questions here were (Chapter 6):
(III) How common were infections in the initial phase of Wernicke-Korsakoff syndrome 
in our patient group?
(IV) Were infection parameters related to the cognitive outcomes?
1.2.3. Subsidiary questions regarding the patients’ impaired mobility
Muscular weakness and wasting are frequent symptoms of alcoholic myopathy, causing 
difficulties, e.g., in rising from a chair or in climbing a staircase. In chronic alcoholic my-
opathy, improvement of muscle weakness usually takes at least 2–3 months (Diamond 
& Messing, 1994) up to 6–9 months following alcohol abstinence (Preedy & Peters, 1994; 
Slavin et al, 1983).
Vitamin D deficiency is a well-recognized cause of myopathy and excessive drinking is 
often associated with low or subnormal levels of vitamin D. As many alcoholic patients 
have low vitamin D levels, this prompted us to raise the question whether the muscle 
weakness might be caused by vitamin D deficiency.
This research question was formulated as follows (Chapter 7 & 8):
(V) Is vitamin D deficiency a confounder in alcoholic muscle weakness?
1.3. SuPPlEMEntary chaPtErS
The relation of sign-symptoms and neuropathological substrate of delirium or WKS is 
largely unknown. Therefore future challenges may be found in uniting the spectrum of 
WKS symptoms in terms of successive neuropathological changes, including the acute 
delirium and the end-stage symptoms. In an attempt to further understand the WKS 
symptom profile, we proposed a neuropathological correlate for Korsakoff syndrome 
involving cerebellar neurocognition at brainstem level (Chapter 9).
Finally, we gave some background information (Chapter 10) on thiamine treatment of 
Wernicke encephalopathy according to recommendations of current guidelines.
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The subject of delirium due to thiamine deficiency and impaired mobility is further 
introduced in the following Chapter 2.5
5 The results of this thesis are presented in Chapters corresponding with papers published in, or 
submitted to, medical journals.
 Some modest editing was done for section layout (paragraph numbers, e.g., 1.1.1.), Figure/ 
Table numbers (e.g., Figure 1−1), uniform spelling, and frequently used words or descriptions: 
‘behavior’, ‘esophageal’, ‘summarized’; ‘abuse’, ‘alcoholic patient’, ‘Wernicke encephalopathy’, 
‘Korsakoff syndrome’, ‘elderly care physician’, ‘our Center’, rather than: ‘behaviour’, oesopha-
geal’, ‘summarised’; ‘misuse’, ‘alcoholic’, ‘Wernicke’s encephalopathy’, ‘Korsakoff’s syndrome’, 
‘physician−elderly care’, or repeatedly ‘Slingedael Korsakoff Center’.
 References to Chapters in the main body of the text correspond to the full citations used in the 
papers, e.g., ‘(Chapter 3)’ for citation rather than ‘(Wijnia et al, 2012)’.
CHAPTER 2 
Diﬃ  culties in identifying Wernicke 
delirium
Wijnia JW, Nieuwenhuis KG
European Journal of Internal Medicine 2011; 22(6):e160−161
Letter to the Editor
Keywords: Delirium, Alcoholism, Thiamine
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abStract
In daily practice, we saw disappointing results with respect to the number of patients 
that have been appropriately treated with parenteral thiamine after admission to gen-
eral or psychiatric hospitals. Delirium and inability to walk are important symptoms of 
Wernicke encephalopathy, but can easily be mistaken for alcohol withdrawal delirium. 
Apparently, a history of alcohol abuse may unintentionally influence the diagnosis of 
patients with delirium, such that Wernicke encephalopathy is overlooked. In order to 
identify possible Wernicke encephalopathy in malnourished alcoholic patients, it is es-
sential to give proper attention to any signs of delirium and to problems with gait and 
posture, as well.
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2.1. IntroDuctIon
Wernicke-Korsakoff syndrome is one of the serious consequences of vitamin B1 de-
ficiency, in affluent countries most commonly seen in chronic alcoholism. Wernicke 
encephalopathy is an acute, potentially life-threatening condition that may initially be 
reversible, if treated adequately by giving intravenous thiamine (Arts, 2007; Thomson et 
al, 2002; van den Brink & Jansen, 2009).
Slingedael Korsakoff Center offers a long-stay facility for patients with Korsakoff syn-
drome. For triage purposes, we visited referred patients previous to admission. Most of 
the patients were post-discharge patients of general or psychiatric hospitals and treated 
by specialists in psychiatry, neurology or internal medicine. In daily practice we found 
that several of these patients appear to not be getting appropriate thiamine treatment 
according to multidisciplinary guidelines for managing suspected Wernicke encepha-
lopathy (Thomson et al, 2002; van den Brink & Jansen, 2009).
2.2. hoSPItal aDMISSIon
The reason why an alcoholic patient is hospitalized, can be gradually increasing physical 
illness, but is often a collapse. Depending on the present symptoms this may lead to 
admission to various departments: Internal Medicine, Geriatrics, Pulmonology, Cardiol-
ogy, Neurology, Psychiatry, Surgery, Urology, or ENT-department.6 On our hospital visits, 
members of the admitting team often expressed feelings that the confused alcoholic 
patient ‘had fallen between two stools’ − currently having been referred to a department 
that would not be the appropriate one. The patients had not been eating well for at 
least several weeks before admission and appeared seriously confused on admission. 
They indeed suffered from a long history of alcohol abuse, but the onset of Wernicke-
Korsakoff syndrome was often associated with one of the first clinical admissions. 
This finding emphasized the need for an active treatment approach in malnourished 
alcoholic patients once they are admitted to the hospital. Undertreatment may occur 
because of a missed diagnosis.
6 ENT, Ear, Nose & Throat-department, e.g., admitting a confused alcoholic patient with head 
and neck cancer.
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2.3. claSSIfIcatIon of DElIrIuM
According to literature and our experience, Wernicke encephalopathy is often undiag-
nosed in its less evident presentations (Arts, 2007; Thomson et al, 2002; van den Brink & 
Jansen, 2009). In the initial stage, different syndromes with confusion, such as delirium 
and Wernicke-Korsakoff’s, are difficult to distinguish in relation to the underlying dis-
order, e.g., alcohol withdrawal or thiamine deficiency. In the literature this is described 
mainly from the point of view that patients with delirium tremens may often also have 
Wernicke encephalopathy (Thomson et al, 2002; McKeon et al, 2008).
Knowing the classification of the delirium in patients with alcohol abuse histories 
should not make a major difference in clinical management or outcome of thiamine 
treatment, because any patient with heavy alcohol consumption before hospitalization 
should be routinely given thiamine treatment regardless of presence or absence of 
delirium. However, in current practice of about seventeen referring hospitals, we found 
that deliria without obvious physical cause had frequently been indicated as ‘alcohol 
withdrawal’ delirium, even though it was not made clear whether or not the patient had 
stopped or diminished drinking alcohol. Apparently, a history of alcohol abuse influ-
ences the diagnosis of patients with delirium, such that a potentially underlying cause 
for delirium, such as Wernicke encephalopathy, may be overlooked (Rosenbaum, 2003). 
In several cases this represented considerable diagnostic error, leading to inadequate 
treatment with thiamine given nonparenterally, in too small a dose, or too late (Thom-
son et al, 2002).
2.4. IMPaIrED gaIt
In order to identify possible Wernicke encephalopathy, it is essential to give proper 
attention to any problems with gait and posture. Although the formal examination 
of cerebellar signs, including ataxia may be difficult in more severely ill patients, it is 
obvious that the patient cannot walk normally. Patients may have been found on the 
ground after different periods of time, ranging from minutes to even days following a 
fall, and are now bedridden or wheelchair-bound. The differential diagnosis of gait dis-
orders in alcoholic patients is extensive: alcohol intoxication, alcoholic polyneuropathy, 
alcoholic myopathy, rhabdomyolysis, central pontine myelinolysis, subdural hematoma, 
cerebellar atrophia. Despite this fact, impaired gait is an important feature of Wernicke 
encephalopathy.
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2.5. DElIrIuM anD WErnIcKE EncEPhaloPathy
As Wernicke himself described: “The question of whether the signs of alcoholic delirium 
should be regarded as a complication or as a separate general manifestation pertaining 
to this (Wernicke’s) disease may be posed but cannot be decided” (Thomson et al, 2008a). 
During our visits we frequently saw patients who were wheelchair-bound, suffering 
from a delirium, and in several cases we observed that the delirium had been assigned 
to alcohol withdrawal, even if no alcohol withdrawal was found. We had to conclude that 
the delirium might have been a possible expression of Wernicke encephalopathy, as was 
illustrated by the course of symptoms in patients showing an acute onset of delirium 
subsequently progressing into a chronic Korsakoff syndrome.
To summarize: In self-neglecting alcoholic patients, delirium can be an expression of 
Wernicke encephalopathy and this should be treated as such to prevent further damage 
from the neurological complications of thiamine deficiency. We hope this approach will 
contribute to changing the discharge diagnosis of delirium: from ‘alcohol withdrawal 
delirium’ to ‘treated Wernicke encephalopathy’.
CHAPTER 3 
Evolution of Wernicke-Korsakoff  
syndrome in self-neglecting alcoholics: 
preliminary results of relation with 
Wernicke delirium and diabetes 
mellitus
Wijnia JW, van de Wetering BJ, Zwart E, Nieuwenhuis KG, Goossensen MA
The American Journal on Addictions 2012; 21(2):104−110
Regular article
Keywords: Alcohol, Medical complications, Psychiatric aspects, Withdrawal, Assessment
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abStract
We present a descriptive, retrospective study of initial symptoms, comorbidity, and 
alcohol withdrawal in 73 alcoholic patients with subsequent Korsakoff syndrome. In 
25/73 (34%) of the patients the classic triad of Wernicke encephalopathy with ocular 
symptoms, ataxia, and confusion, was found. In at least 6/35 (17%) of the initial deliria 
(95%-confidence interval: 10−25%) we observed no other underlying causes, thus ex-
cluding other somatic causes, medication, (recent) alcohol withdrawal, or intoxication. 
We suggest that these deliria may have been representing Wernicke encephalopathy. A 
high frequency (15%) of diabetics may reflect a contributing factor of diabetes mellitus 
in the evolution of the Wernicke-Korsakoff syndrome.
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3.1. IntroDuctIon
3.1.1. clinical features
The Korsakoff syndrome is a chronic condition that may emerge when the acute phase 
of the Wernicke-Korsakoff syndrome resolves (American Psychiatric Association, 2000; 
Thomson et al, 2002). Korsakoff syndrome is characterized by impairments of memory 
and executive functions (Table  3−1), whereas the patients themselves experience no 
problems due to reduced awareness of illness. Disturbances of executive functioning 
constitute an important component of severe functional limitations that can be ob-
served in Korsakoff patients, regarding initiative, planning, organizing and regulating of 
behavior (Goossensen et al, 2007; Kessels et al, 2008; Thomson et al, 2002).
Timely and adequate treatment of thiamine deficits in patients with Wernicke-
Korsakoff syndrome is critical to prevent the progress into the end-stage of the disease 
(Thomson et al, 2002). When the Korsakoff syndrome is diagnosed without clinical 
table 3−1. Definitions
Korsakoff syndrome The diagnostic criteria of alcohol-induced persisting amnestic disorder are contained 
in the DSM-IV category of substance-induced persisting amnestic disorder:
“A.  The development of memory impairment as manifested by impairment in the 
ability to learn new information or the inability to recall previously learned 
information.
B.  The memory disturbance causes significant impairment in social or occupational 
functioning and represents a significant decline from a previous level of 
functioning.
C.  The memory disturbance does not occur exclusively during the course of 
a delirium or a dementia and persists beyond the usual duration of alcohol 
intoxication or withdrawal.
D.  There is evidence from the history, physical examination, or laboratory findings 
that the memory disturbance is etiologically related to the persisting effects of 
alcohol use.”1
Clinical description: “Sergei Korsakoff characterized the memory disorder as occurring 
in a setting of clear consciousness, such that the patient gave the impression in 
conversation that he was entirely in possession of his faculties but showed a severe 
impairment current and recently memory, asking the same questions over and over 
again, reading the same page for hours on end, and not being able to recognize 
people whom he had met many times since the onset of the illness. Current en 
recent memory was affected more than remote memory, but the impairment could 
involve memories from up to 30 years earlier. Sometimes, the disorder was associated 
with patients inventing ‘fictions’ (confabulations) in their discourse, and these false 
recollections often represented real memories jumbled up and recalled out of 
temporal sequence.”2
Wernicke 
encephalopathy
The classic triad of ocular motility abnormalities: external ophthalmoplegia and/ or 
nystagmus, ataxia affecting primarily the gait, and mental confusion or delirium.2,3
alcohol withdrawal 
delirium
Delirium after cessation or reduction of previously significant and/ or prolonged 
alcohol abuse. The worst symptoms occur the 2nd−5th day following abstinence.4
1 American Psychiatric Association, 2000. 2 Kopelman et al, 2009. 3 McKeon et al, 2008. 4 van den Brink & 
Jansen, 2009.
26 CHAPTER 3
features of preceding Wernicke encephalopathy (the triad of ocular symptoms, gait 
disorder, and confusion), the syndrome may have developed insidiously. However, the 
presence of Wernicke encephalopathy is often not recognized because of an atypical 
or incomplete presentation (Thomson et al, 2002; Thomson & Marshall, 2006a; van den 
Brink & Jansen, 2009). An early assessment of the risk of Wernicke-Korsakoff syndrome 
is essential to prevent further damage from the neurological complications of thiamine 
deficiency.
3.1.2. Initial delirium
Slingedael Korsakoff Center offers a long-stay facility for patients with Korsakoff 
syndrome. For triage purposes, an elderly care physician and psychologist visited all 
referred patients before admission. During these visits we frequently saw patients who 
were wheelchair-bound and suffering from delirium. In several cases we observed that 
the delirium had been assigned to alcohol withdrawal, even though it was not made 
clear whether or not the patient had recently stopped or diminished drinking alcohol. 
Because of these ‘anecdotal’ observations we wondered whether the delirium might 
have been a primary manifestation of encephalopathy prior to the development of 
Korsakoff syndrome, on the basis of an unrecognized Wernicke encephalopathy with 
incomplete presentation.
3.1.3. Wernicke’s syndrome
The concept of a classic triad of signs and symptoms in Wernicke encephalopathy 
was based on the original description by Carl Wernicke. The triad consists of an acute 
onset of a confusional state and impairment of consciousness, ataxia, and eye signs 
(nystagmus and ophthalmoplegia). However, as Wernicke himself described, and has 
been shown in subsequent studies, other important clinical signs and symptoms, such 
as nausea, vomiting, loss of appetite and emotional changes, are often present before 
the later ‘classical’ signs appear (Thomson et al, 2008a; 2008b). Furthermore, Wernicke 
wrote: “The question of whether the signs of delirium potatorum should be regarded 
as a complication or as a separate general manifestation pertaining to this (Wernicke’s) 
disease may be posed but cannot be decided” (Translation by Thomson et al, 2008a).
In a review of clinical findings in alcoholic and non-alcoholic patients whose diagno-
sis of Wernicke-Korsakoff syndrome has been confirmed postmortem, the symptoms 
selected for recording were dependent upon what clinicians considered to be the 
diagnosis at the time. Delirious symptoms were reported to be present in four out of 
13 studies, but unfortunately not as prevalence rates per study (Thomson et al, 2008b).
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3.1.4. aim of the study
We systematically examined the symptoms that preceded the Korsakoff syndrome in 
our patient group. We explored the idea that delirium in itself can be a primary present-
ing feature of Wernicke-Korsakoff syndrome and might be one of the key symptoms of 
an active Wernicke encephalopathy.
3.2. MEthoD
3.2.1. Data collection
We registered all applications for admission to Slingedael Korsakoff Center from April 
1, 2005 to March 31, 2010. The patients’ medical history was obtained from informa-
tion on application forms, discharge letters, records of general practitioners, and other 
sources, such as a parent or a spouse. Following diagnostic hospitalization in a gen-
eral or psychiatric hospital, or alcohol clinic, patients may have been admitted first to 
a nursing home elsewhere or discharged home, before being referred to the Korsakoff 
department of our nursing home. In this paper, the prior (clinical) admission in which 
Korsakoff syndrome was diagnosed or strongly suspected, will be denoted as ‘diagnostic 
admission’. Patients were visited within 1−2 weeks after application for admission to 
our Center. Data collection involved the patients’ age, sex, age of onset and duration 
of alcohol abuse, information on alcohol consumption and self-neglect (malnutrition) 
 
 
 
figure 3−1. Phases of data sampling in patients referred to Slingedael Korsakoff Center
№, number of patients. a Dementia (17), acquired brain injury (8), hepatic encephalopathy (2), minimal or 
atypical cognitive symptoms (6), other (2). b Long-standing diagnosis having been established before the 
current illness episode.
28 CHAPTER 3
before the diagnostic admission, number of previous admissions up to and including 
the diagnostic admission, and the name of institution signing up for admission to our 
Center. Reasons for exclusion of the patients from the study are given in Figure 3−1.
3.2.2. Initial symptoms
Symptoms preceding the Korsakoff syndrome were identified on the basis of registration 
data, the patients’ medical history obtained from other sources, and personal observa-
tion. This included data of the diagnostic admission concerning the state of conscious-
ness, (dis)orientation, memory disorders, executive (dys)functioning, confabulations, 
presence of a delirium, presence of the classic triad of Wernicke encephalopathy, or 
collapse (patient had been found on the floor). We also registered data of current and 
previous psychiatric/ somatic comorbidity, and the social situation of the patient.
3.2.3. assessment of alcohol use
For the aim of the research, possible alcohol withdrawal at the time of the diagnostic 
admission was assessed based on various sources: data of emergency departments or 
clinical departments regarding signs of alcohol intoxication; if available test results on 
blood alcohol concentrations; data on alcohol consumption for the last days/ weeks 
before admission, previous GP consults; and/ or outpatient care. Because presenting 
symptoms of alcohol withdrawal delirium may be considered most severe during the 
2nd−5th day of alcohol withdrawal (van den Brink & Jansen, 2009), we defined alcohol 
withdrawal delirium unlikely to happen in patients that were abstinent for more than 
one week. And by definition, we would not expect alcohol withdrawal delirium on 
admission if patients had continued drinking. Therefore we chose to divide previous al-
cohol abuse into three groups: (i) The patient continued drinking up until the diagnostic 
admission, (ii) the patient had discontinued or diminished alcohol drinking during the 
week before admission, and (iii) the patient had discontinued drinking alcohol for more 
than one week before admission.
3.2.4. Korsakoff diagnosis
The diagnosis of Korsakoff syndrome can usually appropriately be made after a four 
week (van den Brink & Jansen, 2009) to six week period (Goossensen et al, 2007) of 
alcohol abstinence. Patients were alcohol abstinent during the diagnostic admis-
sion and were not allowed to drink alcohol in our Center. The diagnosis of Korsakoff 
syndrome was made by clinical assessment of consulting specialists in psychiatry or 
neurology, and (infrequently) by neuropsychological assessment during the previous 
hospitalization period. If patients were admitted to our Center, additional tests were 
done after 2−6 months to assess the Korsakoff syndrome. Neurocognitive assessment 
demonstrating a relatively isolated amnestic disorder (American Psychiatric Association, 
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2000) with a relatively intact intellect, and executive dysfunctioning, were documented 
by neurocognitive assessment, including: Cambridge Cognitive Examination (CAMCOG), 
Kaufman Short Neurological Procedure, Rivermead Behavioral Memory Test, 15 Words 
Test, Visual Association Test, Groningen’s Intelligence Test (an alternative for Wechsler 
Adult Intelligence Scale), Verbal Fluency Test, Figure Fluency Test, Clock Drawing Test, 
Behavioral Assessment of the Dysexecutive Syndrome (BADS), Stroop Color-Word Test, 
Trail Making Test part A & B, and Numerical Series Test.
3.3. rESultS
3.3.1. Patient characteristics
Patient data of the 128 Korsakoff patients are listed in Table 3−2. Of these patients, 122 
(95%) were single and living alone, 19 of them were divorced, 8 widow(er), and an-
other 8 homeless. In 69% of patients and number of admissions known, the diagnosis of 
Wernicke-Korsakoff syndrome was made at the first admittance following a prolonged 
period of heavy alcohol abuse and serious self-neglect. Patients may have been staying 
in hospital for 2−8 weeks before they were visited. Of the 128 patients with a Korsa-
koff diagnosis, eventually 11 patients were not admitted to our Center, but admitted 
elsewhere. In seven of these patients the diagnosis was made by clinical assessment of 
consulting specialists in psychiatry or neurology, without further neurocognitive assess-
ment.
3.3.2. alcohol withdrawal
Additional data on the duration of alcohol withdrawal were available in a smaller group 
of 73/128 Korsakoff patients (Table 3−3). These patients were diagnosed having a deliri-
um in 35/73 (48%) and the triad symptoms of Wernicke encephalopathy in 25/73 (34%). 
The patients had multiple potential causes for delirium, including alcohol withdrawal, 
alcohol intoxication, hepatic disease, delirium associated with pneumonia, and delirium 
associated with cerebrovascular disease.
In 15/35 (43%) of the deliria we had to conclude that there was no alcohol withdrawal 
involved as a contributing factor. That is, 12/35 (34%) of the delirious patients were 
already delirious on admission, but had not yet stopped or diminished alcohol drinking, 
and 3/35 (8.5%) were delirious after an abstinence period for more than one week. A 
concomitant diagnosis of Wernicke encephalopathy was made in 8/15 (53%) of these 
patients, according to classic symptoms having been observed of ocular symptoms, 
gait disorder and confusion. In the other 7/15 patients with delirium, in six patients no 
other possible causes were identified. None of those six patients received medication 
before the index hospitalizations, which theoretically could also have contributed to 
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table 3−2. Korsakoff patients referred to Slingedael Korsakoff Center, Rotterdam
characteristics Mean (range) Patients
Age Male 58 (33−87) years 105
Female 62 (41−80) years 23 (18%)
Quantity of pure alcohola Male 275 (60−800) mL/dayb
Female 230 (120−700) mL/dayb
Length of alcohol abuse 31 (2−64) yearsc
Number of admissionsd 2.4 (1−10)e
Referred by General Hospital 39 (30%)
Alcohol Clinic 21 (16%)
Psychiatric Hospital 21 (16%)
Nursing Home 22 (17%)
General Practitioner 20 (16%)
Other 5 (4%)
Period of self-neglect
(malnutrition)
< 1 Month 11 (9%)
≥ 1 Month, < 1 Year 28 (22%)
≥ 1 Year 82 (64%)
Not known 7 (5%)
Increase of self-neglect
(not eating at all)
< 3 Weeks 13 (10%)
≥ 3 Weeks, < 6 Weeks 7 (5.5%)
≥ 6 Weeks 7 (5.5%)
No increase mentioned or known 101 (79%)
Presenting symptoms Delirium 46 (36%)
Wernicke encephalopathy (triad) 32 (25%)
Collapse, found on the floor 25 (20%)
Psychiatric disorders Depression 23 (18%)
Personality disorder 20 (16%)
Psychosis/ Hallucinosis 9 (7%)
Other 9 (7%)
Somatic disorders Liver cirrhosis/ Alcoholic hepatitis 40 (31%)
Diabetes mellitus 19 (15%)
COPD/ Pneumonia 16 (12%)
Stroke/ Subdural hematoma 15 (11.5%)
Vascular disease, including myocardial infarction 9 (7%)
Carcinoma 9 (7%)
Pancreatitis 7 (5%)
Peptic ulcers/ Esophageal stenosis 5 (4%)
Other 9 (7%)
Total № = 128 patients. a Beer 250 mL = 12.5 mL pure alcohol, wine 100 mL = 12 mL pure alcohol, liquor 
35 mL = 12.25 mL pure alcohol. b In 41 (39%) men, 13 (57%) women; unspecified as ‘Alcohol abuse’ in the 
other patients. c Unspecified as ‘Chronic abuse’ in 72 (56%) patients. d Before the Korsakoff syndrome was 
diagnosed. e Not known in 26 (20%) patients.
Evolution of WKS in self-neglecting alcoholics 31
the occurrence of delirium; and also in these patients, no alcohol intoxication, nor any 
other underlying somatic causes could be confirmed. In summary, in 6/35 (17%) of the 
delirious patients, no recent alcohol abstinence, alcohol intoxication, somatic comor-
bidity, nor classic Wernicke encephalopathy was observed in relation to the delirium. 
These findings in a selected patient group of Korsakoff patients signified that at least 
17% (95%-CI: 10−25%) of the delirious conditions in the early stages of WKS may have 
occurred on the basis of an unrecognized Wernicke encephalopathy with incomplete 
presentation.
3.3.3. Diabetes mellitus
A striking finding was the high frequency of diabetics in our patient group (Table 3−2). 
That is, in 19/128 (15%) of the Korsakoff patients (95%-CI: 8.5−21%) diabetes mellitus 
was found as a comorbid condition. If corrected for age and sex, we would expect 7% 
diabetics according to the prevalence of diabetes in the Netherlands (Statistics Nether-
lands, 2007/ 2008).
3.3.4. Missing data
In 36/128 (28%) of the patients no detailed data were available on actual alcohol 
consumption at the time of presentation. The amount of missing data was negatively 
associated with the number of admissions prior to the diagnostic admission − previous 
information being less available and recent information being less detailed, when the 
patient had experienced more admissions prior to the diagnostic admission.7
7 We found a negative association between the patients’ total number N (1−10) of hospital 
admissions and the percentage (72%−0%) of patients with a more detailed medical history 
regarding their alcohol consumption before the current Nth admission − other than ‘chronic 
alcoholism’ or ‘chronic alcohol abuse’.
table 3−3. Symptoms preceding Korsakoff syndrome, diagnosed as delirium and/ or Wernicke encepha-
lopathy triad
№ is 73 patients Delirium no diagnosis of 
delirium is made 
during admission
Present upon 
admission
Developing during 
admission
alcohol drinking № WE № WE № WE
Continued up till admission 12 6 9 1 22 6
Discontinued or diminished during 
week before admission
11 3 0 0 5 3
Discontinued for more than a week 
before admission
3 2 0 0 11 4
total 26 11 9 1 38 13
№, number of patients. WE, number of patients with Wernicke encephalopathy triad symptoms.
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3.4. DIScuSSIon
3.4.1. Incomplete Wernicke’s
It is already well known that it is common for Wernicke syndrome to present incompletely 
or partially, with only one or two of the pathognomonic features and that many cases 
of Korsakoff syndrome occur without a preceding episode of Wernicke encephalopathy 
(Kopelman et al, 2009; Thomson & Marshall, 2006a). For these reasons, it is established 
good practice that patients with a history of alcohol and current presentation of delirium 
receive treatment even without the triad of Wernicke encephalopathy.
3.4.2. background information
Victor et al (1989, p. 195) concluded: “The diagnosis of Wernicke’s disease is made most 
readily on the basis of the acute appearance of ocular palsies, nystagmus, ataxia of 
gait, and disturbances of consciousness and mentation, which may present single or 
in various combinations.” More than 80% of the patients show signs of polyneuropathy 
as well, and associated liver disease is found in two-thirds of the patients (Thomson et 
al, 2008b). The work of Harper et al (1986) demonstrated that the diagnosis of Wernicke 
encephalopathy was only made clinically in 16% of cases prior to autopsy.
Thomson et al (2008b) are concerned with the early identification of patients at risk 
of developing Wernicke encephalopathy and who have developed the prodromal 
symptoms of thiamine deficiency. They have prepared several guidelines for identify-
ing early thiamine deficiency and to aid the doctor in predicting whether the patient 
has Wernicke encephalopathy (Thomson et al, 2002; 2008b). Early sign-symptoms of 
thiamine deficiency are involving loss of appetite, nausea/ vomiting, fatigue, weakness, 
apathy, giddiness, diplopia, insomnia, anxiety, difficulty in concentration, and/ or loss of 
memory (Thomson et al, 2008b).
Caine et al (1997, p. 54) developed operational criteria to differentiate between 
Wernicke encephalopathy alone or in combination with Korsakoff’s psychosis or hepatic 
encephalopathy: “The criteria for Wernicke encephalopathy require two of the following 
signs: (i) dietary deficiency, (ii)  oculomotor abnormalities, (iii) cerebellar dysfunction, 
and (iv) either altered mental state or mild memory impairment.” According to the 
information in Caine’s article, however, six out of the 40 patients (15%) with Wernicke en-
cephalopathy pathology, were not clinically diagnosed using these operational criteria.
3.4.3. thiamine therapy
Because of atypical presentation, Wernicke encephalopathy is difficult to diagnose 
(Thomson et al, 2002; van den Brink & Jansen, 2009). Therefore, immediate initiation of 
thiamine treatment is advised (van den Brink & Jansen, 2009) in every alcoholic patient 
presenting with self-neglect, cognitive impairment and gait disorders or polyneuropa-
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thy (high risk of Wernicke encephalopathy). In case of significant other symptoms, e.g., 
acute confusion, decreased conscious level, or eye movement disorders, and thereby 
suspicion of an existing Wernicke encephalopathy, higher amounts of thiamine are ad-
vised; length of treatment is dependent on the clinical course (van den Brink & Jansen, 
2009). For a full outline of thiamine therapy, the reader is advised to consult the Free 
PubMed Central article by Thomson et al (2002), available at www.ncbi.nlm.nih.gov/
pubmed/12414541.
3.4.4. Mental confusion
In general, different syndromes with confusion, such as Wernicke-Korsakoff’s and de-
lirium, are difficult to distinguish in relation to the underlying disorder, e.g., thiamine de-
ficiency or alcohol withdrawal (Rosenbaum, 2003). In fact, the two conditions – Wernicke 
encephalopathy and alcohol withdrawal – can co-exist. In the literature this is described 
mainly from the point of view that patients with delirium tremens may often also have 
Wernicke encephalopathy (McKeon et al, 2008; Thomson et al, 2002). However, delirium 
is a possible expression of Wernicke encephalopathy itself as well, given that delirium is 
one of the features of Wernicke encephalopathy. In our study, this symptom pattern was 
observed in at least a group of patients without (recent) alcohol withdrawal, showing 
an acute onset of delirium subsequently progressing into a chronic Korsakoff syndrome. 
Seventeen per cent of the patients with delirium had no evidence of underlying so-
matic causes, no (recent) alcohol withdrawal or intoxication, and no triad symptoms of 
Wernicke encephalopathy. We assumed that these patients with unexplained delirium 
who went on to develop Korsakoff syndrome may have had some type of incomplete 
form of Wernicke encephalopathy without the classic symptoms of ophthalmoplegia, 
nystagmus, and ataxia.
3.4.5. Epidemiological findings
Our patient group represented a specialized population of patients being referred to 
Slingedael Korsakoff Center. The total number of Korsakoff patients in our region, i.e., 
the city of Rotterdam and its surrounding areas, is unknown. The Rotterdam-Rijnmond 
Public Health Service (GGD) made an estimation of 275−450 Korsakoff patients (corre-
sponding with a prevalence of 3.0−4.8 patients per 10,000 inhabitants) living at home, in 
homeless shelters, residential care homes, or staying in alcohol clinics, general/ psychi-
atric hospitals, and other care facilities, in Rotterdam and surrounding areas (Wierdsma 
et al, 1994).
3.4.6. Patient characteristics
We provided data on the initial hospitalization of Korsakoff patients that led to the 
diagnosis and categorized patients as to whether they had Wernicke encephalopathy, 
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alcohol withdrawal, or some other type of delirium at the time of presentation. Most of 
the patients that were referred to our Center, were inpatients of general or psychiatric 
hospitals, and diagnosed by specialists in psychiatry, neurology or internal medicine. 
Patients studied had not been eating well for at least several weeks, and appeared seri-
ously confused on admission. The patients had suffered from a long history of alcohol 
abuse, but the diagnosis of Wernicke-Korsakoff syndrome was often associated with one 
of the first clinical admissions. This finding emphasized the need for an active treatment 
approach in self-neglecting alcoholic patients once they are admitted to the hospital.
3.4.7. Diabetes mellitus
It is not clear whether heavy alcohol abuse might have been a contributing factor in 
the pathogenesis of diabetes (Carlsson et al, 2005; Koppes et al, 2005; van den Brink & 
Jansen, 2009), or whether diabetic patients may be more sensitive in getting Korsakoff 
syndrome. As described in the literature, acute alcohol intoxication may be associated 
with hypoglycemia (van der Meulen, 1976), and occasionally chronic alcohol abuse 
may be as well (Sporer et al, 1992). Treatment of hypoglycemia (Thomson et al, 2002) 
or administering of glucose (Corcoran et al, 2002; Muller Kobold & Endtz, 1975) without 
correction of a coexisting thiamine deficiency in chronic alcoholism holds the risk of 
precipitating Wernicke encephalopathy.8 This serious condition, and progression to 
Korsakoff syndrome, can probably be successfully prevented by administering thiamine 
prior to glucose (Corcoran et al, 2002) or simultaneously with glucose (Thomson et al, 
2002).
3.4.8. limitations
The application of benzodiazepine medication for prevention of alcohol withdrawal 
delirium and length of delirium periods were not systematically assessed in this study. 
There were too few data on thiamine blood levels (18 patients) to be of use for system-
atic analysis. Although our findings suggest that a delirium may represent the initiation 
phase of Wernicke-Korsakoff syndrome, extensive confirmation of this pattern requires 
further research. The completed available patients’ information on alcohol withdrawal 
was small in number, but it will be difficult to obtain reliable data, considering self-
neglecting patients seldom seek medical care. Wernicke encephalopathy might also be 
confused with alcohol intoxication delirium, but the proportion of alcoholic delirium 
contributed by patients with Wernicke-Korsakoff syndrome is unknown. We did not find 
any epidemiologic data concerning the incidence of alcohol intoxication delirium.
8 Administering of glucose, e.g., parenteral feeding, enteral feeding, refeeding, IV glucose fol-
lowing starvation.
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3.5. concluSIon
In patients with long alcohol abuse histories, a coincidental collapse may have been 
the reason of admission. These patients often appeared seriously confused on admis-
sion. According to our experience, any delirium in malnourished alcoholic patients is 
representing Wernicke’s syndrome − until proven otherwise. The phenomenon of Wer-
nicke delirium does not present a new entity, but might be one of the answers to the 
original question of Carl Wernicke: whether alcohol-related delirium should be regarded 
as a complication or as a separate general manifestation pertaining to his eponymous 
encephalopathy.
acKnoWlEDgMEnt
We would like to give special thanks to Alberta Buitendijk, R.N., for her comment on an 
earlier version of the manuscript.
CHAPTER 4 
Need for early diagnosis of mental 
and mobility changes in Wernicke 
encephalopathy
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Delirium, Thiamine
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abStract
The intra-individual course of Wernicke-Korsakoff syndrome has not been studied ex-
tensively, nor has the temporal progression of gait disturbances and other symptoms 
of Wernicke encephalopathy. Here we present the detailed history of a patient whose 
acute symptoms of Wernicke encephalopathy were far from stable. We follow his mo-
bility changes and the shifts in his mental status from global confusion and impaired 
consciousness to more selective cognitive deficits. His Wernicke encephalopathy was 
missed and left untreated, being labeled as ‘probable’ Korsakoff syndrome. Patients 
with a history of self-neglect and alcohol abuse, at risk of or suffering with Wernicke 
encephalopathy, should receive immediate and adequate vitamin replacement. Self-
neglecting alcoholics who are bedridden may have severe illness and probably active 
Wernicke encephalopathy. In these patients, mobility changes, delirium, or impaired 
consciousness can be an expression of Wernicke encephalopathy, and should be treated 
to prevent further damage from the neurologic complications of thiamine deficiency.
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4.1. IntroDuctIon
4.1.1. Wernicke encephalopathy
Wernicke encephalopathy is a neurologic disease caused by vitamin B1 (thiamine) de-
ficiency (Table 4−1). Most patients with Wernicke encephalopathy have a background 
of chronic alcoholism and self-neglect (Sechi & Serra, 2007). Patients with Wernicke 
encephalopathy may present with the classic triad symptoms of ocular motility ab-
normalities, ataxia primarily affecting gait, and confusion or delirium (Thomson et al, 
2002). More often, however, patients show disturbances of attention and consciousness 
ranging from delirium to profound unconsciousness, in combination with a loss of 
the ability to walk. Because of this variety in presentation, Wernicke encephalopathy 
can mimic other conditions such as alcohol withdrawal delirium, or may be mistaken 
for other conditions that produce cognitive disturbances. Ultimately, patients with 
Wernicke encephalopathy whose thiamine deficiency continues may develop Korsakoff 
syndrome, which is characterized by chronic amnesia. Wernicke-Korsakoff syndrome is a 
combination of the two conditions.
4.1.2. Slingedael Korsakoff center
The Slingedael Korsakoff Center in Rotterdam, the Netherlands, is one of ten Dutch 
long-term care facilities for patients with Korsakoff syndrome. Many of our patients 
table 4−1. Defining characteristics
Wernicke encephalopathy Neurologic disorder caused by lack of vitamin B1 and most often affecting 
chronic alcohol abusers. The classic symptom triad is ocular motility 
abnormalities (external ophthalmoplegia and/ or nystagmus), ataxia primarily 
affecting gait, and confusion or delirium.1,2 More patients present atypically with 
disturbances of attention, impaired consciousness, and loss of ability to walk.
Korsakoff syndrome Chronic amnesia that can complicate unrecognized or undertreated Wernicke 
encephalopathy. The Diagnostic and Statistical Manual of Mental Disorders, 
Fifth Edition, lists these diagnostic criteria for substance-induced major 
or mild neurocognitive disorder, including alcohol-induced major or mild 
neurocognitive disorder:
“A. The criteria are met for major or mild neurocognitive disorder.
B.   The neurocognitive impairments do not occur exclusively during the course 
of a delirium and persist beyond the usual duration of intoxication and 
acute withdrawal.
C.  The involved substance…and duration and extent of use are capable of 
producing the neurocognitive impairment.
D.  The temporal course of the neurocognitive deficits is consistent with the 
timing of substance…use and abstinence (e.g., the deficits remain stable or 
improve after a period of abstinence).
E.  The neurocognitive disorder is not attributable to another medical condition 
or is not better explained by another mental disorder.”3
1 McKeon et al, 2008. 2 Thomson et al, 2002. 3 American Psychiatric Association, DSM-5, 2013, p. 627–628.
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are referred to us by general and psychiatric hospitals in the Rotterdam region. The 
Center offers day care, observation and diagnosis, and specialized nursing home care. 
Slingedael cooperates with other care facilities supporting similarly affected patients. 
Gerridzen and Goossensen (2014) conducted a retrospective study of the patients at an-
other of the Dutch facilities, in Markenhof, Beekbergen. The authors reported that many 
of their patients had challenging behaviors, including poor awareness of illness, apathy, 
disinhibition, and sometimes aggression. These observations match our experience.
Before admitting patients to Slingedael, our physicians and psychologists make a 
triage visit to the patients who probably have cognitive disorders related to Wernicke-
Korsakoff syndrome. We find that disappointingly few patients have been appropriately 
treated with parenteral thiamine during their hospital stay. In fact, up to 90% of all pa-
tients whom our team visited between 2009 and 2013 had not been receiving adequate 
thiamine supplementation according to van den Brink and Jansen’s guidelines on 
dosages and preparations (Day et al, 2013; Galvin et al, 2010; Thomson et al, 2002; van 
den Brink & Jansen, 2009). In their studies of patients who were referred to an inpatient 
psychiatry service for alcohol addiction disorders, Isenberg-Grzeda et al (2012, 2014) 
showed that diagnosis of Wernicke encephalopathy remains difficult and that patients 
are underdiagnosed and undertreated, even in countries that have national guidelines.
4.1.3. Mental and motor symptoms
Few studies have reported the temporal progression of the gait disturbances and other 
symptoms of Wernicke encephalopathy. In this case report we describe a man with 
Wernicke encephalopathy, followed by Korsakoff syndrome. One of our objectives is to 
detail how his mental symptoms and gait disturbances evolved over a lengthy follow-up. 
Our second objective is to increase early clinical suspicion of Wernicke encephalopathy 
in self-neglecting alcoholic patients with severe mental and mobility problems before 
the disorder progresses to Wernicke-Korsakoff syndrome.
4.2. caSE rEPort
4.2.1. Medical history
A 65-year-old man was transferred from a local Rotterdam hospital to the Slingedael 
Korsakoff Center. He had been admitted to the hospital 24 days earlier for confusion 
and recent falls. He had a history of angina pectoris, hypertension, and a myocardial 
infarction seven years earlier. According to the hospital record, he had previously been 
smoking 20 cigarettes/day and drinking 2−3 bottles of wine/day and unknown quan-
tities of beer and whiskey. The hospital treated him with a single 300 mg dose of IV 
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thiamine, followed by daily 100 mg thiamine tablets and vitamin B complex tablets.9 
When he was transferred from the hospital to the Slingedael Korsakoff  Center on day 
24, he had a discharge diagnosis of “cognitive disorder due to alcohol abuse – probable 
Korsakoff  syndrome.”
Following is a more detailed description of his course, starting with his admission to 
the local hospital.
4.2.2. Day 1 − hospital admission
On admission, the patient looked disheveled and was reluctant to cooperate. He had 
impaired consciousness (Figure  4−1), with fl uctuating drowsiness. He was bedridden 
because his poor balance had left him unable to walk (Figure 4−2). On the Glasgow Coma 
Scale (Teasdale & Jennett, 1974) he scored 12/15 for eye, motor, and verbal responses: 
‘opens eyes in response to voice’ (grade = 3), ‘localizes painful stimuli’ (grade = 5), and 
‘confused’ verbal responses (grade = 4). Neurologic examination of his cranial nerves was 
normal. His arms and legs showed no paralysis. His coordination and sensory functions 
could not be tested. His blood pressure was 120/90 mm Hg, pulse 100 beats/minute, 
peripheral oxygen saturation 100%, and body temperature normal.
9 According to Thomson et al (2009): “It seems unlikely that the oral route could provide 
the blood concentrations required in an emergency situation; this includes the ataxic and 
confused drunk […] with the presentation of ‘collapse’. It has been shown that parenteral 
thiamine doses of up to 1 g may be required in the fi rst 12 h.”
 
figure 4−1. The patient’s evolving neuropsychiatric symptoms of Wernicke-Korsakoff  syndrome (dashed 
line), starting with initial hospitalization at 0 months. Arrows depict alternative outcomes: further decline, 
full recovery, or protracted delirium.
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Laboratory results: C-reactive protein 22 mg/L, hemoglobin 7.3 mmol/L, leukocytes 
8.8*109/L, sodium 130 mmol/L, potassium 4.3 mmol/L, creatinine 52 μmol/L, aspartate 
transaminase 52 U/L, alanine transaminase 42 U/L, gamma-glutamyl transpeptidase 
322 IU/L, albumin 37 g/L, troponin < 20 ng/L, glucose 6.2 mmol/L, vitamin B1 25 nmol/L 
(reference range 70–140), and blood alcohol concentrations < 0.010% (0.1 g/L). Unfortu-
nately, he was not tested for blood concentrations of other vitamins and micronutrients, 
such as niacin and magnesium.
An electrocardiogram showed sinus rhythm at 106 beats/minute, right bundle branch 
block, and no other abnormalities. Computed tomography imaging of the brain and 
duplex imaging of the carotid arteries (extracranial carotid circulation) did not reveal 
any abnormalities. Magnetic resonance imaging of the brain was impossible because of 
motion artifacts.
4.2.3. Day 8
The patient scored 21/30 on the Mini-Mental State Examination (Folstein et al, 1975).
+
+
+
+
+
+
+ ++
  
figure 4−2. This patient’s evolving mobility as he moved through the neuropsychiatric stages (dashed 
line) of Wernicke-Korsakoff  syndrome. For the fi rst two weeks of his hospitalization, he was bedridden. 
From weeks 3 through 17, he walked with a walker (+ signs). Starting at week 18 (4 months), he was able 
to walk unaided.
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4.2.4. Day 16
We visited the patient in preparation for transferring him to the Slingedael Korsakoff 
Center. He told us that he had been admitted to the hospital after collapsing at the 
airport, and he could not remember what had happened since that day. He reported 
misusing alcohol since his youth. He told us he had recently reduced his drinking to 
about six pints of beer a day, and sometimes whiskey (he did not mention wine, which 
the hospital record showed he had also recently been abusing).
In the past few months he had been not eating well. He said that he had attended 
group sessions as part of an alcohol abuse treatment program, but he could not re-
member the exact details. He had completed intermediate school, and after training in 
several jobs, he had become an industrial foreman.
The patient was cooperative on examination. He sustained his attention relatively well, 
but his glazed eyes showed that he was not very alert. At first, his speech was slightly 
dysarthric, but it improved during the interview. Throughout the interview, he had mild 
difficulty finding words. His memory problems were obvious, and he was disoriented to 
time and place. He thought that he was in an office building near a bus station. He incor-
rectly assumed that he must have met one of us before. He had difficulty organizing his 
thoughts and he expressed himself incoherently. We were aware that he confabulated. 
He reported no hallucinations. His mood and affect appeared normal.
By now the patient could walk again with a walker and help from one person. In test-
ing his coordination we found that his finger-to-nose test was normal but his heel-to-
knee-to-toe test showed ataxia and hypermetria of both legs, left worse than right. We 
tested his eye movements by asking him to follow a slowly moving finger; his smooth 
pursuit was impaired in the right-horizontal direction. On admission to the Slingedael 
Korsakoff Center, the patient showed fluctuating symptoms, with his confusion worsen-
ing in the late afternoon. He held attention fairly well (tenacity), but he was distracted 
by surrounding noises (hypervigilance). Numbness in both feet and reduced tendon 
reflexes indicated polyneuropathy.
4.2.5. Day 24
He had normal laboratory test results for vitamin B6, B12, folate, and thyroid-stimulating 
hormone. His vitamin B1 was 311 nmol/L (reference range 78–143). Because he had 
a vitamin D deficiency, with a serum (25OH) vitamin D of 25 nmol/L (reference range 
50–150), we started him on oral cholecalciferol 100,000 IU bimonthly. By week 31 after 
his initial hospitalization, this treatment had brought his (25OH) vitamin D level up to 
76 nmol/L.
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4.2.6. follow-up testing
Table  4−2 shows results of mobility, muscle strength, and neuropsychological testing 
done over most of the year after the patient’s hospital admission. After week 17 (4 
months), he could walk independently without any aids. By his final test at week 37 (8.5 
months), his risk of falling was low. His gait was wide-based, he spread his arms while 
walking, and his balance became more unsteady with eyes closed. Muscle strength tests 
done in weeks 8 and 24 showed improvement in his muscle strength. His weakness may 
have been caused by alcoholic myopathy.
During week 15, we gave the patient a full neuropsychological assessment. Clini-
cally, he showed striking perseverations and confabulations. The assessment revealed 
disorders in orientation, memory, and executive functions, consistent with a developing 
Korsakoff syndrome.
table 4−2. This patient’s test results during follow-up
Week after hospital
 admission
Score Interpretation
gait and balance
Performance Oriented Mobility 
Assessmenta
4 12/28 High fall risk
9 19/28 Medium fall risk
17 22/28 Medium fall risk
37 25/28 Low fall risk
Muscle strength
Right quadriceps muscle maximum 
voluntary contraction
8 112 newtons 28% of 389 newtonsb
24 182 newtons 47% of 389 newtonsb
neuropsychological tests
CAMCOG1
15
79/105 Impaired
Visual Association Test2 5/24 <1st percentile
Rey’s Verbal Learning Test3 2-1-3-3-3 <1st percentile
Stroop Color Word Test I4 53 seconds 12th percentile
Stroop Color Word Test II4 69 seconds 18th percentile
Stroop Color Word Test III4 120 seconds 21st percentile
Trail Making Test Part A4 54 seconds 16th percentile
Trail Making Test Part B4 131 seconds 4th percentile
BADS5 2-4-2-0-2-1 1st percentile
a Performance Oriented Mobility Assessment (Tinetti, 1986) is a task-oriented 16-item test that measures 
an adult’s gait and balance abilities. The total test score of 28 points combines the gait score (12 points) 
and the balance score (16 points). Fall risks in geriatric patients: low (25–28 points), medium (19–24 points), 
high (<19 points). b Reference value of 389 newtons related to sex, age, and body weight, described by An-
drews et al, 1996. CAMCOG, the cognitive and self-contained part of the Cambridge Examination for Mental 
Disorders of the Elderly. BADS, Behavioral Assessment of the Dysexecutive Syndrome. 1 Roth et al, 1992. 
2 Lindeboom & Schmand, 2008. 3 van der Elst et al, 2005. 4 Schmand et al, 2004. 5 Maharasingam et al, 2013.
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At nine months after admission, he was still living at our Center and needing long-
term nursing home care.
4.3. DIagnoStIc DIffIcultIES
4.3.1. reflection upon the case study
Physicians run a risk of undertreating their patients − even hospitalized patients − who 
have alcohol-related disorders. During our patient’s hospitalization, his symptoms were 
so unstable that a diagnosis of “probable” Korsakoff syndrome could not adequately ex-
plain them. With his history of alcohol dependence, he was in danger of suffering severe 
vitamin deficiencies (Sechi & Serra, 2007). He had arrived at the hospital in a somnolent 
state.
Two weeks later, he was in a transitional state, with his delirium partly in remission and 
his other symptoms fluctuating through the day: subnormal attention, memory deficits, 
disorientation, and mild language disturbances in the form of slight dysarthria and 
mild word finding difficulty. His positive symptoms that were consistent with Korsakoff 
syndrome were his memory deficits, disorientation, disturbances of time perspective, 
and confabulations.
4.3.2. neuropsychological profile of Korsakoff syndrome
In general, Korsakoff syndrome is characterized by severe anterograde and, to a lesser 
extent, retrograde amnesia for declarative knowledge (Kopelman et al, 2009). Moreover, 
many patients have executive function deficits (Joyce & Robbins, 1991; van Oort & 
Kessels, 2008) such as problems with initiative, planning, organizing, and regulating 
behavior. Patients themselves are not tuned in to these problems because they have a 
limited awareness of their illness (Chapter 3). While patients with Korsakoff syndrome 
can exhibit confabulations (Bajo et al, 2010; Borsutzky et al, 2008; Kessels et al, 2008), 
these are also found in other neurologic conditions (Lorente-Rovira et al, 2011), and the 
intensity of confabulations may vary from one patient to another (Schnider, 2003).
Our patient’s confabulations, along with his disturbances of memory and executive 
functions, make him look classic for Korsakoff syndrome (Kopelman et al, 2009; van Oort 
& Kessels, 2008). His clinical picture, however, was complicated by residual symptoms 
of Wernicke encephalopathy, most prominently mild attention difficulties, fluctuating 
symptoms, and worsening confusion in the late afternoon.
4.3.3. timing of Korsakoff diagnosis
In most patients, Korsakoff syndrome can be diagnosed only after a four week (van den 
Brink & Jansen, 2009) to six week period of total alcohol abstinence (Goossensen et al, 
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2007). The diagnosis can take even longer in patients who have protracted delirium or 
repeated bouts of Wernicke encephalopathy. Although our patient was discharged from 
the hospital with a diagnosis of “probable” Korsakoff syndrome, his diagnosis could not 
be confirmed until several weeks later when his persistent attention deficit resolved. 
Because his symptoms were prematurely classified as “probable” Korsakoff syndrome, 
the real cause of his symptoms was overlooked. This may have led to the insufficient 
treatment of his initial Wernicke encephalopathy.10
4.4. DIScuSSIon
4.4.1. acute Wernicke phase
Alcoholic patients may be hospitalized for gradually worsening physical illness (Draper 
et al, 2011). However, many patients with Wernicke encephalopathy come to medical 
attention only after they collapse (Chapter 3). They may have been found on the ground 
or suddenly became bedridden within hours or days. According to autopsy-based series 
(Harper et al, 1986), the most common symptoms of Wernicke encephalopathy are 
mental status changes. The cognitive impairments range from apathy or mild confu-
sion to severe coma (Donnino et al, 2007). Thomson et al (2002) showed that preceding 
Wernicke encephalopathy often goes unrecognized because it is atypical or incomplete. 
The diagnosis is also often missed because physicians have been led to believe that 
Wernicke encephalopathy is much rarer than it actually is, and so they are not looking 
for it (Cook, 2000).
4.4.2. Disturbances of gait
The physician may not be able to examine patients for signs of Wernicke encephalopathy 
if, like our patient, they are severely ill (Chapter 2; Donnino et al, 2007), bedridden, and 
unable to walk. Thus, it can be difficult to work through the extensive differential diag-
nosis of gait disorders in alcoholic patients. In addition to Wernicke encephalopathy, the 
more common possibilities include alcohol intoxication, central pontine myelinolysis, 
cerebellar atrophy, concussion, subdural hematoma and other processes that occupy 
intracranial space, polyneuropathy, myopathy, rhabdomyolysis, and cerebral vasculopa-
thy of small vessels.
10 According to British (Thomson et al, 2002), Dutch (van den Brink & Jansen, 2009), and 
European (Galvin et al, 2010) guidelines for diagnosis, therapy and prevention of Wernicke 
encephalopathy.
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4.4.3. Mental confusion
Further difficulty arises with syndromes that cause confusion, e.g., Wernicke-Korsakoff 
syndrome and delirium (Table 4−3). In a given patient, the physician may be challenged 
to distinguish among the possible syndromes and find the true underlying disorder, 
whether it is thiamine or niacin deficiency, alcohol withdrawal, or something else. Stud-
ies report that many patients with delirium tremens also have Wernicke encephalopathy 
table 4−3. Differential diagnosis of confusion, agitation, or drowsiness in patients with alcohol addiction
complications of alcohol abuse
Alcohol intoxication
Alcohol withdrawal: delirium tremens, epilepsy
Hypoglycemia, acidosis*
Electrolyte disorders: hyponatremia, hypomagnesemia
acute or progressive cerebral disorders
Wernicke encephalopathy†
Central pontine myelinolysis
Head injury: subdural hematoma, concussion
Stroke
Intracranial space-occupying process
Hepatic encephalopathy
Serious infections*
Pneumonia, urosepsis, septicemia of unknown origin
acute abdominal conditions
Gastrointestinal bleeding: ulcers, esophageal varices
Portal hypertension, alcoholic hepatitis, cirrhosis
Alcoholic pancreatitis
Peritonitis associated with ascites
Acute mesenteric ischemia, other vascular diseases‡
Decompensation in response to other conditions
Dysregulation in diabetes mellitus, dehydration
Myocardial infarction, heart failure; cardiomyopathy*
Severe chronic obstructive pulmonary disease, emphysema, hypoxia, hypercapnia‡
Malignancy: mouth, throat, lung‡
Delirious state
May accompany all causes listed above
other neuropsychiatric conditions
Korsakoff syndrome†
Dementia
Psychosis, schizophrenia
Personality disorders, e.g., schizotypal, paranoid
Depression and anxiety disorders
other substance dependences or intoxications
Illicit drugs, benzodiazepines
Conditions were collected from medical records of patients admitted to Slingedael Korsakoff Center, Rot-
terdan, the Netherlands. * Possibly caused by or in combination with thiamine deficiency. † Caused by 
thiamine deficiency. ‡ In combination with smoking.
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(McKeon et al, 2008; Thomson et al, 2002). However, it would be more precise to say that 
we assume that a delirium can be an important presenting feature of Wernicke-Korsakoff 
syndrome (Chapter 3 & 5). In alcoholics with self-neglect, delirium may be synonymous 
with active Wernicke encephalopathy, and should be treated as such.
The manifestations of delirious states in Wernicke-Korsakoff syndrome may vary. 
Wyszynski and Wyszynski (2005) reported that most patients show attention disorders; 
however, Caulo et al (2005) found that, like our patient, some patients can maintain their 
attention fairly well. MacDonald et al (2009) presented a video of a patient who had severe 
ophthalmoplegia and prominent gait ataxia, but no apparent neurocognitive changes; 
the authors did not make clear how they had evaluated the patient’s cognitive functions.
Postscript. Park et al (2014) presented a case study of Wernicke encephalopathy as-
sociated with malnutrition and nausea due to a neuroblastoma in a child showing gait 
disturbances, nystagmus, and dizziness, but no changes of his alertness.
4.5. aDEquatE thIaMInE trEatMEnt
4.5.1. timely thiamine treatment
Because Wernicke encephalopathy is potentially life-threatening, patients with sus-
pected disease must be evaluated and managed aggressively (McCormick et al, 2011). 
Even before the diagnosis is confirmed, we recommend starting adequate vitamin 
replacement (Thomson et al, 2002; Thomson & Marshall, 2006a, 2006b; van den Brink & 
Jansen, 2009), alcohol detoxification, alcohol abstinence, and continued assessment of 
developing symptoms.11
4.5.2. recommendations for parenteral thiamine
The multidisciplinary Mental Health Care guideline on alcohol-related disorders (van den 
Brink & Jansen, 2009;12 Table 4−4), initiated by the Dutch Association for Psychiatry, and 
organized by the Dutch Institute for Healthcare Improvement and the Institute of Men-
tal Health and Addiction (Trimbos Institute), recommends immediate treatment with 
parenteral thiamine for alcoholics who present with self-neglect, cognitive impairment, 
and gait disorders or polyneuropathy. When other symptoms, e.g., altered conscious-
ness or eye movement disorders, further raise suspicion of Wernicke encephalopathy, 
van den Brink and Jansen (2009) advise larger doses of thiamine, with treatment dura-
tion depending on the clinical course.
11 Cf., results of the reexamination we did during our visit on the 16th hospital day.
12 Available at www.diliguide.nl/document/1820.
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4.6. concluSIon
In summary, self-neglecting alcoholic patients who are bedridden may have severe 
illness and should be suspected of having Wernicke encephalopathy. If such patients 
exhibit delirium, impaired consciousness, or mobility changes, they should be managed 
as though they have Wernicke encephalopathy, to prevent further neurologic complica-
tions of thiamine deficiency.
table 4−4. Wernicke encephalopathy (WE) Recommendations from guidelines on Alcohol-related disor-
ders: English-language paraphrase from van den Brink and Jansen (2009)
alcohol abusers
at high risk for WE With suspected WE
Diagnosis
Because of atypical presentation, WE is 
difficult to diagnose. Therefore, alcoholic 
patients should be treated immediately if 
they have:
-Self-neglect
-Cognitive impairment
-Gait disturbance
-Polyneuropathy
Significant acute or subacute 
impairment of:
 -Consciousness
 -Cognition
 -Gait
 -Eye motility (nystagmus,
 double vision)
Consider WE in people with serious 
alcohol use disorders who have impaired 
consciousness, cognition, gait, or eye 
motility
treatment
Give vitamins as shown.
Test for and replenish deficiencies of 
sodium, magnesium, and phosphate
for 3−5 days:
Thiamine* 250 mg once/
day IM
 or IV
Vitamin B complex forte†
 once/day PO
Vitamin C 500 mg once/day 
PO
Days 1−3:
Thiamine* 500 mg IV (given 
slowly in 100 mL of normal saline 
solution) three times/day
Vitamin B complex forte† three 
times/day PO
Vitamin C 500 mg three times/
day PO
after Day 3:
If patient improves, switch to 
regimen for patients at high risk
If patient does not improve, stop 
treatment and reconsider the 
diagnosis
* In the Netherlands, thiamine is available in injection fluid 100 mg/mL ampoules of 1 mL. † Vitamin B 
complex forte tablets contain 200% of the daily recommended amounts of vitamins B1, B2, B3, B5, B6, B8, B11, 
and B12.
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abStract
Background. Wernicke encephalopathy (WE) and Korsakoff syndrome are considered 
to be different stages of the same disorder due to thiamine deficiency, which is called 
Wernicke-Korsakoff syndrome (WKS).
The earliest biochemical change is the decrease of α-ketoglutarate-dehydrogenase 
activity (α-KGDH) in astrocytes. According to autopsy-based series, mental status 
changes are present in 82% of WE cases. The objective of the present review is to identify 
possible underlying mechanisms relating the occurrence of delirium to WKS.
Method. Studies involving delirium in Wernicke-Korsakoff syndrome, however, are rare. 
Therefore, first, a search was done for candidate biomarkers of delirium irrespective of 
the clinical setting. Secondly, the results were focused on identification of these bio-
markers in reports on WKS.
Results. In various settings, ten biochemical and/ or genetic biomarkers showed strong 
associations with the occurrence of delirium. For Wernicke-Korsakoff syndrome, three 
of these candidate biomarkers were identified, namely brain tissue cell counts of CD68-
positive cells as a marker of microglial activation, high cerebrospinal fluid lactate levels, 
and MHPG, a metabolite of norepinephrine.
Based on current literature, markers of microglial activation may present an interest-
ing pathoetiological relationship between thiamine deficiency and delirium in WKS.
Conclusion. In WKS cases, changes in astroglia and microglial proliferation were reported. 
The possible loss-of-function mechanisms following thiamine deficiency in WKS are 
proposed to come from microglial activation, resulting in a delirium in the initial phase 
of WKS.
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5.1. IntroDuctIon
5.1.1. Wernicke encephalopathy
Wernicke encephalopathy is an acute neuropsychiatric syndrome due to brain lesions 
caused by high metabolic demands on already depleted intracellular vitamin B1 (thia-
mine) stores (Thomson et al, 2002). This depletion can directly lead to a cellular energy 
deficit, focal acidosis, regional increase in glutamate, and ultimately cell damage and 
death, although in an early phase these deficits may be reversible when restoration of 
thiamine takes place (Thomson et al, 2006a). In thiamine deficiency, the earliest bio-
chemical change is the decrease of α-ketoglutarate-dehydrogenase activity (α-KGDH) 
in astrocytes (Sechi & Serra, 2007). According to autopsy-based series, mental status 
changes are present in 82% of WE cases (Harper et al, 1986). Wernicke encephalopathy 
is a rather common condition in comparison with other neurological disorders (Sechi & 
Serra, 2007). In affluent countries, 90% of the cases of thiamine deficiency are associated 
with alcohol abuse (Thomson et al, 2002). While the classic clinical signs of Wernicke 
encephalopathy are well known, namely ocular motility abnormalities, ataxia of gait and 
mental status changes, many cases of Wernicke encephalopathy remain unrecognized 
because the complete triad of symptoms is present in only 16% of patients with Wernicke 
encephalopathy (Thomson et al, 2002; Harper et al, 1986). Another reason why Wernicke 
encephalopathy may be underdiagnosed is that symptoms can easily be mistaken for 
alcohol withdrawal delirium (Rosenbaum, 2003).
5.1.2. Mental confusion in Wernicke’s
In the literature, the mental phenomenon of Wernicke encephalopathy is sometimes 
described as ‘mental confusion’ without precise definition or description of its features 
in detail. Wyszynski and Wyszynski (2005) described the Wernicke delirium component 
in the encephalopathic phase of thiamine deficiency with reference to a number of rec-
ognizable pathologic states, such as Wernicke encephalopathy, that may be associated 
with the occurrence of delirium (Adams & Victor, 1985a). In DSM-IV-TR terminology, the 
diagnosis is delirium due to thiamine deficiency. According to the diagnostic criteria, 
delirious symptoms tend to fluctuate over the course of the day (American Psychiatric 
Association, 2000) such that relatively lucid periods alternate with episodes of more 
severe symptoms. In most cases of Wernicke encephalopathy, patients show attention 
disorders (Wyszynski & Wyszynski, 2005), although the patients’ attention occasionally 
is relatively well sustained (Caulo al, 2005).
5.1.3. aim of the study
We hypothesize that the recognition of Wernicke encephalopathy may frequently 
be based on the correct recognition of symptoms of delirium in the initial stages of 
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Wernicke-Korsakoff syndrome. The aim of the study is to review the main candidate 
biomarkers of delirium in Wernicke-Korsakoff syndrome and other clinically related con-
ditions as an aid to WKS diagnosis and as a possible clue to its pathogenesis. This review 
may be useful in clinical practice to foster early diagnosis and treatment of Wernicke-
Korsakoff syndrome and other delirious states.
5.2. MEthoD
5.2.1. Search strategy and selection criteria
We conducted searches in PubMed, Cochrane Library, and PsycINFO for articles describ-
ing possible underlying causal mechanisms in delirium and alcohol withdrawal delirium 
(Figure 5−1) from January 1997 to December 2012. We searched for ‘delirium’ (Cochrane 
Library); ‘delirium’ and ‘biomarker/ biomarkers’ (PsycINFO); and by title (Delirium[ti]), 
Delirium[Mesh] terms (‘Delirium’, ‘Alcohol Withdrawal Delirium’, or ‘Delirium, Dementia, 
Amnestic, Cognitive Disorders’), and subheadings/ etiology, immunology, metabolism, 
pathology, physiopathology, or physiology (PubMed). The delirium studies were sum-
marized and categorized by biomarker findings. We statistically identified studies where 
specific biomarkers were strongly associated with delirium. Subsequently, we searched 
for articles by  <  name of marker  >  and (‘Wernicke Encephalopathy’ [Mesh], ‘Korsakoff 
Syndrome’[Mesh] (PubMed); or ‘Wernicke’ (Cochrane Library; PsycINFO)). Studies com-
prising only small patient groups were also included. Application of more stringent 
criteria for selection of studies would compromise the number of biomarkers worthy of 
further consideration and review.
Studies on serum anticholinergic activity in the development of delirium were not 
taken into account, considering the test results of Cox et al (2009) who argued that 
previous research based on serum anticholinergic activity may need re-evaluation.
5.2.2. Statistics
Statistical effect size measures included standardized measures of effect such as odds 
ratios (OR) and effect-size correlations (r). P-values and OR with corresponding 95%-con-
fidence intervals (CI) were copied over from the original articles. Effect-size correlations 
with 95%-CI were calculated from descriptive statistic data, including means and stan-
dard deviations of the two groups (delirious patients versus non-delirious patients), if 
appropriate, and were weighted when the sample sizes were not equal. Associations are 
considered to be ‘positive’ if the mean difference is in the predicted direction, i.e., high 
levels of a substance corresponding with high frequency of delirium. When appropriate, 
‘negative’ associations were described in terms of ‘low’ substance levels, ‘protective’ as-
sociations, or ‘decreased’ risk of delirium. The symbols + and ++ were used to describe 
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moderate and strong relationships with delirium respectively, irrespective of the positive 
or negative direction of the association. Studies presenting weak or no relationship with 
occurring delirium (OR between 0.5 and 2.0) or small magnitudes of group differences 
(r < 0.20, or ηp2 < 0.06) were not included.
 
 
figure 5−1. Flow chart of article selection
a Including substance-induced delirium, substance intoxication delirium, and substance withdrawal de-
lirium, other than alcohol. b Including both medication and nonpharmacologic interventions. c Hypoxia, 
hemoglobin, mean corpuscular volume, blood platelet count, C-reactive protein, glucose, aspartate ami-
notransferase, bilirubin, creatine kinase, electrolyte disorders. d Studies presenting weak or no relationship 
with occurring delirium: odds ratio >0.5 and <2.0, or small magnitudes of group differences (effect-size 
correlation (r) <0.20, or partial eta-squared (ηp2) <0.06) were excluded. e Studies presenting moderate to 
strong relationship with delirium are summarized in Table 5−1. f Studies presenting strong relationship with 
delirium: odds ratio >5.0 (or <0.2), and large effect-size correlation (r) >0.50 (or <-0.50) are summarized in 
‘Result section’.
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5.3. rESultS
5.3.1. Studies selected
Five studies were related to delirium with alcohol withdrawal syndrome; 22 studies 
were related to delirium associated with other conditions (Table  5−1). With regard to 
the strength of the relationship between potential biomarkers and delirium, potential 
markers from nine articles showed strong relationships (++) with delirium, namely 
neuron-specific enolase (NSE) and S100B, catecholamine metabolites [homovanillic acid 
(HVA) and 3-methoxy-4-hydroxyphenyl (ethylene) glycol (MHPG)], lactate in cerebrospi-
nal fluid, and brain tissue cell counts of CD68-positive cells and of human leukocyte 
antigen-DR-positive cells (Grandi et al, 2011; van Munster et al, 2010a; van der Cammen 
et al, 2006; Nakamura et al, 2001; van Munster et al, 2011; Caplan et al, 2010).
Strong ‘protective’ associations with delirium were found in a glucocorticoid recep-
tor type (Manenschijn et al, 2011) and in combined dopamine receptor and serotonin 
transporter types in alcohol withdrawal delirium (Karpyak et al, 2010). Strong opposite 
association were found in serum brain-derived neurotrophic factor (BDNF) in two differ-
ent papers describing, among others, patients admitted to intensive care (Grandi et al, 
2011) and patients suffering from alcohol withdrawal delirium (Huang et al, 2011). We 
did not find a clear explanation for substantial differences in magnitude of BDNF levels 
between the latter two studies.
5.3.2. neuron-specific enolase
Neuron-specific enolase (NSE) is an enolase-isoenzyme that is normally present in 
neuronal and neuroendocrine tissues. Lower levels of cerebrospinal fluid NSE were as-
sociated with occurrence of delirium (Caplan et al, 2010), in contrast with higher levels 
of serum NSE (Grandi et al, 2011). No studies were found that simultaneously measured 
NSE in cerebrospinal fluid and peripheral blood among patients with delirium.
5.3.3. other potential biomarkers
Van Munster et al (2010a) reported higher median levels of S100B in blood samples 
taken after delirium compared with levels in patients during delirium and in patients 
without delirium. No associations were found in S100B levels of delirious patients with-
out dementia versus non-delirious patients with dementia Caplan et al, 2010). Van der 
Cammen et al (2006) found that mean HVA levels were higher in delirious Alzheimer pa-
tients (195.0 ± 101.0 nmol/L) than in age- and gender-matched, non-delirious Alzheimer 
patients (68.3 ± 33.2 nmol/L). In patients undergoing cardiac surgery, Nakamura et al 
(2001) showed that, 1–2 days before operation, plasma levels of MHPG were higher 
in patients suffering from postoperative delirium (10.8 ± 6.6 ng/mL) than in the non-
delirium group (5.3 ± 3.7 ng/mL). Compared with participants with dementia, patients 
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with delirium demonstrated higher cerebrospinal fluid lactate (mean 1.87 ± 0.31 versus 
1.48 ± 0.23 mmol/L) (Caplan et al, 2010).
table 5−1. Biomarkers in pathophysiology of delirium
category Estimatea [95%-cI] № of 
patientsb
reference
candidate risk markersc
- Serum cortisol levels* Three levels, +,
OR=3.1 [1.8–5.4], P<0.001
123/243 (51%) Elective CABG surgery1
- Serum cortisol levels 
after dexamethasone 
suppression test (DST)
Means, mild vs. no delirium 
r=0.25 [0.10–0.39], P=0.006; 
moderate-severe vs. 
no delirium, +, r=0.36 
[0.20–0.49], P=0.01
67/172 (39%) Age <80, demented patients2
- Serum brain-derived 
neurotrophic factor, resp. 
neuron-specific enolase*
Means, +, r=0.41 [0.18–
0.58], resp. ++, r=0.98 
[0.97–0.99], P<0.01
30 delirious vs. 
30 controls
Critically ill patients3
- Low plasma catalase levels Means, +, r=0.31 [0.04–
0.52], P<0.035
12/50 Patients undergoing cardiac 
bypass surgery4
candidate biomarkersd
- Serum cortisol* Three levels, +,
OR=3.4 [1.7–6.8], P=0.001
73/164 (45%) Critically ill patients after 
surgery5
- Log serum S100B protein* +, OR=4.0 [1.9–8.6], P<0.001 62/120 (52%) Age 65+, hip fracture surgery6
- Serum S100B protein* 
levels; highest levels after 
delirium
Median levels during 
delirium, after delirium, 
no delirium, P=0.004; after 
vs. no delirium, ++, r=0.57 
[0.50–0.63]e
126/412 (31%) Age 65+, acutely admitted 
medical patients7
- Low circulating insulin 
growth factor 1 (IGF-1)*
r=0.28 [0.03–0.49], P=0.012 22 with history 
of delirium 
/ 57
Age 70+, admitted to Elderly 
Care Unit8
neurotransmitter precursors
- Low serum tryptophan 
(Trp) levels*
Means, +, r=0.48 [0.24–
0.65], P=0.001
21/49 Age 50+, post-surgery, I.C.9
- Low plasma Trp*
Low Trp / other LNAAs ratio
r=0.24 [0.13–0.34], P=0.005
r=0.22 [0.10–0.32], P=0.017
40/296 
(13.5%)
Age 25+, patients undergoing 
elective cardiac surgery10
neurotransmitter 
metabolites
- Homovanillic acid (HVA) Means, ++, r=0.65 
[0.42–0.78], P<0.05
17 delirious 
vs. 17 non-
delirious
Patients suffering from 
Alzheimer’s disease11
- Plasma 3-methoxy-4-
hydroxyphenyl (ethylene)
glycol (pMHPG)
++, r=0.54 [0.22–0.73], 
P=0.08
11/26 Patients undergoing operation 
for cardiovascular diseases12
Inflammation-related
- Human herpes virus 6 
reactivation
+, OR=2.5 [1.2–5.3], P=0.02 19/111 (17%) Patients undergoing hemato-
poietic cell transplantation13
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table 5−1. Biomarkers in pathophysiology of delirium (continued)
category Estimatea [95%-cI] № of 
patientsb
reference
- Serum interleukin-6 (IL-6)*; 
interleukin-8 (IL-8)
Median levels,
r=0.27 [0.08–0.43]e, P=0.01;
+, r=0.33 [0.14–0.48]e, 
P=0.03
50/98 Age 65+, hip fracture surgery14
- Serum IL-6*; IL-8 Detection level, +,
OR=2.4 [1.03–5.6], P=0.04; 
OR=2.6 [1.06–6.3], P=0.04
64/185 (35%) Age 65+, acutely admitted 
medical patients15
- Plasma neopterin +, OR=3.8 [1.3–11], P=0.02 58 delirious vs. 
67 controls
Age 70+, elective cardiac 
surgery: CABG, valve16
genetics
- Glucocorticoid receptor, 
homozygous BclI-TthIIII 
haplotype
++, protective† association 
with delirium, OR=0.08 
[0.01–0.71], P=0.029
299/807 (37%) Internal Medicine patients and 
(24.7%) hip fracture surgery17
- Dopamine transporter 
gene (solute carrier family 
6, member 3) rs393795 
homozygous AA genotype
+, protective† association 
with delirium,
OR=0.4 [0.2–0.6], P=0.0003
558/1641 
(34%)
Meta-analysis18
- Apolipoprotein E e4 allele*f r=0.21 [0.07–0.34]g 
(P=0.005)
29/190(15%) Age 65+, major non-cardiac 
surgery19
Postmortem brain tissue
- Human leukocyte antigen-
DR resp. CD68 cell counth;
IL-6 immunoreactivity
Mean positive cell count,
++, r=0.82 [0.58–0.91]i resp.
++, r=0.79 [0.52–0.89];
Detection level, P≤0.002
9 cases 
(delirium),
6 controls
Age 60+, 7 cases and 4 controls 
dying with infection20
cerebrospinal fluid
- Interleukin-8 (IL-8) Means, +, r=0.48
[0.40–0.67]i, P=0.03
15/36 Age 60+, hip surgery21
- Lactate;
Protein;
Lower levels of neuron-
specific enolase
Means, ++, r=0.58 [0.34–
0.73], P<0.001; +, r=0.33 
[0.03–0.56], P=0.036;
++, r=0.62 [0.40–0.75], 
P<0.001
20 delirious vs. 
20 Alzheimer’s
Geriatric Medicine unit22
alcohol withdrawal
- Low serum brain-derived 
neurotrophic factor (BDNF)
Delirious vs. non-delirious 
alcoholics, ++, r=0.71 
[0.58–0.79]; P<0.001 (three 
groups including controls)
25; 40; 39 Alcoholic cases, healthy 
controls23
- Combined DRD2 rs6276 
G allele and SLC6A4 LL 
genotype
++, decreased† risk 
of delirium, OR=0.14 
[0.04–0.52], P<0.0001j
112/204 Alcohol-dependency24
- Dopamine transporter gene, 
A9 allele
+, OR=2.5 [1.1–5.8], P=0.03k 34k; 86; 65
20/120 (17%) 
delirious
Alcohol-dependency25
Delirium in WKS 59
5.3.4. Postmortem brain tissue
Expression of CD68 protein on microglia – used as a marker of microglial activation – was 
found higher in a postmortem study of septic patients compared with controls, indi-
cating an enhanced immunological response in human brain tissue during systemic 
inflammatory reaction (Lemstra et al, 2007). Similar differences were observed in the 
postmortem case–control study of delirious patients and non-delirious controls (van 
Munster et al, 2011) regarding markers of microglial activation, including CD68 and 
human leukocyte antigen-DR expression. In this study of van Munster et al (2011), we 
calculated large effect-size measures in delirium associated with brain tissue cell counts 
of CD68-positive cells (r = 0.79, 95%-CI: 0.52–0.89) and human leukocyte antigen-DR-
positive cells (r = 0.82, 95%-CI: 0.58–0.91).
table 5−1. Biomarkers in pathophysiology of delirium (continued)
category Estimatea [95%-cI] № of 
patientsb
reference
- Dopamine transporter gene 
(DAT1); VNTR polymorphism 
in the 3’ untranslated region 
of DAT1, nine-repeat allele
+, OR=2.4 [1.4–4.4], 
P=0.003k
93k; 200; 93
59/293 (20%)
Alcohol-dependency26
- GRIK3 gene (Ser310Ala) 
coding for glutamatergic 
kainate receptor subunit 
GlurR7
r=0.20 [0.07–0.32]l, P=0.008 45/233 (19%)
233 alcoholics 
vs. 309 
controls
Alcohol-dependency27
CABG, coronary artery bypass graft. I.C., Intensive Care unit. LNAAs, large neutral amino acids.
a Statistical association measures and 95%-confidence interval [95%-CI]: * Similar studies presenting weak 
or no relationship with occurring delirium are not depicted. + moderate relationship (medium effect): odds 
ratio (OR) between 2.0 and 5.0 (†or between 0.2 and 0.5), ++ strong relationship (large effect): odds ra-
tio >5.0 (†or <0.2), and effect-size correlation (r): small 0.10, medium 0.30, and large 0.50, using the means 
and standard deviations of two groups (delirious patients, non-delirious patients), when available.
b № of patients: delirious cases / total cases, or case−control matching: delirious cases; non-delirious cases; 
controls. c Risk markers before onset of delirium. d During or after delirium, or during postoperative period 
if applicable. e Effect size correlation (r) based on conversion of data (median, interquartile range) to ap-
proximate mean and standard deviation. f Studies on APOE genotype and duration of delirium, are omitted. 
g Calculated from χ2 and number of subjects in the study. h Markers for microglial activity. i Calculated from 
Z-score and number of subjects in the study. j Corrected for maximum alcoholic drinks/day. k Including alco-
hol withdrawal delirium and/ or seizures. l Calculated from χ2 and number of alcoholic subjects with/ without 
delirium tremens (excluding seizures).
References: 1Mu et al, 2010. 2Robertsson et al, 2001. 3Grandi et al, 2011. 4Karlidag et al, 2006. 5Shi et al, 2010. 
6van Munster et al, 2010b. 7van Munster et al, 2010a. 8Adamis et al, 2007. 9Robinson et al, 2008. 10van der 
Mast et al, 2000. 11van der Cammen et al, 2006. 12Nakamura et al, 2001. 13Zerr et al, 2011. 14van Munster et al, 
2008. 15de Rooij et al, 2007. 16Osse et al, 2012. 17Manenschijn et al, 2011. 18van Munster et al, 2010c. 19Leung 
et al, 2007. 20van Munster et al, 2011. 21MacLullich et al, 2011. 22Caplan et al, 2010. 23Huang et al, 2011. 24Kar-
pyak et al, 2010. 25Gorwood et al, 2003. 26Sander et al, 1997.27Preuss et al, 2006.
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5.3.5. comparison with Wernicke-Korsakoff’s
Subsequently, the focus was directed toward a systematic identification of aforemen-
tioned potential markers in delirium relating to Wernicke-Korsakoff syndrome. Search 
terms13 including < name of marker > in articles on Wernicke-Korsakoff syndrome led to 
search results composed of a much reduced set of items, namely brain tissue cell counts 
of CD68-positive cells in an animal model (Wang & Hazell, 2010) and high cerebrospinal 
fluid lactate levels in six children suffering from Wernicke encephalopathy (Fattal-
Valevski, 2005; Xin et al, 2011). As we were seeking biomarkers for delirium, findings 
of low MHPG concentrations in patients with long-standing Korsakoff’s (Reuster et al, 
2003) and descriptions of cerebrospinal fluid BDNF levels in alcohol-induced dementia 
were not taken into account (Blasko et al, 2006).
5.4. DIScuSSIon
5.4.1. Introduction
Although delirium is a common syndrome, the pathophysiology of delirium remains 
poorly understood and its underlying mechanisms are largely unknown. The aim of the 
present study is to identify possible underlying mechanisms relating the occurrence 
of delirium to Wernicke-Korsakoff syndrome. The ‘Result section’ is initially framed by 
candidate biomarkers of delirium associated with alcohol withdrawal and other condi-
tions. For the cases of Wernicke-Korsakoff syndrome, the selected biomarkers contained 
in the last paragraph of the ‘Result section’ might be of interest. Findings of CD68 as a 
marker of microglial activation are discussed in more detail in § 5.4.2. Increased lactate 
has been reported in thiamine deficiency, presumed secondary to the role of thiamine 
as a cofactor for the pyruvate dehydrogenase complex and α-KGDH (Rodan et al, 2013).
5.4.2. thiamine deficiency and microglial activation
For the most likely mechanisms of action, we would expect metabolic disturbances to 
contribute to the neuronal dysfunction observed in thiamine deficiency. In neuronal 
and glial cells, thiamine is converted to thiamine pyrophosphate, which is necessary for 
several biochemical pathways in the brain. It is well known that the earliest biochemi-
cal change in thiamine deficiency is the decrease in α-KGDH activity in astrocytes. In 
Wernicke-Korsakoff patients, changes in astroglia together with microglial proliferation 
were apparent even in regions of the brain with little if any neuronal cell death (Sechi 
& Serra, 2007). Todd and Butterworth (1999) have identified activated microglia as a 
13 Search terms: Brain-derived neurotrophic factor/ BDNF, CD68, dopamine, glucocorticoid, 
homovanillic acid/ HVA, human leukocyte antigen-DR, cerebrospinal fluid lactate, 3-methoxy-
4-hydroxyphenyl (ethylene)glycol/ MHPG, neuron-specific enolase/ NSE, S100B, serotonin.
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feature of thiamine deficiency, in which levels of CD11b/c (OX-42) and CD68 proteins, 
localized predominantly in these brain cells, were increased in early stages of the disor-
der before the development of neuronal cell death. Wang and Hazell (2010) suggested 
that microglial activation played a role in the development of neurological impairment 
in thiamine deficiency and possibly Wernicke encephalopathy. In their study of a rat 
model, symptoms of thiamine deficiency, among others loss of righting reflex, were 
assessed daily. The rats were killed at the loss of righting reflex stage, and brain tissue 
of three selected areas including vulnerable medial thalamus and inferior colliculus, 
and non-vulnerable frontal cortex, were examined. Expression of CD11b/c and CD68 
mRNA was increased in the vulnerable brain areas in thiamine deficiency, compared 
with control animals. The experimental study of Wang and Hazell (2010) might therefore 
present a potentially interesting link between thiamine deficiency delirium in Wernicke 
encephalopathy and the possible implications of microglial activation in human brain 
diseases.
5.4.3. Some further information on microglia
Microglia are the third type of glial cell, along with astrocytes and oligodendrocytes 
(which together form the macroglia). Microglia vary in appearance depending on 
developmental stage, functional state, and anatomical location; subtype terms include 
ramified, perivascular, amoeboid, resting, and activated. Microglia clearly are capable of 
phagocytosis and play an important role in a wide spectrum of neuropathologies. They 
have also been suggested to act in several roles including in secretion (e.g., of cytokines 
and neural growth factors), in immunological processing (e.g., antigen presentation), 
and in central nervous system development and remodeling (Microglia, MeSH database. 
National Center for Biotechnology Information. www.ncbi.nlm.nih.gov).
5.4.4. Pathogenesis of delirium
Although applying information from animal research to humans should be done with 
caution, many features of the rat/ mouse models of thiamine deficiency closely correlate 
with those seen in Wernicke encephalopathy (Vetreno et al, 2012). However, we don’t 
know whether the biomarkers listed in this review, do provide an objective measure of 
disease pathophysiology in delirious patients. Instead, biomarkers may reflect:
(i) general medical conditions, e.g., systemic infection with a concomitant delirium,
(ii) a general state of arousal occurring during delirium, or
(iii) stable trait characteristics originating from genetic factors, which influence the risk 
of delirium but are not directly involved in the acute process.
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For an overview of brain pathology in thiamine deficient rodent models, the reader is 
advised to consult the Free PubMed Central paper of Vetreno et al (2012). Additional evi-
dence on microglial activation in thiamine deficiency is found in studies of Calingasan 
et al (1999), Ke et al (2005), and Yang et al (2011).
5.5. concluSIon
In patients with Wernicke-Korsakoff syndrome, changes in astroglia together with mi-
croglial proliferation were reported (Sechi & Serra, 2007). According to autopsy-based 
series, mental status changes are present in 82% of Wernicke encephalopathy cases 
(Harper et al, 1986). Delirium is an important feature of Wernicke-Korsakoff syndrome, 
which may be related to microglial activation (Wang & Hazell, 2010) following thiamine 
deficiency.14 Wernicke-Korsakoff syndrome is considered to be an example of delirium-
related cognitive damage, presenting with delirium subsequently progressing to chronic 
cognitive impairment and in many instances irreversible brain damage. The current 
review suggests that15 in self-neglecting alcoholic patients, recognition of delirium is an 
important clinical target in preventing further damage from the neurological complica-
tions of thiamine deficiency.
5.6. StrEngth anD lIMItatIonS
We proposed a change of viewpoint in the diagnosis and therapeutic approach to 
Wernicke encephalopathy that recognizes the initial symptoms of thiamin deficiency 
overlapping with many symptoms of delirium and examines the interrelations between 
both delirium and cognitive deficit in Wernicke-Korsakoff syndrome.
No descriptions are given of how delirium was assessed in the original studies. From 
an etiological point of view, it is very unlikely that a single genetic or biochemical marker 
would account for most of the symptoms in delirious states. Although the biomarkers 
listed may have an association with delirium, evidence for causality is lacking. The review 
is based on limited selection criteria regarding the pathophysiology of delirium and may 
be prone to selection biases lacking data from grey literature or other articles describing 
loss-of-function mechanism in delirium.
14 The effects of thiamine administration on cytokines and inflammatory markers in thiamine 
deficient patients are not yet known.
15 Postscript: “The current review suggests that…”, might be rephrased as: With these results, we 
suggest that…
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5.7. SuggEStIonS for futurE rESEarch
Future research focusing on strategies for the early identification of delirium in 
Wernicke-Korsakoff syndrome and assessment of the temporal progression of delirium 
including quantification of transitional stages and protracted or persistent delirium is 
recommended. Although our findings suggest that Wernicke delirium may represent 
the initial phase of Wernicke-Korsakoff syndrome due to mechanisms of microglial 
activation, extensive confirmation of this mechanism requires further research. In order 
to determine whether mediating factors in microglial activation other than thiamine de-
ficiency, may account for an ineffective treatment of the more severe cases of Wernicke 
encephalopathy, further investigation is warranted.
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abStract
Background. Acute Wernicke encephalopathy can have different clinical outcomes. 
While infections may precipitate the encephalopathy itself, it is unknown if infections 
also modify the long-term outcome in patients developing Korsakoff syndrome.
Aim of the study. To determine whether markers of infection such as white blood cell 
counts and absolute neutrophil counts in the acute Wernicke encephalopathy are asso-
ciated with cognitive outcomes in the end-stage Korsakoff syndrome. We hypothesized 
that systemic infections in the acute Wernicke phase are associated with cognitive 
deficits in patients with Wernicke-Korsakoff syndrome.
Method. Retrospective, descriptive study of patients admitted to the observation de-
partment of Slingedael Korsakoff Center, from February 1, 2012 to March 1, 2014, and 
patients of the residential care departments, at the set date of March 1, 2014. Hospital 
discharge letters of patients with an acute Wernicke encephalopathy were searched for 
relevant data on infections present upon hospital admission. Patients were selected 
for further analysis if the onset of the Wernicke-Korsakoff syndrome was clearly docu-
mented and if data were available on white blood cell counts in the acute phase and at 
least one of six predefined neuropsychological tests on follow-up.
Results. Infections were reported in 35/68 (51%; 95%-confidence interval: 41−62%) 
patients during the acute phase of WKS: meningitis (1), pneumonia (14), urinary tract 
infections (9), acute abdominal infections (4), sepsis (5) and/ or empyema (1), and infec-
tion ‘of unknown origin’ (4).
The neuropsychological test results showed significant lower scores on the Cambridge 
Cognitive Examination (CAMCOG) non-memory section with increasing white blood cell 
counts (Spearman’s rank correlation, Rho = -0.34; 95%-CI: -0.57−-0.06; 44 patients) and 
on the ‘Key search test’ of the Behavioral Assessment of the Dysexecutive Syndrome 
(BADS) with increasing absolute neutrophil counts (Rho  =  -0.85; 95%-CI: -0.97−-0.42; 
nine patients).
Conclusion. Infections may be the presenting manifestation of thiamine deficiency. 
Wernicke-Korsakoff patients who suffered from an infection during the acute phase are 
at risk of worse neuropsychological outcomes on follow-up.
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6.1. IntroDuctIon
6.1.1. Wernicke-Korsakoff syndrome
Acute Wernicke encephalopathy can have different clinical outcomes: full recovery, 
various degrees of cognitive deficits, coma, or death. Mortality in the acute phase is 
mostly attributable to sepsis frequently originating from the lungs, liver cirrhosis, and 
the effects of irreversible thiamine deficiency (Adams & Victor, 1985b). If the acute phase 
of Wernicke encephalopathy is followed by chronic cognitive impairments of Korsakoff 
syndrome a Wernicke-Korsakoff syndrome can be diagnosed (Joyce & Robbins, 1991; 
Kopelman et al, 2009; Thomson et al, 2002; van Oort & Kessels, 2009). It is already well 
known that executive dysfunction, as well as memory dysfunction, is an important clini-
cal feature of the Korsakoff syndrome (Kessels et al, 2008; Kopelman et al, 2009).
6.1.2. Infections and thiamine deficiency
Recent literature suggests a complex interrelationship between infections and thiamine 
deficiency. Critically ill patients may present with thiamine deficiency or develop this 
deficiency during their acute illness (Donnino et al, 2010). Systemic infection is often re-
vealed by or associated with brain dysfunction (Adam et al, 2013; Young, 2010; Schwalm 
et al, 2014) and Wernicke encephalopathy is one of the main differential diagnoses of 
infection-related encephalopathy (Adam et al, 2013).
In thiamine deficiency, infections may be both a presenting symptom and a com-
plicating factor. According to pediatric literature, infections can be a heralding sign of 
severe thiamine deficiency, as shown in infants with thiamine deficiency presenting 
with infections and lactic acidosis (Fattal-Valevski et al, 2005; Xin et al, 2011). Having 
an infection, moreover, can increase the utilization of thiamine and may precipitate 
Wernicke encephalopathy in patients with marginal thiamine reserves (Donnino et al, 
2007; World Health Organization, 1999).
Although many studies described the transition of Wernicke encephalopathy to Kor-
sakoff syndrome (Harper et al, 1986; Kopelman et al, 2009; Sechi & Serra, 2007; Thomson 
& Marshall, 2006a), the possible role of systemic infections in this transition is not clear.
6.1.3. aim of the study
Based on the relation between thiamine deficiency and infections, we hypothesized 
that infections may be associated with the severity of cognitive deficits in WKS patients 
(Figure  6−1; van Gool et al, 2010; Wang & Hazell, 2010). The research questions were: 
How common were infections in the initial phase of Wernicke-Korsakoff syndrome? 
Were white blood cell (WBC) counts and absolute neutrophil counts (ANCs) related to 
the cognitive outcomes?
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6.2. MEthoD
6.2.1. Study design and subjects
In this retrospective, descriptive cohort study, we included patients admitted to Slinge-
dael Korsakoff Center. From February 1, 2012 to March 1, 2014, 64 patients admitted 
to the observation department were evaluated for inclusion and 96 patients of the 
residential care departments at the set date of March 1, 2014. Inclusion criteria for the 
present analysis were: a diagnosis of Wernicke-Korsakoff syndrome with complete data 
on white blood count during the preceding acute phase and availability of predefined 
neuropsychological test results during follow-up, including cognitive screening tests 
and/ or more extensive neurocognitive tests. Data collection involved the patients’ 
age, sex, body mass index, and alcohol use. Laboratory results consisted of routine 
biochemical and hematological testing from the previous hospital setting. Developing 
WKS symptoms were categorized as: ‘vomiting’ (Moulin et al, 2014), ‘drowsiness’ (Fei et 
al, 2008), ‘confusion’, ‘walking disability’, or ‘collapse’ if the patient was found on the floor. 
Reasons of exclusion from the present analysis are summarized in Figure 6−2.
 
figure 6−1. Interdependency of infections and Wernicke-Korsakoff syndrome
a Microglial cells of the brain. Wang and Hazell (2011) observed induction of microglial activity in their 
thiamine deficient rodent model. Based on an hypothesis of van Gool et al (2011) systemic infections may 
cause microglial hyperactivity leading to a delirium. b Delirium due to thiamine deficiency = Wernicke en-
cephalopathy. c Electrolyte disorders, alcohol withdrawal, hepatic failure, renal failure, brain injury, etcetera. 
d Neurocognitive disorder due to thiamine deficiency = Korsakoff syndrome.
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6.2.2. Infection diagnoses
In this study, ‘infections’ refer to diagnoses listed in the patients’ hospital discharge letters. 
We reviewed these letters for diagnoses of inflammatory diseases (e.g., inflammation of 
the lungs/ pneumonia, urinary tract infections) that were present upon admission in 
the acute phase, according to the reports on the diagnostic work-up including blood 
tests, chest films, bacterial cultures, or any other information. We extracted data on body 
temperature, heart rate, and/ or blood pressure, if available.
6.2.3. neuropsychological tests
Psychological test scores were obtained from neuropsychological tests that were ad-
ministered in the post-acute phase after hospital discharge and at least six weeks of 
alcohol abstinence. We recorded the results of six predefined tests, including Cambridge 
Cognitive Examination (CAMCOG; Roth et al, 1992), Mini-Mental State Examination 
(MMSE; Folstein et al, 1975), Cognitive Screening Test (CST; de Graaf & Deelman, 1991), 
Behavioral Assessment of the Dysexecutive Syndrome (BADS; Maharasingam et al, 2013), 
Trail Making Test A&B (TMT; Schmand et al, 2004), and Verbal fluency test, if available. 
Because of the different aspects of cognition, we chose to separately examine subtest 
scores of the Cambridge Cognitive Examination (CAMCOG) and of the Behavioral As-
sessment of the Dysexecutive Syndrome (BADS).
 
  
  
  
  
  
  
  
  
  
  
  
  
 
figure 6−2. Flow chart of patient selection
WKS, Wernicke-Korsakoff syndrome. CAMCOG, Cambridge Cognitive Examination; MMSE, Mini-Mental 
State Examination; CST, Cognitive Screening Test; BADS, Behavioral Assessment of the Dysexecutive Syn-
drome; TMT, Trail Making Test A&B. a Dementia (9 patients), acquired brain injury (3), hepatic encephalopa-
thy (1), minimal or atypical cognitive symptoms (1), other (4). b No clear starting point of the mental symp-
toms: No data (24 patients), a single episode of Wernicke encephalopathy or Korsakoff syndrome lacking 
details (10), intermittent episodes of Wernicke encephalopathy with current episode of Korsakoff syndrome 
(9), gradual deterioration over time (4).
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6.2.4. Statistical tests
The unpaired Student’s t-test was used to compare laboratory results of patients with 
and without infections. Associations between white blood cell count and cognitive 
scores were explored with plots and Spearman’s Rho coefficients with 95%-confidence 
intervals (95%-CI). The statistical analyses were conducted with SPSS, version 21.
6.3. rESultS
6.3.1. Patient characteristics
Patient characteristics are shown in Table  6−1. All patients had at least two or more 
symptoms according to the DSM-5 diagnostic criteria of alcohol use disorder (American 
Psychiatric Association, 2013, p. 490−491). Malnutrition was recorded in 55/68 patients. 
table 6−1. Patients referred to Slingedael Korsakoff Center
characteristics № (%) Mean (SD)
Age (year)
 Male 132 59 (8)
 Female 28 (18%) 58 (9)
BMI (kg/m2)
 Male 119a 23.1 (4.1)
 Female 25a 23.0 (5.4)
Alcohol use (mL/d)b
 Male 69c 240 (170)
 Female 16c 200 (103)
Prior diagnostic settingd
 Inpatient, general hospital 99 (62%)
 Inpatient, mental health care 26 (16%)
 Outpatient, ambulatory 32 (20%)
 Missing data 3 (2%)
Referred to Slingedael bye
 General hospital 62 (39%)
 Mental health caref 61 (38%)
 Otherg 37 (23%)
№, number of patients. a Missing data in the other male/ female patients. b Quantity of pure alcohol (mL/d): 
beer 250 mL = 12.5 mL pure alcohol, wine 100 mL = 12 mL pure alcohol, liquor 35 mL = 12.25 mL pure alco-
hol. c Unspecified as ‘alcohol abuse’ in the other patients. d Diagnostic setting, in which Korsakoff syndrome 
was diagnosed or strongly suggested. e Following hospitalization, patients may have been admitted to a 
care facility elsewhere or discharged home, before being referred to Slingedael Korsakoff Center. f Psychi-
atric hospital, psychiatric department, alcohol clinic, ambulatory mental health care. g Nursing home, GP, 
homeless shelter, and other.
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The WKS symptoms developed within median 3.5 days (interquartile range [IQR] 1−14 
days) before hospital admission. Symptoms were vomiting in 6/68 (9%) patients, drowsi-
ness in 12 patients (18%), confusion in 48 patients (71%), walking disability in 19 (30%), 
and/ or collapse in 8 (12%).
6.3.2. Infections and laboratory results
Infections were present in 35/68 (51%; 95%-confidence interval: 41−62%) patients dur-
ing the initial phase of WKS. No focus was found in 4/35 patients. The main sites of the 
infections are given in Table 6−2. In 2/35 patients the infections occurred after the first 
week of hospital admission.
In routine biochemical and hematological testing no statistically significant differ-
ences were found between patients with and without infections, except for differences 
of infection parameters. However, clinically relevant laboratory abnormalities were seen 
in both groups, e.g., anemia, electrolyte disorders, renal dysfunction, liver dysfunction, 
and vitamin deficiencies (Table 6−3).
6.3.3. neuropsychological test scores
The time period between laboratory assessment in the acute phase of WKS and neu-
ropsychological assessment in the chronic phase of WKS was median 4.5 months (IQR 
2.5−8 months). CAMCOG total scores were available in 45/68 patients, CAMCOG non-
memory scores in 44/68 patients, MMSE scores in 60/68 patients; the other numbers 
are given in Table 6−4. Overall, the correlation coefficient calculated from white blood 
cell (WBC) counts and neuropsychological test scores was negative, indicating more 
impairments on follow-up with increasing white blood cell counts in the acute phase, 
for almost all cognitive test scores (Table 6−4).
The correlation was statistically significant for the non-memory section of the Cam-
bridge Cognitive Examination (CAMCOG) (Rho = -0.34; 95%-CI: -0.57−-0.06; 44 patients). 
Rho calculated from absolute neutrophil counts (ANCs) and neuropsychological test 
scores was significant for the ‘Key search test’ of the BADS (Rho = -0.85; 95%-CI: -0.99− 
-0.44; 9 patients, Figure 6−3).
table 6−2. Infection diagnosis in patients referred to Slingedael Korsakoff Center
•	 	Pneumonia	(14/35	patients)	complicated	by	or	in	combination	with	empyema	(1	patient),	sepsis	(1),	
urinary tract infections (1), meningitis/ double sided pneumonia (1), recurrent pneumonia (1)
•	 Urinary	tract	infections	(8/35)	complicated	by	sepsis	(2),	possible	pneumonia	(1)
•	 Acute	abdominal	infections	(4/35):	peritonitis	(2),	pancreatitis	(1),	enteritis	(1:	Norovirus)
•	 Sepsis	of	unknown	origin	(2/35)
•	 Infection	of	unknown	origin	(4/35)
•	 Other	(3/35):	Esophagitis	(1),	skin/	wound	infections	(2).
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6.3.4. other measurements
There were no significant differences between patients with and without infections 
for body temperature, heart rate, or blood pressure, although in both groups clinical 
relevant abnormalities were found − the initial body temperature was 85.6−101.1 °F, 
heart rate 70−126 beats/minute and systolic blood pressure 89−175 mmHg, as far as 
described in the hospital discharges letters (< 30 patients).
table 6−3. Laboratory results subdivided by initial infection status
results, mean (SD) № With infectiona № Without 
infection
reference 
value
P valueb
WBC count, /μL 35 13200 (5200) 33 9400 (2700) 3500−10000 <0.001
ANC, /μL 8 11200 (4300) 10 5100 (2400) 1500−8000 0.002
CRP, mg/L 23 58 (55) 19 20 (35) <10 0.014
ESR, mm/h 13 62 (37) 13 28 (24) <20 0.011
Hb, g/dL 26 13.9 (3.1) 27 13.6 (2.1) 14−17.5 0.73
Creatinine, mg/dL 23 1.2 (0.75) 26 0.9 (0.41) 0.6−1.2 0.08
MDRD, mL/min/1.73m2 23 92 (55) 26 106 (38) >90 0.32
Sodium, mEq/L 25 137 (7) 26 134 (10) 136−145 0.40
Potassium, mEq/L 25 3.9 (0.8) 26 4.0 (0.7) 3.5−5.1 0.46
Albumin, g/dL 20 3.3 (0.9) 12 3.8 (0.6) 3.5−5.0 0.071
AST, U/L 23 77 (63) 22 80 (86) <30 0.80c
GGT, U/L 22 189 (179) 24 171 (195) <35 0.82c
Vitamin B1, μg/dLd 7 1.7 (1.3) 10 2.2 (1.0) 2.4−4.7 0.41
25(OH)D, ng/mL 4 5 (3) 8 11 (10) 20−60 0.27
BAC, ‰ 10 <0.1 (0.06) 9 <0.5 (1.1) <0.1 0.28
№, number of patients. WBC, white blood cell; ANC, absolute neutrophil count; CRP, C-reactive protein; 
ESR, erythrocyte sedimentation rate; Hb, hemoglobin; MDRD, estimate of glomerular filtration rate (eGFR) 
based on Modification of Diet in Renal Disease Study; AST, aspartate transaminase; GGT, gamma-glutamyl 
transpeptidase, 25(OH)D, 25-hydroxyvitamin D; BAC, blood alcohol concentrations. a Infections occurred in 
35/68 (51%; 95%-CI: 41−62%) patients. b Student’s t-test P values of laboratory results are based on results 
of patients with and without infections. c P value based on 10log of results (right skewed distribution of 
laboratory results). d 1 μg/dL = 10 ng/mL.
SI conversion factors: To convert Hb to Fe mmol/L, multiply values by 0.6206; to convert creatinine to 
μmol/L, multiply values by 88.4; to convert vitamin B1 to nmol/L, multiply values by 29.6; to convert 25(OH)
vitamin D to nmol/L multiply values by 2.496.
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6.4. DIScuSSIon
6.4.1. Infections in Wernicke-Korsakoff syndrome
In the acute phase of the alcohol-related Wernicke-Korsakoff syndrome, serious infec-
tions were present in our patient group.16 In the end-stage Korsakoff syndrome, almost 
all neuropsychological test results were consistently worse in subjects who had experi-
enced an infection at presentation. This association was significant for lower outcomes 
of the CAMCOG non-memory section with increasing white blood cell (WBC) counts, 
and of the ‘Key search test’ of the BADS with increasing absolute neutrophil counts 
(ANCs). Thus, differences in neuropsychological test scores were mainly observed in 
only two non-memory subtests of the six preselected neuropsychological tests. These 
results might give some indication that delirium and comorbid infections are associ-
ated with worse cognitive outcomes in Wernicke-Korsakoff syndrome.17Although these 
preliminary results should be interpreted with great caution, we suggest that possible 
16 ‘Infections’ refer to diagnoses listed in the patients’ hospital discharge letters.
17 In dementia, the contribution of infection-related delirium to cognitive outcomes is not 
well known either. Risk markers for delirium, including biomarkers such as cytokines and 
proteomics, are being examined in the SAGES study (Schmitt EM, Marcantonio ER, Alsop 
DC, Jones RN, Rogers SO Jr, Fong TG, Metzger E, Inouye SK; SAGES Study Group. 2012. Novel 
table 6−4. Neuropsychological test scores subdivided by initial infection statusa
results, mean (SD) № With 
infection
№ Without 
infection
reference 
value
rhob 95%-cI
CAMCOG total score 28 74.8 (10.5) 17 76.1 (9.6) 76−105 -0.17 -0.44−0.12
 Non-memory section 27 53.1 (6.1) 17 57.2 (8.3) -0.34 -0.57−-0.06*
MMSE 33 21.9 (4.8) 27 21.8 (3.8) 24−30 -0.05 -0.29−0.20
CST-20 9 13.1 (3.3) 14 11.8 (4.9) 16−20 -0.05 -0.44−0.32
BADS total score 17 12.4 (3.3) 13 12.2 (4.2) 13−24 -0.20 -0.57−0.22
 BADS Key search test 20 1.4 (1.4) 17 2.0 (1.4) -0.26 -0.55−0.08
TMT A, percentile 20 15 (17) 25 11 (23) >8 -0.04 -0.33−0.27
TMT Bc, percentile 19 18 (24) 25 12 (22) >8 0.05 -0.26−0.33
Verbal fluency testd 26 14.8 (6) 28 16.5 (7) >14 -0.23 -0.49−0.05
№, number of patients. CI, Confidence interval. * P  <0.05. CAMCOG, Cambridge Cognitive Examination; 
MMSE, Mini-Mental State Examination; CST, Cognitive Screening Test; BADS, Behavioral Assessment of the 
Dysexecutive Syndrome consisting of six subtests; TMT, Trail Making Test A&B. a Infections occurred in 35/68 
(51%; 95%-CI: 41−62%) patients. b Spearman’s rank correlation coefficient (Rho) was calculated from white 
blood cell (WBC) counts and neuropsychological test scores, with 95%-confidence intervals. Interpreta-
tion of strength of correlations: 0−0.15 very weak, 0.15−0.25 weak, 0.25−0.40 moderate, 0.40−0.75 strong, 
0.75−1 very strong. Negative coefficients reflect negative correlations, i.e., when test scores tend to de-
crease as WBC counts increase. c Ceased in 8/44 patients, resulting in 0 percentile score. d Category fluency 
test, naming animals in one minute.
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cognitive effects of systemic inflammation in Wernicke-Korsakoff syndrome can be 
interpreted in terms of a differential vulnerability of brain areas involved in executive 
functioning and those involved in memory function.
6.4.2. thiamine deficiency and sepsis
Sepsis was reported in five of the 35 patients with infection. Initial low body tempera-
ture was observed both in patients with and without infections. This can probably be 
explained by previous observations that thiamine deficiency and sepsis both may pres-
ent as hypothermia. However, hypothermia in thiamine deficiency might be masked by 
infections, in other cases (Hansen et al, 1984). Remarkably, infection ‘of unknown origin’ 
was reported in 4/35 patients. We wondered whether these cases might reflect unidenti-
fied sepsis of unknown origin?
6.4.3. recent literature on thiamine deficiency and sepsis
Thiamine deficiency may be highly prevalent in septic patients as described in a study 
of serum thiamine, oxidative stress, and hospital mortality in adult patients with septic 
shock (Costa et al, 2014).18 Of these patients, 77/108 (71%) had thiamine deficiency, de-
fined as serum thiamine concentrations of < 16 ng/mL (reference range 16−48 ng/mL). 
Serum thiamine levels were not associated with the hospital mortality − although other 
risk markers and long-term outcomes of delirium: the successful aging after elective surgery 
(SAGES) study design and methods. J Am Med Dir Assoc. 13:818.e1−10).
18 Oxidative stress; a disturbance in the prooxidant-antioxidant balance in favor of the former, 
leading to potential damage. Indicators of oxidative stress include damaged DNA bases, 
protein oxidation products, and lipid peroxidation products.
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studies of critical illness in adults and children have shown that absolute or relative thia-
mine depletion was associated with an almost 50% increase in mortality (Manzanares 
& Hardy, 2011). Also, serum thiamine levels were not associated with protein carbonyl 
concentrations of serum samples, as markers of oxidative stress or protein damage.19 In 
another study, 6/30 (20%) of septic patients had absolute thiamine deficiency, defined 
as serum thiamine concentrations of ≤ 9 nmol/L (Donnino et al, 2010). Three of these 
patients had absolute thiamine deficiency upon presentation and three patients devel-
oped absolute thiamine deficiency within 72 hours; with thiamine levels measured at 
intervals of 24 hours. None of 30 control patients (0/30, 0%) showed absolute thiamine 
deficiency.
In a mouse model of sepsis, de Andrade et al (2014) concluded that thiamine deficient 
food (TD) was associated with oxidative stress and inflammatory response changes. The 
septic condition included cecal ligation and puncture (CLP) thus exposing the abdomi-
nal cavity to fecal contamination. Total white blood cell counts and absolute neutrophil 
counts were the highest in the septic condition (CLP) with thiamine deficient food, but 
differences were significant for mononuclear cell counts. Interleukin-6 (IL-6) blood levels 
tended to be higher in CLP. Higher liver 4-hydroxy 2-nonenal (4-HNE; C9H16O2) levels 
were associated with oxidative stress in TD.
6.5. StrEngth anD lIMItatIonS
We provided the first direct indication that systemic infections in the acute Wernicke 
phase might be associated with the long-term cognitive deficits in Wernicke-Korsakoff 
syndrome. The observations of this study may bring more awareness to the relationship 
between infections and thiamine deficiency and contribute to improving early diagnosis 
and treatment of Wernicke-Korsakoff syndrome.
The present study has several limitations. First, our data were collected retrospectively 
and this may have affected the quality of the data in some respects. Selection bias may 
have been introduced by diagnostic conclusions relying on limited data that were re-
trieved from the patients’ hospital discharge letters, rather than from their full medical 
files. There were limited data regarding a complete set of relevant parameters of infec-
tion. Metabolic acidosis was not documented, while thiamine deficiency and sepsis may 
be associated with various degrees of acidosis (Andersen et al, 2013; Donnino, 2010; 
Fattal-Valevski et al, 2005; Xin et al, 2011).
19 Protein carbonylation; the appearance of carbonyl groups, such as aldehyde or ketone groups, 
in proteins as the result of several oxidative modification reactions. It is a standard marker for 
oxidative stress.
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Secondly, possible covariates of white blood cell counts, e.g. smoking, amount of 
stress, or thiamine deficiency itself, were not taken into account. It is not yet clear to 
what extent elevated white blood cell counts do reflect the presence of infections in 
Wernicke-Korsakoff syndrome in those cases where no infections were found.
Furthermore, no corrections were made for the effect on cognitive outcomes of fac-
tors like education or age. Due to lack of detailed data, no analysis could be made of 
the severity of thiamine deficiency, severity of infections and subsequent inflammation, 
critical illness, or number of Intensive Care admissions.
6.6. concluSIonS
In the literature there is limited information available regarding the incidence of infec-
tions in the initial stages of Wernicke-Korsakoff syndrome or the effects of inflammation 
on the ultimate Korsakoff syndrome.20, 21 Infections can be a heralding sign of severe 
thiamine deficiency and Wernicke encephalopathy.22 Patients who suffered from an 
infection during the acute phase of Wernicke-Korsakoff syndrome are at risk of worse 
neuropsychological outcomes.
6.7. SuggEStIonS for futurE rESEarch
The interrelationship of infections and thiamine depletion may represent a relevant area 
for further research in critically ill patients (Manzanares & Hardy, 2011; Ramsi et al, 2014). 
20 Infection: Invasion of the body by microorganisms that can cause pathological conditions or 
diseases.
21 Inflammation: A pathological process characterized by injury or destruction of tissues caused 
by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of 
pain, heat, redness, swelling, and loss of function (MeSH database; www.ncbi.nlm.nih.gov).
22 Post-hoc analysis. In this Chapter, we described the association between infections and thia-
mine deficiency in patients with Wernicke-Korsakoff syndrome without going into detail on 
the frequency of delirium. Although delirium may more frequently occur during infections, a 
post-hoc analysis of the data of the study shows no striking difference between the number 
of delirious patients with and without infections:
table. Delirium and infection in 160 patients
№ Infection
yes no n/a
Delirium yes 36 32 6
no or n/a 26 31 29
№, number of patients. N/A, not mentioned.
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Early and adequate thiamine supplementation could be helpful to self-neglecting alco-
holic patients presenting with infections, confusion, drowsiness, or walking disability. 
The effects of thiamine administration on infection parameters, including cytokines 
and inflammatory markers in thiamine deficient patients are not yet known and may be 
subject to future research.
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abStract
Background. Excessive intake of alcohol is often associated with low or subnormal levels 
of vitamin D even in the absence of active liver disease. As vitamin D deficiency is a 
well-recognized cause of myopathy, alcoholic myopathy might be related to vitamin D 
deficiency. Chronic alcoholic myopathy affects approximately half of chronic alcoholics 
and is characterized by the insidious development of muscular weakness and wasting. 
Although alcohol or its metabolites may have a direct toxic effect on muscles, the rela-
tionship between alcoholic myopathy and vitamin D deficiency has not been examined 
extensively.
Method. We reviewed articles on alcoholic myopathy and hypovitaminosis D myopathy 
and compared the pathophysiological findings to designate possible mechanisms of 
vitamin D action in alcohol-related myopathy.
Results and Conclusion. Given the strong interdependency of suboptimal levels of 
vitamin D, phosphate, and magnesium in chronic alcohol abuse, we hypothesize that 
combined deficiencies interfere with membrane and intracellular metabolic processes 
in alcohol-related chronic myopathy; however it is not yet possible to define exact 
mechanisms of interaction.
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7.1. IntroDuctIon
7.1.1. alcohol-related myopathy
Alcohol may cause either a life-threatening, acute myopathy, or a subacute to chronic 
myopathy (Slavin et al, 1983). The acute form probably results from a direct toxic effect 
of ethanol, acetaldehyde, or other ethanol metabolites. The chronic syndrome is char-
acterized by an insidious development of muscular weakness and wasting (Diamond & 
Messing, 1994; Preedy & Peters, 1994; Slavin et al, 1983). Most of the literature examining 
the effect of alcohol abuse and vitamin D has been in alcohol-related osteopenia and 
osteoporosis, but vitamin D status in patients with muscle weakness associated with 
alcoholism is scarcely reported and sometimes even contradictory. In an earlier study 
by Hickish et al (1989), muscle weakness in male alcoholic patients appeared to be not 
significantly related to vitamin D deficiency. In a murine model of alcoholic myopathy, 
González-Reimers et al (2010) found that low vitamin D levels were related to muscle 
fiber atrophy, and altered levels of muscle antioxidant enzymes could play a role in 
alcoholic myopathy.
7.1.2. aim of the review
We compared literature on ‘alcoholic myopathy’ and ‘hypovitaminosis D myopathy’ in 
order to designate possible mechanisms of vitamin D action in chronic, alcohol-related 
myopathy.
7.2. SEarch StratEgy anD SElEctIon crItErIa
We conducted a search in PubMed for articles from January, 1985 to September, 2011. 
We used the search terms: alcohol + myopathy (or sarcopenia, muscle weakness[MeSH], 
muscle strength[MeSH], falls), and vitamin D + myopathy (or sarcopenia, muscle 
weakness[MeSH], muscle strength[MeSH], falls) and identified English articles related 
to alcoholic myopathy or hypovitaminosis D myopathy on basis of titles and abstracts. 
Studies on vitamin D deficiency in alcoholism were found with combinations of the 
key words [MeSH]: alcoholism, alcohol drinking, vitamin D, and vitamin D deficiency. 
Additional articles were identified by means of reference lists. Studies involving animal 
case histories, and cardiac or smooth muscles, but not skeletal muscles, were excluded.
The concentrations of 25-hydroxyvitamin D (25(OH)D) were defined as insufficient 
when less than 50 nmol/L (1 nmol/L 25(OH)D = 0.4 ng/mL), deficient when less than 25 
nmol/L, and severely deficient when less than 12.5 nmol/L (Bang et al, 2009).
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7.3. alcoholIc MyoPathy
7.3.1. acute alcoholic myopathy
Acute alcoholic myopathy can develop after several days of heavy binge drinking (Dia-
mond & Messing, 1994) or may occur in chronic alcoholics after a period of particularly 
high intake. Repeated ethanol administration to human volunteers for 28 days caused 
muscle damage despite adequate nutrition (Song & Rubin, 1972). The acute syndrome 
is characterized by localized or generalized muscular aching and tenderness (Hewitt & 
Winter, 1995), which is often accompanied by muscle cramps. Weakness is present, but 
may be difficult to demonstrate because of pain; other features include edema of the 
muscles and subcutaneous tissues. Massive rhabdomyolysis causes metabolic acidosis 
and hyperkalemia and can produce myoglobinuria, acute renal failure, and disseminated 
intravascular coagulation (Diamond & Messing, 1994; Hewitt & Winter, 1995; Preedy 
& Peters, 1994). The development of a complicating compartment syndrome may be 
delayed for several days after the initial insult to muscle (Hewitt & Winter, 1995). Recov-
ery of acute myopathy usually occurs within days to weeks of abstinence, but residual 
weakness in proximal muscles may remain (Diamond & Messing, 1994).
7.3.2. chronic alcoholic myopathy
The chronic syndrome affects 40–60% of alcoholics (Preedy et al, 2003) and is clinically 
characterized by muscular weakness and wasting (Diamond & Messing, 1994; Slavin et 
al, 1983), either diffuse, or localized to proximal muscles especially of the pelvic girdle 
and thighs (Preedy & Peters, 1994). Other common presenting features are frequent falls, 
difficulties in gait, and muscle cramps. Sometimes pain or tenderness of the proximal 
muscles occurs (Slavin et al, 1983).
Histologically a decreased diameter of type II muscle fibers (i.e., fast twitch fibers with 
predominantly anaerobic glycolytic metabolism) is observed. Type IIb fibers, which 
have no or scarce mitochondria, were more affected than the type IIa fibers (Preedy & 
Peters, 1994; Slavin et al, 1983). The ultrastructural changes in muscle fibers included 
intracellular edema, enlarged and distorted mitochondria, dilatation of sarcoplasmic 
reticulum, excess of glycogen, and lipid deposits containing triglyceride subjacent to 
the cell membrane and between muscle fibers (Slavin et al, 1983).
In contrast, the mitochondrial-rich type I fibers (i.e., slow twitch fibers with aerobic or 
oxidative metabolism) are less sensitive and, at least in the early stages, show a compen-
satory hypertrophy (Trounce et al, 1987). Atrophy of type I and type IIa fibers, which also 
use aerobic mitochondrial respiration, only occurred in the most severe cases and to a 
lesser degree (Slavin et al, 1983). In some patients muscle biopsies are normal or show 
minimal changes. Fiber necrosis or inflammatory cellular infiltration is not seen.
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Improvement of chronic myopathy usually takes at least 2–3 months (Diamond & 
Messing, 1994) up to 6–9 months after abstinence (Preedy & Peters, 1994; Slavin et al, 
1983).
7.3.3. Mechanisms in chronic alcoholic myopathy
Patients drinking more than 80–100 g alcohol/day for longer than three years may de-
velop muscle atrophy (Slavin et al, 1983). When ethanol becomes the main source of en-
ergy, the low protein content of alcoholic beverages may lead to nitrogen malnutrition, 
as reflected by low serum urea nitrogen levels. In chronic alcoholism protein breakdown 
exceeded the rate of muscle protein synthesis (Lang et al, 2005), thus compromising the 
sources of muscle protein and inducing loss of muscle mass.
Further details on the biochemical mechanisms in disturbances of protein metabolism 
were described in a review by Preedy et al (2001). Evidence for increased oxidative stress 
by free radicals in alcohol-exposed skeletal muscle was inconsistent (Preedy et al, 1999; 
2002).23, 24
The predominant atrophy of type IIb fibers suggests that an alcohol-induced effect 
on carbohydrate metabolism in muscle fibers plays a role (Diamond & Messing, 1994; 
Slavin et al, 1983). However, the glycolytic pathway tends to be reduced in a variety of 
myopathies (Preedy et al, 1999) and not exclusively in relationship with alcohol abuse.
Several studies of electrolytes in muscles of chronic alcoholic patients and in alcohol-fed 
animals showed depletion of electrolytes such as magnesium, potassium, and phos-
phate (Flink, 1980). Chronic phosphate deficiency has been known to cause subclinical 
myopathy, and acute hypophosphatemia can lead to proximal myopathy, generalized 
weakness, and rhabdomyolysis (Berkelhammer & Bear, 1984). Hypokalemia is com-
mon in chronic alcoholism and may be associated with myopathy, but its role in the 
development of alcoholic myopathy is uncertain (Flink, 1980). Hypokalemia, decreased 
intracellular potassium content, and renal potassium wasting are frequently found in 
magnesium deficiency. Impaired activity of Na/K-ATPase induced by hypomagnesemia 
23 Although various studies presented molecular and cellular events in alcohol-induced muscle 
disease, the mechanism of how alcohol produces chronic myopathy remains elusive. A recent 
review focused on the etiology by which alcohol perturbs the skeletal muscle protein balance 
and thereby over time produces muscle wasting and weakness (Steiner & Lang, 2015).
24 Does zinc deficiency play a role in the oxidative stress in alcoholic myopathy? In a rodent 
model of alcoholic myopathy, muscle atrophy was mainly due to alcohol and protein mal-
nutrition. Muscle atrophy was associated with increased lipid peroxidation; either with or 
without zinc supplementation, in form of zinc sulphate (Durán Castellón et al, 2005).
 In comparison, low zinc concentrations were asscociated with oxidative damage and inflam-
mation in other conditions, e.g., critically ill patients with sepsis (Mertens et al, 2015).
84 CHAPTER 7
would be the cause of these disturbances (Pitts & van Thiel, 1986). Clinically, restoration 
of potassium cannot be accomplished unless the magnesium deficiency is also corrected 
(Pall et al, 1987). Furthermore, magnesium deficiency may cause a state of hypocalcemia 
due to hypoparathyroidism that is resistant to the action of vitamin D or calcium supple-
ments even in substantial doses (Pall et al, 1987; Pitts & van Thiel, 1986). Under these 
circumstances, supplementation with magnesium corrects the hypocalcemia without 
the need for calcium supplementation (Pall et al, 1987).
Earlier literature mentioned that features of muscle atrophy in alcoholism would be 
caused by alcoholic polyneuropathy (Mills et al, 1986), but alternatively coexistent pe-
ripheral neuropathy may contribute to muscle atrophy, without a direct causal relation 
(Diamond & Messing, 1994).
Previous reviews of alcoholic myopathy suggested that muscular atrophy in alcoholics 
was not primarily related to the patient’s nutritional status, or deficiencies of one or 
more of B vitamins (Preedy & Peters, 1994).
7.4. alcoholISM anD IMPaIrED vItaMIn D StatuS
The low serum 25(OH)D concentrations in alcoholic patients were discussed by Pitts 
and van Thiel (1986), describing 14 studies concerning 215 alcoholic patients. Mean 
serum 25(OH)D levels of 40 nmol/L were found in cirrhotic alcoholics, and 62 nmol/L 
in non-cirrhotic alcoholics. In the general population, the prevalence of serum 25(OH)D 
concentrations below 25 nmol/L, ranged from 7.9% [95%-CI: 7.3–8.5] to 16.4% [95%-CI: 
15.3–17.5] in two different cohorts of 7,437 persons with a mean age of 45 year (Hyp-
pönen & Power, 2007), and of 4,030 persons aged 18–79 year (Hintzpeter et al, 2008). 
Studies presenting more detailed data on the prevalence of vitamin D deficiency in 
alcoholic patients are summarized in Table 7−1. In a group of 89 cirrhotic alcoholics, 55% 
[95%-CI: 45–65] of all patients had 25(OH)D concentrations below 25 nmol/L (Malham et 
al 2011). In a recent cohort of 21 male alcoholics living in municipal homeless shelters, 
we found a mean 25(OH)D concentration of 27.9 nmol/L and a median concentration of 
17 nmol/L at baseline. Of these alcoholics, 17/21 (81%) [95%-CI: 64–97] had concentra-
tions below 25 nmol/L, and 8/21 (38%) [95%-CI: 18–58] had concentrations below 12.5 
nmol/L, indicating severe vitamin D deficiency (Nieuwenhuis, unpublished data).
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7.5. hyPovItaMInoSIS D MyoPathy
7.5.1. Previous literature
Early clinical descriptions of a myopathy associated with severe vitamin D deficiency rec-
ognized a potential association between vitamin D and muscles (Ceglia, 2009). Myopa-
thy has been described in severe vitamin D deficiency responsible for rickets in children 
and osteomalacia in adults. Traditionally, it was felt that this myopathic presentation 
was secondary to osteomalacia and inactivity, rather than a direct effect of vitamin D 
on muscles (Hamilton, 2010). The direct association between vitamin D deficiency and 
myopathy was based on findings of vitamin D receptors (VDR) present in human muscle 
tissue (Bischoff et al, 2001), and by VDR knockout mice (Endo et al, 2003). Biopsies of 
skeletal muscle in adults with vitamin D deficiency have shown predominantly muscle 
fiber atrophy of the fast twitch type II fibers (Boland, 1986), fibrosis, enlarged interfibril-
lar spaces and infiltration of fat, and glycogen granules (Yoshikawa et al, 1979), with 
no signs of inflammatory reactions. Vitamin D supplementation restored muscle tissue 
(Annweiler et al, 2010) and was associated with an increase of mean diameter and per-
centages of type II fibers (Ceglia, 2009).
VDR null mutant mice (Bouillon et al, 2008) show growth retardation, osteomalacia, 
diffuse muscle fiber loss (differing from the human hypovitaminosis D myopathy with 
a predominance of type II fiber loss), and metabolic changes such as secondary hyper-
parathyroidism and hypocalcemia (Ceglia, 2009).
table 7−1. Prevalence of vitamin D deficiency in alcoholic patients
Studies
Malham
et al, 2011
bang
et al, 2009
Kim
et al, 2003
bjørneboe 
et al, 1986
hyppönen 
et al, 2010
abnet
et al, 2010
№ of alcoholic 
patients
89 13 18 12 N/A N/A
Details
Cirrhotic 
patients
N/A N/A
Vitamin D 
intakea
General 
population
General 
population
Alcohol abuse Unspecified Unspecified
Mean 98 g/
dayb
Unspecified
>21 drinks/
wk
>14g/dayb
Mean or median 
25(OH)D (nmol/L)
Median 24 Mean 31 Median 54 Mean 56 N/A N/A
25(OH)D <25c
or <30d nmol/L,
№ of patients (%)
49/89
(55%)c
5/13d 3/18c None
63/590
 (10.7%)a,c
122/512
(23.8%)a,c
25(OH)D <12.5 
nmol/Le,
№ of patients (%)
16/89
(18%)
4/13 N/A None N/A N/A
a Not significantly different from controls or non-drinker. b One alcoholic drink is 8–14 g ethanol. c 25(OH)
D <25 nmol/L, vitamin D deficiency. d 25(OH) <30 nmol/L. e 25(OH)D <12.5 nmol/L, severe vitamin D defi-
ciency. N/A, No further details.
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7.5.2. clinical findings
Myopathy associated with vitamin D deficient osteomalacia is presenting predomi-
nantly as a proximal muscle weakness, muscle wasting, and difficulty in walking upstairs 
(Hamilton, 2010). Apart from severe cases, hypovitaminosis D myopathy is generally un-
derdiagnosed because of the non-specific symptoms and signs (Annweiler et al, 2010). 
The first observed symptoms often are muscle weakness and musculoskeletal pain. 
Generally, the pain is symmetrical and starts in the lower back then spreads to the pelvis, 
upper legs, and ribs. It is felt mainly in the bones; not in the joints (de Torrenté de la Jara 
et al, 2004). Muscle weakness can exist during deficiency without biochemical signs of 
bone involvement (Glerup et al, 2000). The course of myopathic symptoms varied, usu-
ally improving within three months (de Torrenté de la Jara et al, 2004), or lasting six to 
twelve months (Annweiler et al, 2010), mainly depending upon baseline serum 25(OH)D 
levels and dosage of subsequent vitamin D treatment.
7.5.3. vitamin D deficiency
Normal serum 25(OH)D levels proved to be necessary for maintaining adequate muscle 
function in a group of 55 vitamin D-deficient women (Glerup et al, 2000). Serum 25(OH)
D concentrations below 50 nmol/L were associated with poorer physical performance 
in 1,234 persons aged 65 year and older in the Longitudinal Aging Study Amsterdam 
(Wicherts et al, 2007), and concentrations below 25 nmol/L were associated with an 
increased risk of falling in the same study.
The required serum 25(OH)D concentration is defined by the Institute of Medicine 
(IOM) as higher than 50 nmol/L (Ross et al, 2011). Others have defined the optimal 
serum 25(OH)D concentration as ≥ 75 nmol/L (Sievenpiper et al, 2008). Even though a 
traditional reference range of mean ± two standard deviations is difficult to determine, 
because serum 25(OH)D varies with season and geography, concentrations below 20 
nmol/L indicated severe deficiency (Compston, 1998; de Torrenté de la Jara et al, 2004). 
To prevent increased bone turnover, serum 25(OH)D should be higher than 40 nmol/L 
according to Kuchuk et al (2009), whereas physical performance increased up to 25(OH)D 
levels of 60 nmol/L in the Longitudinal Aging Study Amsterdam including 1,319 persons 
aged 65 or older. Concentrations of at least 50 nmol/L were needed to prevent second-
ary hyperparathyroidism and low bone mineral density in other studies (Malabanan et 
al, 1998).
Various authors recommend a daily vitamin D intake of 800–1,000 IU (50–62.5 nmol; 
20–25 μg) for benefits in health (Compston, 1998; Vieth, 1999). The report on dietary 
requirements for calcium and vitamin D from the Institute of Medicine recommends 600 
IU/day of vitamin D for adults, and 800 IU/dag for > 70 years old persons, corresponding 
to a serum 25(OH)D concentration of at least 50 nmol/L based on the requirements for 
bone health in ≥ 97.5% of the population (Ross et al, 2011; www.iom.edu).
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7.5.4. Mechanisms in vitamin D-related myopathy
The etiology of the myopathy is multifactorial and attributed to secondary hyperpara-
thyroidism, hypocalcemia, hypophosphatemia, and vitamin D deficiency itself (Holick, 
2006; Pfeifer et al, 2002). Studies in rodents have demonstrated that parathyroid 
hormone induces muscle catabolism (Garber, 1983), and reduces calcium transport, 
intracellular phosphate, creatinine phosphokinase, mitochondrial oxygen consumption 
and oxidation of long-chain fatty acids in skeletal muscles (Annweiler et al, 2010).
Research on the vitamin D receptor (VDR) suggested the existence of lower muscle 
strength in different single nucleotide polymorphisms of the VDR gene and differences 
of responders and non-responders to vitamin D (Annweiler et al, 2010). The biologi-
cally active form of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)2D) is critical for the 
regulation of calcium and phosphate levels that in turn support mineralization and 
neuromuscular activity (Wang & DeLuca, 2011). In addition to the nuclear 1,25(OH)2D 
receptor (VDR), a less clearly defined cell membrane receptor has been reported (Ceglia, 
2009) that mediates the rapid non-genomic actions. The genomic pathway of vitamin 
D action in muscle involves genomic control (Ceglia, 2009) to regulate the synthesis of 
proteins responsible for multiple phenomena such as calcium influx into the cell (de 
Boland & Boland, 1985), membrane phosphate transport, phospholipids metabolism 
(Drittanti et al, 1988), and muscle fiber proliferation and differentiation (Wu et al, 2000). 
Rapid responses to 1,25(OH)2D are mediated by a membrane-bound vitamin D receptor, 
through second-messenger pathways that influence calcium transport and regulate 
intracellular calcium (Ceglia, 2008). According to other investigations, however, iden-
tification of tissues expressing VDR has been controversial (Wang et al, 2010) due to 
false-positive results in detecting specific vitamin D receptors in muscle tissue. Wang & 
DeLuca (2011) therefore suggested that underlying mechanisms of vitamin D action in 
muscles are either of an indirect nature or do not involve the known receptor.
Finally, vitamin D may act on the peripheral nervous system, since a reduction of nerve 
conduction velocity has been reported in cases of severe vitamin D insufficiency (Skaria 
et al, 1975).
7.6. vItaMIn D anD chronIc alcoholIc MyoPathy
7.6.1. vitamin D, alcoholism, and myopathy
Although alcoholics in the general population may have normal serum 25(OH)D concen-
trations (Abnet et al, 2010; Hyppönen et al, 2010), in clinical and outpatient ambulatory 
settings the majority had subnormal levels even in the absence of active liver disease 
(Bang et al, 2009; Pitts & van Thiel, 1986). Articles specifically addressing vitamin D in 
relation to myopathy in alcoholism are rare. Previous studies suggested that changes 
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in alcoholic muscle disease were not due to dietary deficiencies, but effects of severe 
vitamin D deficiency in alcoholic myopathy have not been extensively examined. Low 
1,25-dihydroxyvitamin D (1,25(OH)2D) levels were related to reduced handgrip strength 
and reduced lean mass in a study performed on 90 alcoholics (González-Reimers et al, 
2011). Hickish et al (1989) concluded that muscle weakness in 41 male alcoholics was 
not significantly related to vitamin D deficiency. For serum 25(OH)D concentrations, 
which had a highly skewed distribution, a transformation of data was used in statistical 
analysis. However, in smaller patient groups 25(OH)D distributions frequently appeared 
right-skewed, corresponding with fewer high values in the right tail of the distribution 
(Figure 7−1) and median < mean values.
Serum 25(OH)D concentrations were below 12.5 nmol/L and maximum voluntary con-
tractions (MVC) of the dominant quadriceps ranging from 70–390 newtons (N) in 10/41 
(24%) of the alcoholic patients. The quadriceps MVC of controls ranged from 310–800 
newtons (Hickish et al, 1989).
The causes of 25(OH)D deficiencies in alcoholics may include reduced hepatic 25-hy-
droxylase activity, lack of sun exposure, inadequate dietary intake, and malabsorption. 
Low vitamin D activity may contribute significantly to the calcium and phosphate 
deficiencies observed in chronic alcoholism. In a female rat model, Shankar et al (2008) 
showed that there was a reduction in 1,25(OH)2D due altered metabolism in possible re-
lation with ethanol-induced oxidative damage. Alcohol-related osteoporosis responded 
well to vitamin D therapy (Pitts & van Thiel, 1986). Likewise, chronic alcoholic myopathy 
might be treated by vitamin D therapy, but a clear understanding of the exact role of 
vitamin D in alcoholic myopathy is currently lacking. Vitamin D appears to be impor-
tant for normal skeletal muscle development and optimal muscle strength (Pfeifer et 
al, 2002), and this may imply a protective role of vitamin D in alcoholic myopathy (cf., 
vitamin D and nervous system (Annweiler et al, 2010)).
7.6.2. overlap and difference
Similarities between hypovitaminosis D myopathy and chronic alcoholic myopathy 
were found in:
(i) clinical descriptions of predominantly proximal myopathy,
(ii) morphological descriptions of muscle fiber atrophy, lower protein content, and ac-
cumulation of glycogen and lipid deposits, and
(iii) were also found in suggested pathological mechanisms comprising free radicals or 
muscle antioxidant enzymes.
Finally, (iv) in both conditions comorbidity of polyneuropathy was observed.
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Similarities between hypovitaminosis D myopathy and alcoholic myopathy suggest 
an association between the two, but this does not prove a causal relationship of vitamin 
D deficiency in alcoholic myopathy. The association of vitamin D deficiency and alcohol-
ism with type II fiber atrophy may be non-specifically related to a similar final pathway of 
disease occurring in various metabolic myopathies (Slavin et al, 1983).
Differences between hypovitaminosis D myopathy and chronic alcoholic myopathy were 
found in multiple deficiencies in alcoholic myopathy, such as magnesium, phosphate 
and thiamine deficiencies. Given the strong interdependency of suboptimal levels of 
vitamin D, phosphate, and magnesium in chronic alcohol abuse, combined deficiencies 
may possibly interfere with membrane and intracellular metabolic processes in chronic 
alcohol-related myopathy; however, it is difficult to identify exact mechanisms of action.
7.7. concluSIon
Vitamin D supplementation may possibly be an effective target in prevention and 
treatment of alcoholic myopathy. However, the underlying mechanisms remain unclear. 
Further research is needed to determine if vitamin D supplementation additionally  
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figure 7−1. Distribution of vitamin D status in alcoholics and controls
Example of right-skewed distribution of vitamin D concentrations in 74 alcoholic patients (pooled data 
from: Bjørneboe et al, 1986; Hickish et al, 1989; Nieuwenhuis), and 1,066 controls: median age 61 year, 
male 73% / female 27%, serum 25(OH)D concentration median 39.1 nmol/L, interquartile range 25.8–56.7 
nmol/L, season of blood draw: winter 52% / summer 48% (Abnet et al, 2010). Areas under curves represent 
100% of cases. Lowest serum 25(OH)D concentrations are unspecified <7 nmol/L.
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can improve muscle function in alcoholic myopathy if alcohol is stopped, and if so, to 
estimate optimal vitamin D dosages for treatment and prevention of alcohol-related 
myopathy.
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abStract
Background. Decreased bioavailability of vitamins may be due to inadequate dietary 
sources, lower intestinal absorption and/ or liver dysfunction. Muscular weakness and 
wasting is frequently found in chronic alcoholism and might be related to severe vitamin 
D hypovitaminosis.
Design, Setting and Participants. Participants are community-dwelling adults with a 
history of alcohol use and who are at risk of multiple vitamin deficiencies. Participants 
with vitamin D deficiencies of  <50 nmol/L serum 25-hydroxyvitamin D (25(OH)D) are 
randomly allocated to one of two different strategies of vitamin D supplementation. The 
Vitamin D Intensive Outreach (VIDIO) program includes a cholecalciferol loading dose, 
if applicable, and subsequent bimonthly high-dose cholecalciferol through an outreach 
approach of the Street Doctor Service in Rotterdam, the Netherlands. Care As Usual 
(CAU) includes daily prescriptions of cholecalciferol 800 IU, available in combination 
with calcium carbonate, and depending on medication compliance of the participants. 
The VIDIO intervention is based upon general principles to enhance medication compli-
ance for successful treatment, disease prevention, and health promotion, by means of a 
simple medication regime in one-on-one patient contacts.
Primary outcomes are serum 25(OH)D concentrations. Secondary outcomes include 
the participants’ quadriceps maximal voluntary contractions, gait and balance abilities, 
results of cognitive screening, and a health-related quality of life evaluation. Prevalences 
of vitamin D and B1 deficiencies will be described.
Discussion. Mediating variables of vitamin D status are identified by assessing baseline 
characteristics, liver function and other laboratory findings, help-seeking behavior, 
social support, and service engagement. Comparison between the two strategies of 
vitamin D therapy and serum 25(OH)D levels provides insight in the effectiveness of the 
intervention. Progress in muscle strength in the VIDIO intervention reflects an effect of 
vitamin D. Possible associations between results of cognitive screening and vitamin D or 
B1 deficiencies are discussed.
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8.1. bacKgrounD
8.1.1. vitamin deficiencies
Alcoholics often develop multiple nutritional deficiencies due to inadequate food intake 
and because alcohol abuse interferes with the absorption and utilization of several key 
nutrients. The classic signs of vitamin deficiency only occur in states of extreme deple-
tion and are unreliable indicators for early treatment or prophylaxis of alcoholic patients 
at risk (Thomson, 2000). The potential health consequences from severe vitamin B1 
(thiamine) deficiency are well described in recommendations concerning diagnosis and 
management of vitamin B1 deficiency in alcoholism (Thomson et al, 2002; van den Brink 
& Jansen, 2009). Other common vitamin deficiencies are in vitamins B6, folic acid, and 
vitamin C (Devgun et al, 1981; Glória et al, 1997). Alcohol abuse may also lead to low 
serum vitamin D concentrations (Bang et al, 2009; Malham et al, 2011), but estimation 
of deficiency prevalence in alcoholics is strongly dependent on the population selected 
to participate in a study. In chronic alcohol abuse, alcohol-related muscle weakness is 
associated with suboptimal levels of serum vitamin D (Glerup et al, 2000; Latham et al, 
2003, Wicherts et al, 2007), and possibly phosphate and magnesium (Pall et al, 1987; 
Pitts & van Thiel, 1986). Reports on vitamin D status in alcohol-related myopathy are, 
however, scarce and sometimes even contradictory (Hickish et al, 1989).
8.1.2. aim of the study
The aims of this study are to observe the effectiveness of oral vitamin D supplementation 
on vitamin D status and muscle performance in vitamin D-deficient alcoholics during 
two different vitamin D treatment strategies (Figure 8−1) including bimonthly dosages 
(VIDIO) and care according to standard practice (CAU). The VIDIO intervention is based 
upon general principles to enhance medication compliance for successful treatment, 
disease prevention, and health promotion, by means of a simple medication regime in 
one-on-one patient contacts.
Hypothesis. Regarding the aims of the study, it is hypothesized that vitamin D supple-
mentation may be more effective on vitamin D status and muscle performance when 
given through VIDIO, rather than CAU depending upon medication prescriptions and 
medication compliance of the participants.
8.2. MEthoD
8.2.1. Design
This is a randomized controlled trial using two different vitamin D treatment strategies 
in participants with vitamin D deficiencies of < 50 nmol/L serum 25-hydroxyvitamin D 
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(25(OH)D) and a history of alcohol use. Blood tests are done before vitamin D therapy is 
started.
 
 
figure 8−1. Flow diagram of subject progress through the phases of the study
VIDIO, Vitamin D Intensive Outreach. CAU, Care As Usual. a Immediate initiation of parenteral vitamin B1 
(thiamine) treatment is advised in cases as a high risk or serious suspicion of Wernicke encephalopathy has 
been identified.
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Group 1. VIDIO intervention. This group consists of vitamin D-deficient participants who 
are treated with (bimonthly) high-dose oral cholecalciferol for 12 months, after an initial 
loading dose according to Table 8−1. They are assigned to two members of the Street 
Doctor team of the Rotterdam-Rijnmond Public Health Service (GGD, www.ggdrotter-
damrijnmond.nl). Both professionals, registered nurse and elderly care physician (KGN), 
are experienced workers in providing primary health care to marginalized people in 
municipal homeless shelters in Rotterdam since 2001.
Group 2. Care As Usual. The participants in this group receive prescriptions of Calci 
Chew D3 ‘500/800’ tablets (containing 500 mg calcium carbonate and 800 IU cholecalcif-
erol) by the elderly care physician (KGN) of the Street Doctor team.
The concentrations of serum 25(OH)D are defined as insufficient when less than 50 
nmol/L (25 nmol/L 25(OH)D = 10 ng/mL), deficient when less than 25 nmol/L, and se-
verely deficient when less than 12.5 nmol/L (Bang et al, 2009).
Primary outcomes are serum 25(OH)D concentrations. Secondary outcomes include 
the participants’ quadriceps maximal voluntary contractions, gait and balance abilities, 
results of cognitive screening, and a health-related quality of life evaluation.
8.2.2. Participants/ Setting
Participants in the study are community-dwelling adult persons with a history of alcohol 
use and are selected from previous contacts with the Street Doctor Service/ Rotterdam-
Rijnmond Public Health Service (GGD), in Rotterdam, the Netherlands. Candidate 
participants are visited by the Street Doctor and receive information about the research 
goals and randomized treatments.
Inclusion criteria are having a history of alcohol use and currently living in Rotterdam 
and vicinity. Exclusion criteria are knee surgery, first year after hip surgery, pregnancy/
lactating or trying to conceive, inability to give informed consent because of mental 
incapacity, insufficient command of the Dutch language, already having vitamin D 
prescriptions for treatment of osteoporosis or hypovitaminosis D myopathy, and con-
traindications of Calci Chew D3 or cholecalciferol (Health Care Insurance Board (CVZ) 
Netherlands: Farmacotherapeutic Compass: Medical Farmacotherapeutic Information, 
www.fk.cvz.nl): hypercalcemia, renal failure (glomerular filtration rate  <  30 mL/min 
per 1.73m2), history of sarcoidosis, lymphomas, hyperparathyroidism, nephrolithiasis/ 
calciuria, and soya or peanut allergy.
8.2.3. Procedure
After providing written informed consent, the Street Doctor discusses the further proce-
dure with the participant and collects information in the baseline interview, preferable 
in the same session. The Street Doctor will notify regular GP of patient’s participation in 
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the study. The blood tests (Table 8−2) are scheduled within two weeks after the baseline 
interview. Laboratory results are sent to both Street Doctor and GP. In case of serum 
25(OH)D concentrations < 50 nmol/L participants are randomized either to VIDIO or CAU 
(Figure 8−1). GP’s are notified of the randomization outcome. Naturally, participation is 
on a purely voluntary basis. The protocol is not binding, because a clinician may devi-
ate from the content if strictly necessary for the treatment of the patient. Participants 
receive €10 with every laboratory and muscle strength testing (a total of €60).
8.2.4. Definition of the interventions
Group 1. Vitamin D Intensive Outreach: VIDIO
Vitamin D-deficient/ insufficient participants ( 25(OH)D  <  50 nmol/L ) randomized to 
VIDIO will be treated with high-dose vitamin D supplementation consisting of a chole-
calciferol loading dose, if applicable (see Table 8−1), and subsequent maintenance dose. 
The cholecalciferol is dispensed as watery solution (cholecalciferol 50,000 IU  =  1 mL) 
according to a formulation of the Dutch Pharmacists Association (van Groningen et al, 
2010). A cholecalciferol loading dose of total 2–4 mL is modified from: dose (IU) = 40 * 
( 75 – serum 25(OH)D at baseline ) * body weight (kg). This equation of van Groningen 
et al (2010) should not be used in subjects weighing  >  125 kg and is here truncated 
to 4 mL = 200,000 IU. Cholecalciferol maintenance doses are 600 IU/kg once a month, 
based on a further study of de Boer et al (unpublished data) in visitors of the Outpatient 
Internal Medicine Clinic.
Holick (2007) described maintenance doses of 800–1,000 IU of cholecalciferol per day 
or 50,000 IU every two weeks or every month for vitamin D inadequacy in adults. Even 
higher doses may be considered in case of decreased bioavailability, including malab-
sorption of vitamin D or obesity. Physicians should use these guidelines in combination 
with their clinical judgment according to the circumstances. For practical reasons, the 
VIDIO intervention uses bimonthly maintenance doses of 100,000 IU cholecalciferol, 
rather than 50,000 IU/month. It has been demonstrated that single doses of cholecal-
ciferol 50,000 or 100,000 IU are safe and effective (Ilahi et al, 2008; van Groningen et al, 
2010).
Group 2. Care As Usual: CAU
Vitamin D-deficient/ insufficient participants ( 25(OH)D  <  50 nmol/L ) randomized to 
CAU receive prescriptions of Calci Chew D3 ‘500/800’ tablets (containing 500 mg calcium 
carbonate and 800 IU cholecalciferol) by the elderly care physician of the Street Doctor 
team.
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8.2.5. follow-up
After 6 and 12 months of supplementation, participants in both vitamin D supplemen-
tation groups undergo retests, summarized in Table 8−3, and reassessment of alcohol 
use, medication currently taken concerning (other) vitamin D preparations, various B 
vitamins, calcium medication, and benzodiazepines. If serum 25(OH)D levels are > 125 
nmol/L, cholecalciferol maintenance strategies will be adjusted to half of the dose (e.g., 
50,000 IU bimonthly instead of 100,000 IU bimonthly) or will be discontinued in case of 
25(OH)D levels > 200 nmol/L. For safety purposes the toxicity level of 375 nmol/L = 150 
ng/mL is used (Holick, 2007), although others reported toxicity usually doesn’t occur 
until 25(OH)D > 600 nmol/L (Hathcock et al, 2007).
8.2.6. Effect of interventions
In the analysis phase, the following impact evaluations will be made: Firstly, effects of 
VIDIO will be compared to CAU, regarding restoration of vitamin D deficiencies. The de-
gree of effectiveness of the VIDIO intervention is evaluated by comparing serum 25(OH)
table 8−1. Cholecalciferol doses related to participants’ weight and baseline serum 25(OH)D
Serum 25(oh)D 
baseline
body 
weighta
cholecalciferolb doses (ml) in Month 1–12c
Month 1 Month 2 Month 3 Month 4 Month 5 Month 6
<12.5 nmol/l
48–59 kg 1.5 mld 1 mld - 1 mL - 1 mL
59–70 kg 1.5 ml 1.5 ml - 1.5 mL - 1.5 mL
70–81 kg 2 ml 1.5 ml - 1.7 mL - 1.7 mL
81–93 kg 2 ml 2 ml - 2 mL - 2 mL
93–120 kge 2 ml 2 ml - 2 mL - 2 mL
12.5–25 nmol/l
48–59 kg 1 ml 1 ml - 1 mL - 1 mL
59–70 kg 1.5 ml 1 ml - 1.5 mL - 1.5 mL
70–81 kg 1.5 ml 1.5 ml - 1.7 mL - 1.7 mL
81–93 kg 1.5 ml 1.5 ml - 2 mL - 2 mL
93–106 kg 2 ml 1.5 ml - 2 mL - 2 mL
106–120 kge 2 ml 2 ml - 2 mL - 2 mL
25–50 nmol/l
48–59 kg 1 mL - 1 mL - 1 mL -
59–70 kg 1.5 mL - 1.5 mL - 1.5 mL -
70–81 kg 1.7 mL - 1.7 mL - 1.7 mL -
81–93 kg 2 mL - 2 mL - 2 mL -
93–120 kge 2 mL - 2 mL - 2 mL -
<50 nmol/l <48 kg 0.5 mL 0.5 mL 0.5 mL 0.5 mL 0.5 mL 0.5 mL
25(OH)D, 25-hydroxyvitamin D. a Body weight limits are chosen on weight distribution for Dutch males and 
females aged 31–60+ (Delft University of Technology: DINED Anthropometric Database, www.dined.nl). 
b Dutch registered Aqueous: 50,000 IU per mL. c Bimonthly maintenance doses: Month 7 & 9 & 11 equal to 
Month 5; Month 8 & 10 & 12 equal to Month 6; - = None. d Bold text = cholecalciferol loading dose of total 
2–4 mL. Target 25(OH)D level = 75 nmol/L. e Doses calculations >2 mL are truncated to 2 mL.
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D levels in VIDIO at T1 to levels achieved in CAU at T1 (see Figure 8−1). Secondly, possible 
beneficial effects of vitamin D on muscle performance are reviewed. Vitamin D action 
on muscle strength may be shown by differences in the participants’ muscle strength 
at VIDIO T1 compared to VIDIO T0. Improvements in muscle strength in the VIDIO group 
reflect an effect of vitamin D. Calculations will also be done for the 12-month (T2) follow-
up period.
table 8−2. Blood tests at baseline, besides 25-hydroxyvitamin D
test reference rangesa remarks
Hemoglobin ♂ 8.5–11 mmol/L
♀ 7.5–10 mmol/L
Anemia?
Cell indices: MCV 80–100 fL Macrocytic anemia?
Trombocytes 150–370 x 109/L Trombopenia in alcoholism?
ALT ♂ <45; ♀<34 U/L Liver dysfunction?
AST ♂ <35; ♀<31 U/L Liver dysfunction?
GGT ♂ <55; ♀<38 U/L Liver dysfunction?
Albumin 35–50 g/L Malnutrition? Liver dysfunction?
CDT <1.6%b Chronic alcohol abuse?
Vitamin B1 70–140 nmol/L Deficiency?
Vitamin B2 200–360 nmol/L Malnutrition? Myopathy?
Vitamin B12 145–637 pmol/L Malnutrition? Liver dysfunction?
Folic acid 8–28 nmol/L Malnutrition? Liver dysfunction?
Magnesium 0.70–1.05 mmol/L Malnutrition?
Phosphate 0.9–1.5 mmol/L Malnutrition?
CK ♂ <171; ♀<145 U/L Acute alcoholic myopathy?
Urea 2.5–7.5 mmol/L Protein deficiency? Muscle atrophia?
Creatinine ♂ 65–115 μmol/L
♀ 55–90 μmol/L
Renal dysfunction (MDRDc)?
Sodium 136–145 mmol/L Hyponatremia?
Potassium 3.5–5.5 mmol/L Hypokalemia? Muscle weakness?
Calcium 2.2–2.65 mmol/L Hypocalcemia?
TSH 0.4–4.3 mU/L Myopathy? Cognitive impairment?
Glucose 4.0–6.1 mmol/L Metabolic dysregulation?
MCV, Mean corpuscular erythrocyte volume. ALT, Alanine transaminase. AST, Aspartate transaminase. 
GGT, Gamma-glutamyl transpeptidase. CDT, Carbohydrate-deficient transferrin. CK, Creatine kinase. TSH, 
Thyroid-stimulating hormone. Malnutrition: and/ or Malabsorption. a Erasmus MC, Rotterdam: Table. Se-
lected Laboratory Tests (www.erasmusmc.nl/akc/Patientenzorg/Professionals/labgids/3295019/). b Society 
for Clinical Chemistry and Laboratory Medicine (NVKC) Netherlands (www.uwbloedserieus.nl/cdt.php). c 
MDRD, Modification of Diet in Renal Disease Study equation to estimate glomerular filtration rate (eGFR; 
Levey et al, 1999).
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8.2.7. Dissemination of information
Results of the blood test are sent to both GP and Street Doctor. Allocated vitamin D 
strategies are known to GP and Street Doctor. All data are included in the electronic 
record of the study by two members of the research group (JWW, supervised by AIW), 
except for the allocated vitamin D supplementation strategies (separate files included 
by AIW).
8.3. MEaSurEMEntS
8.3.1. baseline variables
Data on age and sex are collected from the patients’ records. Symptoms of alcohol abuse 
or alcohol dependence are classified according to DSM-5 criteria (American Psychiatric 
Association, 2013, p. 490−491). Furthermore, participants are interviewed about drug 
use and psychiatric history. Other baseline variables are given in Table 8−4.
table 8−3. Measurements at three research contacts
baseline 6 months 12 months
Serum albumin X X X
Vitamin D and B1 X X X
Serum calcium and phosphate X X X
Serum creatinine X X X
Other blood testsa X
Medication assessmentb X X X
Average alcohol use X X X
MVC quadricepsc X X X
POMAc X X X
EQ-5Dd X X X
SESd X
ASR; section Social Supportd X
SSMd X
MoCAd X X X
№ of direct patient contactse X X
MVC, Maximal Voluntary Contraction. POMA, Tinetti Performance Oriented Mobility Assessment. EQ-5D of 
the EuroQol Group, a standardized instrument for use as a measure of health outcome. SES, Service Engage-
ment Scale. ASR, Adult Self Report scale. SSM, Self-Sufficiency Matrix. MoCA, Montreal Cognitive Assess-
ment. a Further details are given in separate Table 8−2. b Medication as listed in exclusion criteria and Table 
8−4. c Tests performed by JWW or physiotherapist. d Tests performed by KGN or Registered Nurse. e Street 
Doctor, RN, and GP for the past six months.
100 CHAPTER 8
8.3.2. Primary outcome measure
Primary outcome measures are serum 25(OH)D concentrations.
8.3.3. Secondary outcome measures
Secondary outcome measures are maximal voluntary muscle strength of the par-
ticipants’ dominant quadriceps muscle, the participants’ gait and balance abilities, and a 
health-related quality of life evaluation.
8.3.4. tinetti Performance oriented Mobility assessment (PoMa)
The Tinetti assessment tool is a task-oriented test of 16 items that measures an (older) 
adult’s gait and balance abilities. The Total test score is 28 points composed of Gait score 
(12 points) and Balance score (16 points). Interpretations of the Total POMA scores are 
25–28 points = low fall risk, 19–24 points = medium fall risk, and < 19 points = high fall 
risk (scores of geriatric patients; Tinetti, 1986).
8.3.5. Muscle function tests
Isometric muscle strength measurement is performed with a hand held dynamometer, 
MicroFET2. Measurements are only performed on the knee extensors (quadriceps mus-
cle) of the dominant leg with the knee in 90° flexion. The dynamometer is placed at the 
distal tibia just above the ankle. When necessary, stabilization strips are used to control 
the dynamometer while testing knee extension in stronger persons. Maximal voluntary 
contraction (MVC) of the quadriceps muscle will be estimated as the best of three mea-
surements given in newtons (Force of 9.8 newtons ≈ Weight of 1 kilogram). In literature 
reference values of MVC are available, corrected for gender S (0=male, 1=female), age A 
in years (A>40), and body weight W in kilograms. For the dominant quadriceps muscle 
reference values of MVC are defined in newtons (N) as 358.455 – (87.581 * S ) – ( 3.136 * A) 
+ ( 2.914 * W ) based on regression equation in 154 patients aged 50–79 years, R2 = 0.63 
(Andrews et al, 1996).
8.3.6. health-related quality of life (Eq-5D)
EQ-5D of the EuroQol Group is a standardized instrument for use as a measure of health 
outcome (Brooks, 1996; The EuroQol Group, 1990) and consists of the EQ-5D descriptive 
system and the EQ visual analogue scale (EQ VAS). The EQ-5D-3L descriptive system 
comprises the following five dimensions: mobility, self-care, usual activities, pain/ dis-
comfort, and anxiety/ depression. Each dimension has three levels: ‘1  =  no problems, 
2 = some problems, 3 = extreme problems’. The EQ VAS records the respondent’s self-
rated health on a vertical, visual analogue scale where the endpoints are labeled ‘Best 
imaginable health state’ and ‘Worst imaginable health state’. This information can be used 
as a quantitative measure of health outcome as judged by the individual respondents.
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8.4. MEDIator varIablES
8.4.1. characteristics
Age, sex, ethnicity,25 sunlight exposure (season), education level, weight, body mass 
index, smoking, level of physical activity, somatic comorbidity, and various biochemical 
parameters (see Table 8−2) are considered as potential confounders and effect modi-
fiers because these variables may be associated with both vitamin status and muscle 
strength (Kuchuk et al, 2009).
Level of education is assessed by asking the participant for the highest educational 
level whether or not completed, classified as primary school, high school, vocational 
school, college, graduate studies. The level of physical activity (minutes/day) is esti-
mated by assessing household activities, sports, walking outdoors, and bicycling during 
25 In keeping with Statistics Netherlands, ethnicity is defined by the parental country of birth; 
participants with at least one parent born outside the Netherlands are considered to be non-
Dutch Statistics Netherlands. Statline; Definitions: Origin, www.statline.cbs.nl/StatWeb/select
ion/?DM=SLEN&PA=37325ENG&LA=EN&VW=T
table 8−4. Characteristics at baseline in all participants
Measurements Body weight Kg
Body length M
BMIa Kg/m2
Medicationb Calcium supplements, vitamin D, Dose/day
B vitamins, thiamine, benzodiazepines
Antiepileptic drugs (Phenytoin, Carbamazepine)c
Alcohol use On average, days/week Days
Number of drinks on a typical drinking day
Period of alcohol use / abuse Years
Sun exposure Outdoor daytime activities Minutes/week
Self-neglect Malnutrition Yes/ no
Period of malnutrition Months, years
Loss of weightd Kg
Complaints Muscle pain Yes/ no
Muscle cramps Yes/ no
Deep bone pain Yes/ no
Difficulties in raising from a chair Yes/ no
Difficulties in climbing a staircase Yes/ no
a BMI, Body Mass Index. b Over-The-Counter medication included. c Enzyme-inducing antiepileptic drugs 
affect endogenous biochemical pathways, as bone metabolism and metabolism of vitamin D resulting in 
reduction of vitamin D levels (Johannessen & Landmark, 2010; Verrotti et al, 2010). d Compared to partici-
pant’s regular weight.
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the previous two weeks (Kuchuk et al, 2009). Cigarette smoking is classified as never, 
quit, current < 20 cigarettes/day, current ≥ 20 cigarettes/day. Somatic comorbidity is as-
sessed by obtaining a medical history including chronic obstructive pulmonary disease, 
cardiovascular disease, peripheral arterial disease, stroke, diabetes mellitus, malignant 
neoplasm, and joint disorders (Kuchuk et al, 2009), without asking for further details.
Other possible mediator variables include the number direct patient contacts, medi-
cation compliance, help-seeking behavior, social support, self-sufficiency, cognitive 
functions, and specific somatic conditions as malnutrition, malabsorption, and liver 
dysfunction (Figure 8−2). 
figure 8−2. Mediator variables of the effect of vitamin D in alcoholism and self-neglect
VIDIO, Vitamin D Intensive Outreach. CAU, Care As Usual. 25(OH)D, 25-hydroxyvitamin D. a Enzyme-inducing 
antiepileptic drugs, including hepatic first-pass effects. b Biochemical parameters, see Table 8−2.
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8.4.2. laboratory results
Testing serum albumin gives an impression of liver synthesis function in chronic liver 
disease. Other causes of decreased liver synthesis of albumin are malnutrition and mal-
absorption. In alcoholism malnutrition, malabsorption, and liver disease may occur in 
different degrees. Participants are divided in four subgroups by the concentration of 
serum albumin, including normal serum albumin > 35 g/L, and ‘subnormal’ 28–35 g/L, 
‘low’ between 21 and 28 g/L, and ‘very low’ ≤ 1 g/L serum albumin concentrations. The 
limits of 28 g/L and 35 g/L are based on the albumin concentrations of Child-Pugh cri-
teria of severity of liver disease (Child & Turcotte, 1964; Pugh et al, 1973). Other possibly 
confounding laboratory results in relation to vitamin D and B status are summarized in 
Table 8−2.
8.4.3. Service engagement (SES)
The Service Engagement Scale is used from the clinician’s perspective. The 14 items are 
rated on a four-point scale 0–3, from ‘not at all or rarely’ to ‘most of the time’. The four 
subscales refer to availability, collaboration, help seeking and treatment adherence. The 
English version of the scale has good psychometric properties (Tait et al, 2002).
8.4.4. Social support (aSr)
Social support is measured with the Adult Self Report (ASR) ‘social support’ scale (Achen-
bach & Rescorla, 2003). A Dutch translation of the ASR is available. The ASR; section social 
support includes thirteen items on support by friends or relatives during the past twelve 
months, from the participant’s perspective. Each item is rated on a five point scale 1–5, 
from ‘no help at all’ to ‘very much help’.
8.4.5. Self-Sufficiency Matrix (SSM)
The Self-Sufficiency Matrix used is adapted from SSM versions of Utah and Arizona26 and 
is composed of 11 items selected from original 18 domains: Income, daytime activities, 
shelter, family relations, mental health, health care, substance abuse, activities of daily 
living, social support, community involvement, and legal. Each item is rated on a five 
point scale: ‘1 =  in crisis, 2 = non-self supporting, 3 =  limited self-supporting, 4 = suf-
ficiently self-supporting, 5 = fully self-supporting’.27
26 SSM version, www.mnhousing.gov/idc/groups/public/documents/document/mhfa_010879.
pdf
27 Zelfredzaamheidmatrix, 2013, Lauriks et al, www.zelfredzaamheidmatrix.nl/LinkClick.aspx?fil
eticket=1JZyUHdPoDQ%3D&tabid=40
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8.4.6. Montreal cognitive assessment (Moca)
The Montreal Cognitive Assessment is a screening instrument of ten items to assist first-
line physicians in detection of cognitive dysfunction, concerning attention and concen-
tration, executive functions, memory, language, visuoconstructional skills, conceptual 
thinking, calculations, and orientation. MoCA scores of ≥ 26/30 points are considered 
normal.28
8.5. furthEr InforMatIon
8.5.1. randomization
After receiving the baseline laboratory results, an independent Doctor’s Assistant al-
locates participants to one of the two vitamin D supplementation strategies (VIDIO and 
CAU).
8.5.2. Power
To compare differences between both intervention groups in the development of 
25(OH)D concentrations in nmol/L and maximal voluntary muscle strength along two 
follow-up measures, the correlation between repeated measurements must be taken 
into account (Twisk, 2003). Based on few previous studies (Bang et al, 2009; Hickish et 
al, 1989), we expect an overall standard deviation in scores of 20 points for 25(OH)D in 
nmol/L and 112 points for voluntary muscle contraction. Setting an alpha level of 5% 
and assuming a within-subject correlation coefficient of 0.8, at least 55 patients have to 
be enrolled to ensure a 80% probability of detecting 50 to 60-point changes in vitamin 
D concentrations and muscle strength respectively. We have decided to use 80 subjects 
in each group to make up for those that we anticipate will be lost in follow-up.
8.5.3. Statistical analyses
Univariate associations between intervention condition and vitamin D concentrations 
and voluntary muscle strength are analyzed using standard statistical tests. Longitudi-
nal regression analyses will be performed using mixed models. Interaction effects and 
collinearities are checked for all significant main factors. Model selection is based on 
likelihood ratio test statistics. The fit of the final model will be assessed using McFadden 
R2 and residual plots. SPSS for Windows is used to perform all statistical procedures.
28 The Montreal Cognitive Assessment, www.mocatest.org
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8.5.4. Ethical principles
The study protocol, information brochure and informed consent form were approved by 
the Erasmus Medical Center ethical committee (registration number NL40553.078.12), 
and will be performed in accordance with the Helsinki declaration. At this moment 
the effects of vitamin D supplementation on muscle performance and cognition are 
unknown and therefore we think it is justified to allocate the participants randomly 
over the two conditions. The Street Doctor informs the patient of the research aims and 
randomization method and asks for his or her written informed consent. The patient is 
free to refuse participation at any time during the research period, without having to 
disclose a reason why. The collected patient data are treated according to the Medical 
Confidentiality Rules. Access is limited to members of the research group and the medi-
cal ethical committee.
8.6. DIScuSSIon
8.6.1. vitamin D Intensive outreach
The choice and design of the interventions is based on an outreach approach in self-
neglecting alcoholics. In daily prescribed medications actual intake is not well known, 
whereas this uncertainty is excluded when providing (bimonthly) supervised doses. 
Alcohol may have direct toxic effects on muscles, but the relation between muscle 
weakness and vitamin D deficiency in alcoholism has not been extensively examined. 
Alcohol-related osteoporosis responded well to vitamin D therapy (Pitts & van Thiel, 
1986). A clear understanding of the role of vitamin D in alcoholic myopathy, however, 
is currently lacking. The central research question in this study is whether either of the 
two vitamin supplementation strategies can improve muscle performance in hypovita-
minosis D-related muscle weakness, as well as vitamin D status in vitamin D-deficient 
alcoholics.
8.6.2. Muscle strength
The role of serum 25(OH)D levels in maintaining or improving physical performance 
and muscle strength is still being discussed. The available studies often vary in their 
populations studied, severity of baseline vitamin D deficiency, and baseline physical 
functioning (Lagari et al, 2013). Articles specifically addressing vitamin D in relation to 
myopathy in alcoholism were scarce (Girgis et al, 2013; González-Reimers et al, 2010). 
Until now, the effect of vitamin D supplementation on muscle weakness in alcoholic 
patients is not investigated.
Hickish et al (1989) concluded that maximal voluntary contractions (MVC) of the 
quadriceps muscle were not significantly related to serum 25(OH)D concentrations in 
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their study of male alcoholics. The patients were recruited from a Medical Outpatient 
Clinic. Alcohol abuse was diagnosed on the basis of > 80 g of alcohol consumption daily 
for more than three years. Of these patients 16/41 (39%) had established liver cirrhosis. 
The mean age of patients was 43.5 years (range 21–72 years). Vitamin D concentrations 
were severely deficient and quadriceps MVC varied from 70–390 newtons in 10/41 (24%) 
of the alcoholic patients, compared to the quadriceps MVC of 310–800 newtons in con-
trols (none of whom drank more than 20 g alcohol daily).
In a group of 55 vitamin D-deficient (non-alcoholic) women, Glerup et al (2000) found 
that assessment of the serum 25 (OH) D concentrations is a reliable test in the screening 
for hypovitaminosis D myopathy. The vitamin D-deficient women were treated with a 
high-dose vitamin D regimen consisting of intramuscular injections of ergocalciferol 
100,000 IU per week for one month followed by one injection per month for the following 
five months; additionally, an oral supplementation of 800–1,200 mg calcium carbonate 
in combination with 400–600 IU ergocalciferol per day was given. After treatment the 
most pronounced improvements in muscle strength were seen in the weight-bearing 
antigravity muscles of the lower limbs (quadriceps muscle). On average, MVC of the 
quadriceps improved from 259 newtons (66%) at baseline up to 321 newtons (82%) after 
six months of treatment, compared to the mean quadriceps MVC of 393 newtons (100%) 
in controls.
Outcomes are dependent on the severity of vitamin D deficiency and substantial 
dosages in supplementation. Treatment of hypovitaminosis D myopathy may demand 
high-dose vitamin D treatment for six months or more. When estimating the muscular 
effects of vitamin D treatment, it is therefore important that the observation period 
should be at least three months or longer.
8.6.3. cognitive impairment
Cognitive impairment, whether resulting from or predating vitamin deficiencies, is 
included as a potential confounder, because of the possibility that cognitive dysfunc-
tioning may be of influence on help-seeking behavior and progression of self-neglect. 
For older persons, not specifically alcoholics, literature suggests a positive contribution 
of vitamin D to brain functions (Annweiler et al, 2010). As to mild-to-moderate impair-
ments in intellectual functioning, vitamin D action could play a neuroprotective role 
in alcohol-related cognitive dysfunctioning (cf. Annweiler et al (2010), vitamin D and 
nervous system). Furthermore, mild vitamin B1 deficiencies could be responsible for 
the mild cognitive limitations and behavioral changes frequently occurring in chronic 
alcoholic patients – that are commonly attributed to direct toxic effects of alcohol (van 
den Brink & Jansen, 2009). Cognitive impairment can therefore also be defined as an 
outcome measure of vitamin depletion. Possible beneficial associations between results 
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of the cognitive screening and supplementation of vitamin D deficiency or moderate 
vitamin B1 deficiencies will be described.
8.6.4. Strengths and limitations
Important strengths are the clinical relevance and design of this study using reference 
values of muscle strength based on individual patient characteristics. The participants 
are visited at home and therefore may represent a more general population of adult 
patients with alcohol use disorders than a selected group of patients attending ambula-
tory outpatient care. This is, to our knowledge, the first study which examines the effects 
of vitamin D supplementation in alcohol-related muscle weakness.
There is some risk that it will not be possible to generalize the results based on the 
expected response of about 10–20% of the candidate participants. Scores of muscle 
strength and balance are completed only 2–3 times during the study period rather than 
more frequently being repeated to observe the amount of intra-individual progress in 
time. Disadvantages regarding the purpose of a hand held dynamometer are possible 
stabilization difficulties while testing stronger quadriceps muscles – in which case straps 
will be used if necessary for stabilization of the device.
Vitamin D supplementation may possibly be an effective target in prevention and 
treatment of alcohol-related muscle weakness, but in alcoholism the minimal required 
vitamin D doses are unknown. Very high doses may saturate hydroxylation reactions, 
thereby reducing the efficiency to generate 25(OH)D within a given period of time 
(Heaney et al, 2008). Effects of vitamin D supplementation in alcoholism may vary with 
individual differences in comorbid conditions as malnutrition, malabsorption, and 
liver dysfunction. Serum 25(OH)D values on average were found to be lower in cirrhotic 
alcoholics than in non-cirrhotic alcoholics (Pitts & van Thiel, 1986). Determination of 
dose effect may be uncertain in alcoholic patients suffering from malabsorption and 
liver cirrhosis. Comedication of calcium supplementation in hypovitaminosis D is not 
specifically accounted for.
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abStract
In the literature, the cerebellum is given a substantial role in cognitive processes, in addi-
tion to traditional views on cerebellar function of regulating motor behavior (Baillieux et 
al, 2008). The phenomenon of cerebellar damage causing impairments in memory and 
executive functioning was observed in various cerebellar disorders. Cerebellar cognitive 
dysfunction can be interpreted as a disturbance of cerebello-cerebral connections to 
areas of the cerebral cortex involved in cognitive processing, but the exact nature of the 
cognitive dysregulation is not known.
Memory and executive dysfunction are important clinical features of Korsakoff syn-
drome. We hypothesize that the Korsakoff syndrome might be an example of cerebellar 
neurocognitive dysfunctioning (i.c., bilateral crossed cerebello-cerebral diaschisis) 
caused by neural pathways being disconnected in brainstem areas that are classically 
affected in Wernicke encephalopathy. Further research is needed to support the pos-
sibility of cerebellar neurocognitive disturbances in Korsakoff syndrome. If correct, this 
hypothesis may contribute to a better understanding of the clinical en neuropsychologi-
cal profile of Korsakoff syndrome.
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9.1. IntroDuctIon
Despite substantial knowledge, it has not been yet made clear which defects are par-
ticularly responsible for the Korsakoff syndrome, e.g., peri-aqueductal grey matter dam-
age, lesions of the mammillary bodies, the mammillo-thalamic tract, or thalamic nuclei 
(Kopelman et al, 2009). This uncertainty leaves an opportunity for creating alternative 
assumptions. Disturbances of executive functioning were customarily regarded as in-
volving the frontal cerebral cortex, but there could be an impact on cortical functioning 
through disruption of cerebello-cerebral connections (Schmahmann, 2004; Hoppen-
brouwers et al, 2008). Thinking about the neuropathologic substrate of the Korsakoff 
syndrome, we suggest that a bilateral crossed cerebello-cerebral diaschisis (Baillieux et 
al, 2010) may cause the clinical symptoms of the Korsakoff syndrome.
9.2. thE cErEbElluM anD ItS connEctIonS
The traditional view on the functions of the cerebellum consists of regulating motor 
control. The cerebellum is connected to midbrain, pons, and medulla oblongata by three 
paired bundles, the superior, middle, and inferior cerebellar peduncles, respectively. 
These peduncles are among others containing the following tracts: (i) from cerebellum 
to red nucleus (in the midbrain) and thalamus, (ii) from pontine nuclei to cerebellum, 
and (iii) from olive (in the medulla oblongata) to cerebellum. Connections between pons 
and cerebellum, and between olive and cerebellum, are part of cerebellar motor control 
loops: the connection from the pontine nuclei being ‘accelerator’, and the connection 
from the olive being ‘brake’ of motor movements, to establish smooth and coordinated 
movements. This regulatory function is applied to intentional movements, e.g., grasping 
something, as well as to reflex movements, e.g., keeping the eyes focused on a certain 
point during head movements.29
9.3. cErEbEllar nEurocognItIon
In the literature is described that the cerebellum would also play an important role in 
cognitive processing, but this topic inevitably seems to create supporters in favor of 
this concept and opponents against it (Baillieux et al, 2008). Over the last fifteen years 
however, the number of disorders (strokes, schizophrenia, pervasive disorders) that are 
29 De Zeeuw, Erasmus MC, Rotterdam, public lecture, October 9, 2009. Brain language: from 
signal to message.
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being associated with cognitive cerebellar functions, has gradually increased (Glickstein 
& Doron, 2008).30
9.4. oWn ExPErIEncE WIth StroKE PatIEntS
As example, we saw three patients during their multidisciplinary stroke rehabilitation, 
having had acute cognitive impairments following cerebellar stroke, of whom two 
people with secondary intraventricular hemorrhage.
In these patients, we observed the following non-motor deficits:
(i) symptoms such as disturbances of memory and orientation, analogous with global 
dementia.
(ii) Furthermore, symptoms that traditionally are interpreted as frontal symptoms, 
meaning perseveration, impulsivity, disinhibited behavior, and increased distractibility. 
These symptoms were not present to the same extent in all three patients.
(iii) In one of the patients a marked incoherence of thought was observed.
(iv) Finally, we found symptoms like fatigue, sleeping disorders, depression, or anxiety.
However, the association between structural damage and neurological deficit does 
not necessarily mean that cerebellar damage was the cause of cognitive dysfunctioning, 
because hemorrhages may damage neuronal structures or act distantly, e.g., by causing 
brain displacement.
9.5. cErEbEllar nEurocognItIon In SuMMary
Baillieux et al (2008) wrote a review explaining the involvement of the cerebellum in 
a broad spectrum of cognitive, affective, and linguistic functions: Cerebellar damage 
would interfere with aspects of memory that rely on executive functions. Priming ef-
fects, i.e., quick recognizing and faster response to a known (or similar) stimulus, were 
not affected in cerebellar lesions. Recognition tasks and the learning of new information 
the person is not aware of (i.e., implicit learning tasks) remained intact.
30 Based on research in the field of biological psychiatry, cerebellar abnormalities are considered 
to play a role in cognitive functioning in schizophrenia − as the cerebellum is engaged in basic 
cognitive functions such as timing and associative learning (Andreasen & Pierson, 2008).
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9.6. hyPothESIS
We formulate an hypothesis that Korsakoff syndrome might be involving cerebellar 
neurocognitive dysfunctioning due to disconnection of cerebrocerebellar systems in 
the classic brain locations of Wernicke encephalopathy (Figure 9−1A and Figure 9−1B). 
If this hypothesis were to be confirmed, this may provide a better understanding of the 
clinical profile of Korsakoff syndrome, yet being diagnosed on the basis of an alcohol-
related persisting amnestic disorder. In addition, the development and introduction of 
neuropsychological tests more sensitive to the profile of cerebellar neurocognition in 
Korsakoff syndrome, might further improve decision-making in clinical diagnosis.
The hypothesis can possibly be tested using MRI techniques to determine structural 
abnormalities or interruption of neural connections, such as abnormal tissue charac-
teristics in thalamic or brainstem edema, or tissue loss apparent by widening of the 
aqueduct or enlargement of the third ventricle (Sullivan & Pfefferbaum, 2009). Other 
MRI techniques could potentially be used to assess disturbances in neural connectivity 
in these brain regions.
The neural tracts to the cerebellum that might be damaged in Wernicke encephalopa-
thy, are schematically shown in Figure 9−2. The cerebellar superior peduncle, marked by 
the left white arrow, enters the tegmentum (the roof ) of the brainstem and is crossing 
over to the opposite red nucleus (RN) and thalamus. Furthermore, the olivar route is 
 
 
figure 9−1a. Localizations of Wernicke encepha-
lopathy. Schematic medial view of distribution of 
lesions in the brainstem (from a to a; top a is at the 
level of the midbrain, the upper part of the brain-
stem), medial thalamus (b) and mammillary bodies 
(c, convex bulge on both sides of the brain basis 
(Escourolle & Poirier, 1987, p. 185)).
figure 9−1b. Pinpoint hemorrhages in Wernicke 
encephalopathy. Microscopic slide with cross sec-
tion of the pons. There are small black dots (hem-
orrhages) visible in the upper lighter part of the 
figure, i.e., the tegmentum (roof ) of the pons (Es-
courolle & Poirier, 1987, p. 184).
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also crossing the tegmentum, shown by the black arrows. We assume that lesions in 
these pathways may be indicated ‘candidate’ spots for inducing the Korsakoff syndrome, 
including the decussating tracts from cerebellum to red nucleus and thalamus.
9.7. lIMItatIonS
The hypothesis is based on various information from heterogenic sources: literature 
on cerebellar neurocognition (Glickstein & Doron, 2008; Hoppenbrouwers et al 2008), 
personal experience with stroke patients (incomplete and unpublished data), and daily 
practice of Korsakoff patients (Goossensen et al, 2007). No further theoretical support 
is yet available, and the concept of cerebellar neurocognition in Korsakoff syndrome 
has not been previously suggested or described in literature. Further research will be 
necessary to test this hypothesis.
9.8. PoStScrIPt
Referring directly to our hypothesis, the research group of Pitel reported a diffusion 
tensor imaging (DTI) study in Korsakoff patients, showing alterations in structural con-
nectivity regarding the fornix and cingulum tracts of the Papez circuit and the superior 
& middle cerebellar peduncles of the fronto-cerebellar circuit (Segobin et al, 2015). Their 
data may support the idea of compromised white matter integrity in cerebellar tracts − 
regarding the superior and middle cerebellar peduncles.
 
 
 
figure 9−2. Neural tracts possibly in-
volved in Korsakoff syndrome. Sche-
matic paramedian view (modified 
from Nieuwenhuys et al, 1978, p. 53) 
through cerebellum and brainstem, 
showing mammillary body (C, corpus 
mammillare linked to thalamus and 
midbrain), red nucleus (RN), pontine 
nuclei (PN) and olive (O). The posi-
tion of the aquaduct, i.e., the narrow 
channel connecting the third and 
fourth ventricle, is indicated by a dot-
ted line.
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10.1. currEnt guIDElInES
A general review of thiamine treatment dosages is beyond the scope of this thesis, 
considering the diagnostic approach of the thesis and the availability of extensive 
guidelines on thiamine treatment in Wernicke-Korsakoff syndrome (Galvin et al, 2010; 
Thomson et al, 2002; van den Brink & Jansen, 2009). Current treatment guidelines are 
based on data from uncontrolled trials and from empirical clinical practice. The dose of 
thiamine required to prevent or treat Wernicke encephalopathy in most alcoholic pa-
tients is believed to be 250−500 mg three times daily, given intravenously for 3–5 days 
(Thomson et al, 2002); or 200 mg three times daily preferably via intravenous instead 
of intramuscular route, until there is no further improvement in signs and symptoms 
(Galvin et al, 2010).
10.2. InEffEctIvE trEatMEnt
In several cases of Wernicke encephalopathy, no improvement was seen despite early in-
travenous treatment with high doses of thiamine (Cook et al, 1998). The course of illness 
may be complicated by serious infections, liver dysfunction, and effects of irreversible 
thiamine deficiency (Adams & Victor, 1985b). Comorbid deficiencies, such as magnesium 
deficiency, present another reason why complete recovery may not occur (Dingwall et 
al, 2015). Remarkably, some of our patients did show clinical improvement on oral thia-
mine, although orally administered thiamine is generally ineffective in curing Wernicke 
encephalopathy (Galvin et al, 2010). The reason for this discrepancy is unclear.
10.3. lEvEl of EvIDEncE
In a recent update by the Cochrane collaboration, Day et al (2013) concluded that evi-
dence from randomized controlled clinical trials is insufficient to guide clinicians in de-
termining the dose, frequency, route or duration of thiamine treatment for prophylaxis 
against or treatment of Wernicke-Korsakoff syndrome. The study of Ambrose et al (2001) 
met the inclusion criteria provided in the Cochrane Handbook for Systematic Reviews 
of Interventions, but analysis was limited by methodological shortcomings of the study. 
Intramuscular thiamine in a dose of 200 mg/day showed significant differences in the 
patients’ responses to a single working memory test (Ambrose et al, 2001), compared 
with the lowest dose of 5 mg/day.
New controlled trials are unlikely to be undertaken, because of the established cause 
− i.e., thiamine deficiency − and a high mortality of Wernicke encephalopathy.
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10.4. IntravEnouS InfuSIon of thIaMInE
In current practice of referring hospitals in our region we observed that intravenous 
thiamine was omitted frequently, specialists being cautious with regard to the intrave-
nously (IV) administering of thiamine. However, a more active policy is needed to avoid 
inadequate treatment in patients who develop Wernicke encephalopathy (Chapter 4, 
Table 4−4). Therefore, the following practical considerations may possibly encourage a 
successful uptake of the guidelines on higher dosages of intravenous thiamine in clinical 
practice. In general the parenterally administering of thiamine is when necessary, safely 
undertaken in patients without known thiamine hypersensitivity (Arts, 2007; Thomson 
et al, 2002; Wrenn et al, 1989). Precautions that can be taken are availability of appropri-
ate resuscitation facilities during and after administration, and slow IV infusion: 500 mg 
thiamine over 30 minutes (Thomson et al, 2002). Thiamine is rarely a cause of anaphy-
lactic reactions31 (Thomson et al, 2002; Wrenn et al, 1989), but these have incidentally 
been reported following intravenous (and intramuscular) administering, regardless of 
previous uncomplicated use (Morinville et al, 1998; Fernandez et al, 1997; Stephen et 
al, 1992). A possibility is giving a physiological saline IV infusion system and test dosage 
of 25 mg IM thiamine, followed by infusion of thiamine diluted in normal saline after 15 
minutes if no adverse reactions have occurred (Wernicke protocol, Academic Hospital 
of Maastricht, www.neuromaas.nl), but in case of emergency any delay is undesirable 
(Thomson et al, 2002).
31 Life-threatening allergic reactions to any parts in thiamine supplements.
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11.1. WErnIcKE DElIrIuM
Research question (I): Are Wernicke encephalopathy and delirium synonymous condi-
tions in malnourished alcoholic patients?
11.1.1. Introduction
Some authors wondered whether the clinical manifestations of Wernicke-Korsakoff syn-
drome can mask delirium symptoms (Djelantik et al, 2015), while others suggested that 
patients were sometimes diagnosed as having delirium tremens instead of Wernicke-
Korsakoff syndrome (Cook et al, 1998). In this thesis, we have attempted to systemati-
cally examine the clinical significance of delirium in relation to the Wernicke-Korsakoff 
syndrome and to further explore the link between thiamine deficiency, delirium, and 
Wernicke-Korsakoff syndrome.
Wernicke encephalopathy can easily be mistaken for alcohol withdrawal delirium 
(Rosenbaum, 2003). In previous literature, van Epen (1983) emphasized the frequent 
occurrence of atypical and ‘transitional stages’  –  i.e., the variable clinical course of 
alcohol-related syndromes in chronic alcoholism, including atypical features, along with 
well-defined ‘classical’ syndromes. For example, when a patient is admitted to hospital 
with an acute alcohol hallucinosis, suffering with a delirium tremens a few days later, 
and is obviously exhibiting a Korsakoff syndrome after the delirium has resolved (van 
Epen, 1983). This symptom pattern of a delirium progressing to Korsakoff syndrome was 
observed in many of our patients.
11.1.2. alcohol withdrawal delirium
In general, a delirium results from structural brain lesions, systemic disease, and either 
intoxication or withdrawal from pharmacological or toxic agents such as alcohol (Adams 
& Victor, 1985a, p. 307− 308; Kaplan et al, 1994, p. 338−339).
There is little information available regarding the course of alcohol withdrawal 
syndrome in a general hospital (Monte Secades et al, 2010). Prolonged alcohol with-
drawal delirium was described in several case report studies – the patient’s course being 
complicated by somatic comorbidity, failure of benzodiazepine medication to prevent 
delirium or shorten its duration, and occasionally the onset of Wernicke encephalopathy 
(Hayes et al, 2007; Lemyze et al, 2009; Miller, 1994; Narumoto et al, 2005). However, we 
assume that these prolonged and protracted deliria may be a primary manifestation of 
Wernicke encephalopathy preceding the development of Korsakoff syndrome.
11.1.3. results in support of Wernicke delirium
In an observational study of patients with end-stage Korsakoff syndrome (Chapter 3) we 
have highlighted that delirium in malnourished alcoholic patients may be considered 
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to be synonymous with Wernicke encephalopathy. In this study we found support for 
the hypothesis that delirium in itself can be a primary presenting feature of Wernicke-
Korsakoff syndrome in self-neglecting alcoholic patients. During the initial stages of 
disease, deliria were reported in 35/73 (48%) alcoholic patients with subsequent Korsa-
koff syndrome (Chapter 3). The patients had multiple potential causes for delirium, e.g., 
alcohol withdrawal or somatic diseases. However, based on our findings in this study of 
Korsakoff patients, we suggested that at least 17% (95%-confidence interval: 10−25%) 
of their delirious conditions in the early stages of Wernicke-Korsakoff syndrome may 
have occurred due to an unrecognized Wernicke encephalopathy with incomplete 
presentation.
11.1.4. Pathophysiology of Wernicke delirium
In a review of pathophysiological mechanisms in delirium (Chapter 5), we further 
provided arguments in support of a link between thiamine deficiency and delirium. 
The possible loss-of-function mechanisms following thiamine deficiency in Wernicke-
Korsakoff syndrome are proposed to come from microglial activation, resulting in the 
delirium in the initial phase of the syndrome.
11.1.5. Microglial activity in Wernicke delirium
Although delirium is a common disease, the pathophysiology of delirium remains poorly 
understood, and its underlying mechanisms are largely unknown (Inouye & Ferrucci, 
2006). Mechanisms may differ in various clinical settings (Flacker & Lipsitz, 1999).
In inflammatory-associated delirium, literature suggested that the delirium is an im-
munity-induced dysregulation characterized by metabolic alterations and progressive 
neuronal loss (Teeling & Perry, 2009). Van Gool et al (2010) described a delirium model 
on proinflammatory factors released by microglia escaping from cholinergic inhibition. 
The cascade of cytotoxic reactions that might follow, could account for delirium and 
damage to the cholinergic neurons.
The study by Wang and Hazell (2010) suggested that microglial activation played a 
role in the development of neurological impairment in thiamine deficiency and pos-
sibly Wernicke encephalopathy. The combining of this information (Figure  11−1) may 
contribute in favor of the clinical observations that delirium can be seen as an important 
presenting feature of Wernicke-Korsakoff syndrome and might be one of the key symp-
toms of an active Wernicke encephalopathy.
11.1.6. Strength and limitations
We propose a change of viewpoint in the diagnostic and therapeutic approach to 
Wernicke encephalopathy that recognizes the initial symptoms of thiamine deficiency 
overlapping with many symptoms of delirium and examines the interrelations between 
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both delirium and cognitive deficit in Wernicke-Korsakoff syndrome. Based on our 
findings and review of literature, we more distinctly introduced the entity of ‘Wernicke 
delirium’ and provided information on its possible mechanisms of action.
The present studies have several limitations. The completed available patients’ infor-
mation on alcohol withdrawal was small in number (Chapter 3), because it is difficult to 
obtain a reliable past medical history in non self-sufficient alcoholic patients.
In older people, the risk of delirium was associated with alcohol use (Ahmed et al, 
2014; Elie et al, 1998), irrespective of alcohol withdrawal delirium (Robinson et al, 2009). 
However, in many studies on risk factors of delirium, there were only small numbers of 
patients (≤  10) in the comparison of delirium and alcohol consumption and essential 
details of alcohol quantities were frequently lacking.
In our review on delirium-biomarkers (Chapter 5) no descriptions are given of how 
delirium was assessed in the original studies. From an etiological point of view, it is 
very unlikely that a single genetic or biochemical marker would account for most of the 
symptoms in delirious states. Although the biomarkers listed may have an association 
with delirium, evidence for causality is lacking. The review is based on limited selection 
criteria regarding the pathophysiology of delirium and may be prone to selection biases 
lacking data from grey literature or other articles describing loss-of-function mechanism 
in delirium.
11.1.7. conclusion to research question (I)
Based on the preliminary findings of deliria without any other obvious causes (Chapter 
3) we suggest that delirium and Wernicke encephalopathy were synonymous conditions 
in our selected patient group of self-neglecting alcoholic patients − in whom the Wer-
nicke phase resulted in having Korsakoff syndrome. The diagnostic label of delirium due 
to thiamine deficiency or ‘Wernicke delirium’ may be the better alternative to achieve 
 
 
figure 11−1. Thiamine deficiency, microglia, delirium, and Korsakoff syndrome
Relationships are displayed by arrows: a Association from animal study. b Hypothesis (review of literature). 
c Suggested possible mechanism. d Descriptive, retrospective data.
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an early detection of Wernicke encephalopathy. Pathophysiological mechanisms of 
thiamine deficiency delirium were reviewed by combining literature on delirium and 
literature on thiamine deficiency. We suggested that microglial activation noted in stud-
ies of inflammation-related delirium may play a role in the pathogenesis of thiamine 
deficiency delirium.
11.1.8. consequenses for daily practice
As mentioned before, a recognized episode of Wernicke encephalopathy is not always 
obvious. In clinical practice the classical presentation of the triad symptoms is limited 
and constitutes only 16% of cases (Harper et al, 1986). Unfortunately, delirious states 
may also go unrecognized because of either a relatively non-specific clinical presenta-
tion in some cases or poorly recognized clinical symptoms and signs. Compared with 
Wernicke’s triad symptoms, however, Wernicke delirium may pose a new challenge in 
the diagnosis of active Wernicke encephalopathy. Thus recognition of Wernicke delirium 
may be helpful to raise the clinician’s index of suspicion about Wernicke-Korsakoff syn-
drome.
11.2. gaIt DISorDEr In WErnIcKE DElIrIuM
Research question (II): Wernicke-Korsakoff syndrome is a ‘spectrum of disease’ resulting 
from thiamine deficiency, but would it be possible to more specifically determine its 
temporal progression regarding the patients’ mobility and mental symptoms?
11.2.1. representative case report
The Wernicke-Korsakoff syndrome affects both mobility and mental ability. In a detailed 
case history (Chapter 4) we described the association of gait and balance disorders with 
mental status changes in the encephalopathic Wernicke phase and subsequent Korsa-
koff syndrome (Figure 11−2).
“On hospital admission the patient had impaired consciousness, with fluctuating 
drowsiness. He was bedridden because his poor balance had left him unable to walk. 
On day 16, he sustained his attention relatively well, but his glazed eyes showed that he 
was not very alert. He had difficulty organizing his thoughts and he expressed himself 
incoherently. By now the patient could walk again with a walker and help from one per-
son. During week 15, the patient had a full neuropsychological assessment. Clinically, he 
showed striking perseverations and confabulations. The assessment revealed disorders 
in orientation, memory, and executive functions, and was consistent with a developing 
Korsakoff syndrome. After week 17, he could walk independently without any aids.”
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11.2.2. gait disorder in alcoholism
Alcohol-related unsteady gait may result from various problems in diff erent parts of the 
nervous system or of the body. In addition to Wernicke encephalopathy, the more com-
mon alcohol-related gait disorders include alcohol intoxication, cerebellar dysfunction, 
alcoholic polyneuropathy, and alcoholic myopathy, among others.
Purkinje cells of the cerebellum are susceptible to diff erent forms of alcohol-related 
injury. Alcohol can impair cerebellar function by enhancing γ-aminobutyric acid (GABA)-
mediated inhibition of the Purkinje cells, thus depressing Purkinje cell activity. Moreover, 
alcohol is known for its inhibitory eff ects on glutamatergic transmission, most obvious 
for N-methyl-D-aspartate (NMDA) receptors, e.g., in Purkinje cells during development 
and at climbing fi ber synapses onto mature Purkinje cells (Belmeguenai et al, 2008). 
Other studies described that alcohol directly aff ects the cerebellum via inhibition of 
cerebellar granule cells, mediated by extrasynaptic GABA A receptors (Carta et al, 2004; 
Hanchar et al, 2005). The eff ect of this increased GABA inhibition is impaired motor coor-
dination. Alcohol-induced motor coordination defi cits and ataxias are usually reversible, 
but chronic alcohol abuse may cause cerebellar atrophia with permanent gait ataxia 
and memory loss − most probably caused by thiamine defi ciency, rather than alcohol 
consumption alone (Harper, 2009).32
32 Ataxia; www.hopkinsmedicine.org/neurology_neurosurgery/centers_clinics/movement_
disorders/ataxia/conditions/
 
 
figure 11−2. A patient’s mobility and evolving neuropsychiatric symptoms in Wernicke-Korsakoff  syn-
drome (dashed line), starting with initial hospitalization at 0 months. Arrows depict alternative outcomes: 
further decline, full recovery, or protracted delirium.
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11.2.3. Strength and limitations
The temporal progression of Wernicke’s symptoms, including (simultaneous) distur-
bances of gait during follow-up, is seldom described. The combined course of mental 
and mobility changes in Wernicke-Korsakoff syndrome illustrated in this case report, 
may be considered exemplary for many Wernicke-Korsakoff syndrome cases − but needs 
extended descriptive research, regarding the proportions of patients with progression 
to end-stage Korsakoff syndrome, or other, alternative outcomes, i.e., full recovery, 
further decline, or persisting delirium (Figure 11−2).
11.2.4. conclusion to research question (II)
The combined progression of a patient’s mental and mobility symptoms was shown in 
a representative case study. It is crucial to attach a lot of importance to impaired gait in 
malnourished alcoholic patients. If an alcoholic patient is confined to bed because of 
illness, the impaired mobility should weigh heavily in the decision-making process of 
early WKS diagnosis and treatment.
11.2.5. other consequenses for daily practice
Hypothetically, assessing the final Korsakoff syndrome diagnosis becomes relevant 
when the patient with suspected Korsakoff syndrome can walk independently (again).
In the described case history, the patient’s Wernicke encephalopathy was missed and 
inadequately treated, being labeled as ‘probable Korsakoff syndrome’ far too early.
11.3. InfEctIonS In thE WErnIcKE PhaSE anD cognItIvE outcoMES
Research question (III): How common were infections in the initial phase of Wernicke-
Korsakoff syndrome in our patient group?
Research question (IV): Were infection parameters related to the cognitive outcomes?
11.3.1. Introduction
Wernicke encephalopathy arises as a result of thiamine deficiency and is most frequently 
associated with alcohol abuse. However, thiamine deficiency may also occur in clinical 
scenarios such as severe sepsis, unexplained heart failure or lactic acidosis, starvation, 
chronic malnutrition, long-term parenteral feeding, hyperemesis gravidarum, or bariat-
ric surgery (Manzanares & Hardy, 2011). In fact, serious infections are common in the 
initial phase of Wernicke-Korsakoff syndrome (Chapter 6).
Regarding cognitive outcomes, it is already well known that executive dysfunction, as 
well as memory dysfunction, is an important clinical feature of the Korsakoff syndrome 
(Kessels et al, 2008; Kopelman et al, 2009; Thomson et al, 2002). Because of the different 
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aspects of cognitive disturbances, we chose to separately examine the non-memory 
section of the Cambridge Cognitive Examination (CAMCOG) and the subtests of the 
Behavioral Assessment of the Dysexecutive Syndrome (BADS), including the ‘Key search 
test’ among others.
11.3.2. cognitive outcomes
The main result of Chapter 6 was to show that infection parameters such as white blood 
cell (WBC) counts and absolute neutrophil counts (ANCs) in de early stages of Wernicke-
Korsakoff syndrome predict poorer long-term outcome in terms of neuropsychological 
testing. Although most tests showed a negative correlation between white blood cell 
counts and neuropsychological test scores, correlations were statistically significant in 
only one or two non-memory tests.
11.3.3. Strength and limitations
The observations of this study may bring more awareness to the relationship between 
infections and thiamine deficiency and contribute to improving early diagnosis and 
treatment of Wernicke-Korsakoff syndrome.
The present study has several limitations. There were limited data regarding a com-
plete set of relevant parameters of infection. Secondly, possible covariates of white 
blood cell counts, e.g., smoking, amount of stress, or thiamine deficiency itself, were 
not taken into account. Furthermore, it is not yet clear to what extent white blood cell 
counts do reflect the presence of infections in Wernicke-Korsakoff syndrome in those 
cases where no infections were found.
11.3.4. conclusions to research questions (III) and (Iv)
Severe infections were common during the Wernicke phase of Korsakoff patients admit-
ted to Slingedael Korsakoff Center, Rotterdam.
Although the results have to be interpreted with considerable caution, our data 
provided a first direct indication that infections in the acute phase might be associated 
with the long-term cognitive deficits in Wernicke Korsakoff syndrome. Based on current 
results we suggest that infections may exacerbate the negative impact of thiamine 
deficits in vulnerable brain areas, but perhaps not quite as much in already severely 
depleted thiamine reserves.
11.3.5. consequenses for daily practice
The overall message of Chapter 6 is that empirical treatment of infections in a confused 
alcoholic patient should include adequate thiamine supplementation. However, it is 
important not just to focus on the importance of thiamine supplementation in mal-
nourished alcoholic patients, but in any patient who is malnourished for any reason. 
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Although Wernicke-Korsakoff syndrome is far more commonly reported in the context 
of alcohol, there is now established evidence for Wernicke-Korsakoff’s in malnourished 
patients without alcohol, such as in anorexia nervosa, hyperemesis gravidarum, post-
gastric surgery (Kotha & De Souza, 2013; Milone et al, 2014; Renthal et al, 2014), and in 
several cases with serious comorbid infections (Chidlovskii et al, 2012; Kishimoto et al, 
2012; Schattner & Kedar, 2013).
11.3.6. new questions
Along with these results, there are however a number of outstanding questions requiring 
further consideration. These questions include the severity of thiamine deficiency and 
the nature and strength of the impact of systemic infection on cognitive functioning:
(i) If indeed there is a correlation between infection and worse outcomes in Wernicke-
Korsakoff syndrome, then can it be said that infection itself is linked to a poorer prog-
nosis,
(ii) or is it that the infection is a marker of more severe degrees of thiamine deficiency?
(iii) Might there be a bottom effect, since infection will utilize already depleted thia-
mine stores?
(iv) Can possible cognitive effects of systemic inflammation in Wernicke-Korsakoff 
syndrome be interpreted in terms of a differential vulnerability of brain areas involved in 
executive functioning and those involved in memory function?
(v) Are worse cognitive outcomes more specifically related to septic conditions or, e.g., 
endotoxines of gram-negative bacteria? 33
11.4. furthEr conSIDEratIonS on MEchanISMS In WKS
So far, we have highlighted the linkage between thiamine deficiency and delirium and 
emphasized the occurrence of coincidental infections and its possible impact on the 
Wernicke-Korsakoff syndrome. Based on the review of Chapter 5 we suggested that 
inflammation-related delirium (van Gool et al, 2011) and thiamine deficiency delirium 
may share comparable underlying mechanisms. Furthermore, in Chapter 6, we hypoth-
esized on associations between the severity of thiamine deficiency, systemic inflamma-
tory processes, and neurocognitive damage in Wernicke-Korsakoff syndrome. However 
33 Endotoxin (lipopolysaccharides): Toxin contained in the cell walls of some micro-organisms, 
especially gram-negative bacteria, that is released when the bacterium dies and is broken 
down in the body. Fever, chills, shock, leukopenia, and a variety of other symptoms result, 
depending on the particular organism and the condition of the infected person (Mosby’s 
medical dictionary, 8th edition. Elsevier; 2009).
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there is no clear understanding of the basic mechanisms by which the overall syndrome 
occurs (Cf., Hazell & Butterworth, 2009).
The pathogenesis of Wernicke-Korsakoff syndrome may probably consist of different 
interdependent processes related to inflammatory factors, metabolic effects due to thia-
mine deficiency, and occasionally comorbid conditions such as magnesium deficiency 
and diabetes mellitus. For instance, in a postmortem study of Wernicke encephalopathy 
cases, the neuropathological findings in the thalamus and inferior olivary nuclei were 
different compared with those of the mammillary bodies and the subependymal struc-
tures along the third and fourth ventricles and the aqueduct. In contrast with the latter 
brain regions, the thalamus and inferior olivary nuclei showed neuronal loss histologi-
cally resembling neuronal disintegration as seen in anoxic necrosis (Torvik, 1985).
Inflammatory mechanisms in thiamine deficiency. In a recent update Abdou & Hazell 
(2015) summarized the complex pathophysiologic mechanisms in thiamine deficiency 
and the role of impaired oxidative metabolism, lactate production of astrocytes, lac-
tic acidosis, increased extracellular glutamate levels, glutamate receptor activation, 
glutamate-mediated excitotoxicity in glia cells, i.e. astrocytes and microglia, resulting 
in − or associated with − oxidative stress and inflammatory processes, all features of 
thiamine deficiency.34, 35
Magnesium deficiency. Thiamine is an essential co-factor for a number of enzymes 
involved in carbohydrate metabolism and requires optimal levels of magnesium for 
biological function. Chronic alcoholic patients are at risk of developing combined defi-
ciencies of thiamine and magnesium (Peake et al, 2013). Furthermore, hypomagnesemia 
may be a rare but serious complication of proton pump inhibitors in patients concomi-
tantly receiving diuretics (Danziger et al, 2013), e.g., in alcoholic patients suffering of 
esophagitis, liver cirrhosis, and ascites.
Diabetes mellitus. Glucose is the main energy source for the brain. In times of starva-
tion, however, the brain has the capacity to adapt to the use of ketones for its energy 
requirements. Ketogenesis is normally inhibited by insulin hormone. In low levels of 
circulating insulin − as seen during starvation and diabetic ketoacidosis − ketones are 
formed by β-oxidation of free fatty acids in the liver. It appears that astrocytes play a role 
in regulation of brain energy metabolism and are capable of producing ketones from 
fatty acids, as well (White & Venkatesh, 2011).
We assume that hyperglycemia in uncontrolled diabetes mellitus may further deplete 
already marginal thiamine reserves in malnourished alcoholic patients. Further research 
34 Glutamate receptors include among others N-methyl-D-aspartate (NMDA) receptors.
35 Excitotoxicity: Neuronal injury caused by excessive release of excitatory neurotransmitters 
− glutamate and aspartate, causing damage to nerve and glial cells (Segen JC. Concise diction-
ary of modern medicine. The McGraw-Hill Companies, Inc; 2002).
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is necessary to clarify these issues and to determine whether diabetes mellitus could be 
an additional risk factor in thiamine deficiency.
Clearly, a thorough understanding of the course of Wernicke-Korsakoff syndrome is cur-
rently lacking. The associations between the severity of thiamine deficiency, systemic 
inflammatory processes, and neurocognitive damage in Wernicke-Korsakoff syndrome 
are complex and need to be tested by additional studies based on different method-
ological approaches.
11.5. alcoholISM, vItaMIn D DEfIcIEncy, anD MuSclE WEaKnESS
Research question (V): Is vitamin D deficiency a confounder in alcoholic muscle weak-
ness?
11.5.1. vitamin D deficiency
The causes of vitamin D deficiency in alcoholism may include liver dysfunction, lack of 
sun exposure, malabsorption, and inadequate dietary intake. As previous studies sug-
gested that a deficiency in diet could not cause alcoholic muscle disease, our review 
indicates that vitamin D deficiency might partly explain why myopathy is so often 
observed in chronic alcoholism.
11.5.2. recent research on vitamin D supplementation
The serum 25(OH)D response to supplementation depends on several factors, e.g., 
baseline 25(OH)D level, BMI, and genetic factors.36 However, whether this is clinically 
important or not depends on the therapeutic window of vitamin D, an issue that is still 
not settled (Didriksen et al, 2013). Figure 11−3 shows mean 25(OH)D levels at baseline 
and following different vitamin supplementation regimes in small groups of healthy 
participants (Ala-Houhala et al, 2012; Close et al, 2013; Diamond et al, 2013; Goswami 
et al, 2012; Knutsen et al, 2014; Lehmann et al, 2013; Owens et al, 2014; Wicherts et al, 
2011) or in selected patient groups with various degrees of vitamin D deficiency (Bogh 
et al, 2012; Dinizulu et al, 2011; Karaplis et al, 2011 Leidig-Bruckner et al, 2011). In a ran-
domized clinical trial of vitamin D deficiency with baseline serum 25(OH)D levels of < 25 
nmol/L and six months follow-up, supplementation with vitamin D in doses of 800 IU/
day versus 100,000 IU/3 months gave comparable results, i.e., the mean baseline value 
36 BMI; Body Mass Index is calculated from a person’s Weight (kilogram) and Height (meter) as W 
/ ( H )2.
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of 22.5 ± 11.1 nmol/L increased to 53 nmol/L and 50.5 nmol/L, respectively (Wicherts et 
al, 2011).
11.5.3. vitamin D and muscle wellness
The role of serum 25(OH)D levels in maintaining or improving physical performance 
and muscle strength is still being discussed. The available studies often vary in their 
populations studied, severity of baseline vitamin D deficiency, and baseline physical 
functioning (Lagari et al, 2013).
A recent systematic review on vitamin D supplementation showed a small positive 
effect on muscle strength. Results on muscle strength were significantly more important 
in baseline 25(OH)D levels < 30 nmol/L (Beaudart et al, 2014). In adults ≥ 60 year, stud-
ies with daily doses of 800−1,000 IU of vitamin D supplementation showed beneficial 
effects on muscle strength and balance. An effect on gait was not demonstrated. (Muir 
et al, 2011).
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figure 11−3. Effects on mean serum 25(OH)vitamin D levels in twelve studies with 1−3 vitamin D supple-
mentation strategy/ strategies per study. The treatment dose of ‘0 IU/day’ reflects treatment with placebo. 
Mean 25(OH)D levels at baseline ranged from 23 nmol/L to 63 nmol/L, here subdivided in four categories. 
Treatment dose of 20,000 IU/week is plotted as 2,857 IU/day; dose of 40,000 IU/week is plotted as 5,714 IU/
day; 60,000 IU/2 weeks is plotted as 4,285 IU/day; 100,000 IU/3 months is plotted as 1,098 IU/day. Refer-
ences: Ala-Houhala et al, 2012; Bogh et al, 2012; Close et al, 2013; Diamond et al, 2013; Dinizulu et al, 2011; 
Goswami et al, 2012; Karaplis et al, 2011; Knutsen et al, 2014; Lehmann et al, 2013; Leidig-Bruckner et al, 
2011; Owens et al, 2014; Wicherts et al, 2011.
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Until now, the effect of vitamin D on muscle weakness in alcoholic patients has not been 
investigated. We assume that skeletal muscle function may be more commonly affected 
in conditions associated with severe vitamin D deficiency of serum 25(OH)D < 20 nmol/L. 
In fact, vitamin deficiency may reflect less than optimal health in selected populations, 
such as in chronic alcoholism. For instance, in recent observational studies, hypovita-
minosis D was found highly prevalent in critically ill patients and was associated with 
worse disease severity (Nair et al, 2013). In the general population, low serum 25(OH)D 
was associated with an excess risk of death compared to 25(OH)D values greater than 
50−70 nmol/L (Johansson et al, 2012) in men aged 70−81 years.
11.5.4. Strength and limitations
Our review links possible interdependent deficiencies of vitamin D, phosphate, and 
magnesium with muscle weakness in chronic alcoholism. However, since symptoms are 
rather aspecific, this is no more than an association, which is obviously not the same 
as a causal relationship. The review may be important because of this connection, but 
the real proof is in the pudding, by doing further research in clinical trials focusing on 
possible beneficial effects of vitamin D supplementation and on optimal dosages (Study 
protocol, Chapter 8).
11.5.5. conclusion to research question (v)
Severe vitamin D deficiency probably is a confounder in alcoholic muscle weakness.
11.5.6. consequenses for daily practice
We recommend assessment of the vitamin D status in alcoholic patients and supple-
mentation of vitamin D deficiency, when present. Beneficial effects of vitamin D supple-
mentation in chronic alcoholic myopathy remain to be confirmed in clinical trials.
11.6. SuggEStIonS for futurE rESEarch
11.6.1. Delirium, mechanisms, and relation with infections in thiamine 
deficiency
We recommend future research focusing on strategies for the early identification of 
delirium in Wernicke-Korsakoff syndrome and assessment of the temporal progression 
of delirium including quantification of transitional stages and protracted or persistent 
delirium.
Although our findings suggest that Wernicke delirium may represent the initial phase 
of Wernicke-Korsakoff syndrome due to mechanisms of microglial activation, extensive 
confirmation of these mechanisms requires further research. In order to determine 
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whether mediating factors in microglial activation, other than thiamine deficiency, may 
account for an ineffective treatment of the more severe cases of Wernicke encephalopa-
thy, further investigation is warranted.
The interrelationship of infections and thiamine depletion may represent a relevant 
area for further research in critically ill patients (Manzanares & Hardy, 2011; Ramsi et al, 
2014). Early and adequate thiamine supplementation could be helpful to self-neglecting 
alcoholic patients presenting with infections, confusion, drowsiness, or walking disabil-
ity.
11.6.2. neuropathological substrate of Wernicke-Korsakoff syndrome
In future work we hope to further integrate the concept of Wernicke delirium into a 
comprehensive description of the neuropathological substrate of Wernicke-Korsakoff 
syndrome, explaining both delirium and cognitive deficits in terms of alterations or 
structural disconnectivity of relevant neuronal tracts most vulnerable to the effects of 
thiamine deficiency.
Yet we do not have a clear view of which neuronal tracts are particularly involved in 
the mental signs and symptoms of Wernicke-Korsakoff syndrome − e.g., in what way 
cholinergic tracts of the brainstem are involved in the encephalopathic stage of the syn-
drome (Cf., Nardone et al, 2013; Vorhees et al, 1977). Our hypothesis of fronto-cerebellar 
disconnectivity in the end-stage Korsakoff syndrome (supplementary Chapter 9) seems 
somewhat odd in the context of the thesis, but might be a first step in attempting to 
more clearly understand the overall symptom profile of Wernicke-Korsakoff syndrome.
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SuMMary
Early Detection of Mental and Motor Symptoms In the Wernicke-Korsakoff Syndrome
1. WErnIcKE-KorSaKoff SynDroME
Wernicke-Korsakoff syndrome is a neuropsychiatric disorder consisting of mental confu-
sion and irreversible brain damage caused by vitamin B1 deficiency. Wernicke encepha-
lopathy − the acute phase of Wernicke-Korsakoff syndrome − is falsely considered as 
uncommon and is largely misdiagnosed, especially in malnourished alcoholic patients 
at high risk of developing the disease (Chapter 2 of this thesis; Lemyze et al, 2009). Many 
cases of Wernicke encephalopathy remain unrecognized until the classic signs of ocular 
motility impairment, ataxia of gait, and confusion, help to make the diagnosis (Lemyze 
et al, 2009; Thomson et al, 2009). Unfortunately, these classical signs were found in only 
16% of patients with Wernicke encephalopathy (Harper et al, 1986).
2. rESEarch by SlIngEDaEl KorSaKoff cEntEr
Clinical signs of Wernicke encephalopathy most often occur within hours to days 
before a subsequent hospital admission (Chapter 3 & 6). The emergence of Wernicke 
encephalopathy may be identified by the presence of a delirium in malnourished alco-
holic patients who have trouble walking. In these patients, the delirium is usually due 
to the vitamin B1 deficiency among other causes, which may be erroneously diagnosed 
as alcohol withdrawal delirium (Chapter 2−4). Other heralding symptoms of vitamin B1 
deficiency are the serious infections that are likely to occur during the acute Wernicke 
phase (Chapter 6).
Physicians may have a limited comfort zone as far as their knowledge of treating 
patients with alcohol abuse issues. During our hospital visits, we generally heard: “The 
patient was admitted to the hospital for social reasons, should be transferred to a ‘more 
appropriate’ department, or needs no further treatment.”
To improve early detection of Wernicke-Korsakoff syndrome, we studied the associa-
tions between Wernicke-Korsakoff syndrome (vitamin B1 deficiency) and:
-The occurrence of delirium (Chapter 2−5).
-The temporal progression regarding gait- and balance impairments (Chapter 4).
-The occurrence of severe infections in the acute Wernicke phase (Chapter 6).
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Another vitamin (vitamin D deficiency) may potentially affect muscle health in alcohol-
ism. This topic is worked out in two Chapters:
-Vitamin D deficiency and muscle disease in alcoholism (Chapter 7).
-A research protocol on vitamin D deficiency in alcoholic muscle weakness (Chapter 8).
3. thE anSWErS to thE rESEarch quEStIonS
The answers to the research questions of Chapter 1 are summarized as follows:
(I) Wernicke encephalopathy and delirium may be considered synonymous conditions in 
malnourished alcoholic patients.
(II) In a detailed case study, the Wernicke-Korsakoff syndrome is highlighted as a neu-
ropsychiatric disorder with mental and motor symptoms that appear in a combined 
fashion.
(III) Severe infections were common during the Wernicke phase of Korsakoff patients 
admitted to Slingedael Korsakoff Center, Rotterdam.
(IV) Infection parameters (white blood cell counts, absolute neutrophil counts) might be 
related to the cognitive outcomes.
(V) Severe vitamin D deficiency probably is a confounder in alcoholic muscle weakness.
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4. SuMMary of thE chaPtErS of thE thESIS
chapter 1 − general introduction of Wernicke-Korsakoff syndrome
Korsakoff syndrome is a chronic form of amnesia resulting from thiamine deficiency. The 
syndrome can develop from unrecognized or undertreated Wernicke encephalopathy. 
Chapter 1 contains general information on the Wernicke-Korsakoff syndrome and the 
research questions are listed in this Chapter.
chapter 2 − Wernicke delirium mistaken for alcohol withdrawal delirium
Wernicke encephalopathy can easily be mistaken for alcohol withdrawal delirium. Ap-
parently, a history of alcohol abuse influences the diagnosis of patients with delirium, 
such that Wernicke encephalopathy may be overlooked. In order to identify possible 
Wernicke encephalopathy in malnourished alcoholic patients, it is essential to give 
proper attention to any signs of delirium and to problems with gait and posture, as well.
chapter 3 − Descriptive study of delirium onset and alcohol withdrawal 
duration
We presented a descriptive, retrospective study of initial symptoms, comorbidity, and 
alcohol withdrawal in alcoholic patients with subsequent Korsakoff syndrome. We 
investigated whether delirium in these patients might be consistent with unidentified 
Wernicke encephalopathy. In 25/73 (34%) of the patients the classic triad of Wernicke 
encephalopathy with ocular symptoms, ataxia and confusion, was found. In at least 6/35 
(17%; 95%-confidence interval: 10−25%) of the deliria we observed no other underlying 
causes, thus excluding other somatic causes, medication, (recent) alcohol withdrawal, 
or intoxication. We suggest that these deliria may have been representing Wernicke 
encephalopathy without the classic symptoms of ophthalmoplegia, nystagmus, and 
ataxia. Clinicians must be vigilant for these partial cases, and manage them similarly to 
patients manifesting the full syndrome. A high frequency (15%) of diabetics may reflect 
a contributing factor of diabetes mellitus in the evolution of the Wernicke-Korsakoff 
syndrome.
chapter 4 − Detailed case description of mental symptoms and impaired 
mobility
The intra-individual course of Wernicke-Korsakoff syndrome has not been studied ex-
tensively, nor has the temporal progression of gait disturbances and other symptoms of 
Wernicke encephalopathy. In a detailed case history, we followed the patient’s mobility 
changes and the shifts in his mental status from global confusion and impaired con-
sciousness to more selective cognitive deficits.
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Patients with a history of self-neglect and alcohol abuse, at risk of or suffering with 
Wernicke encephalopathy, should receive immediate and adequate vitamin replace-
ment. Self-neglecting alcoholics who are bedridden may have severe illness and prob-
ably active Wernicke encephalopathy. In these patients, mobility changes, delirium, or 
impaired consciousness can be an expression of Wernicke encephalopathy and should 
be treated to prevent further damage from the neurologic complications of thiamine 
deficiency.
chapter 5 − Systematic review of delirium mechanisms
In this Chapter we further highlighted the linkage between thiamine deficiency and 
delirium and presented a review of candidate biomarkers of delirium in Wernicke-
Korsakoff syndrome and other clinically related conditions − as a possible clue to the 
pathogenesis of WKS. The earliest biochemical change in Wernicke-Korsakoff syndrome 
is the decrease of alpha-KGDH activity in astrocytes. According to autopsy-based series, 
mental status changes are present in 82% of Wernicke encephalopathy cases. The objec-
tive of the present review is to identify possible underlying mechanisms relating the 
occurrence of delirium to Wernicke-Korsakoff syndrome. Studies involving delirium in 
Wernicke-Korsakoff syndrome, however, are rare. We therefore chose, firstly, to search 
for candidate biomarkers of delirium irrespective of the clinical setting. Secondly, the re-
sults are focused on identification of these biomarkers in reports on Wernicke-Korsakoff 
syndrome.
In various settings, ten biochemical and/ or genetic biomarkers showed strong as-
sociations with the occurrence of delirium. For Wernicke-Korsakoff syndrome, three of 
these candidate biomarkers were identified, namely brain tissue cell counts of CD68-
positive cells as a marker of microglial activation, high cerebrospinal fluid lactate levels, 
and MHPG, a metabolite of norepinephrine. Based on current literature, markers of 
microglial activation may present an interesting pathoetiological relationship between 
thiamine deficiency and delirium in Wernicke-Korsakoff syndrome. The possible loss-
of-function mechanisms following thiamine deficiency in Wernicke-Korsakoff syndrome 
are proposed to come from microglial activation, resulting in a delirium in the initial 
phase of the syndrome.
chapter 6 − Descriptive study: impact of coincidental infections
In this Chapter we emphasized the occurrence of coincidental infections and its possible 
impact on the Wernicke-Korsakoff syndrome. We presented a retrospective, descrip-
tive study of patients admitted to Slingedael Korsakoff Center. We hypothesized that 
systemic infections in the acute phase are associated with cognitive deficits in patients 
with Wernicke-Korsakoff syndrome. Patients were selected for further analysis if the 
onset of the Wernicke-Korsakoff syndrome was clearly documented and if data were 
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available on white blood cell counts in the acute phase and at least one of six predefined 
neuropsychological tests on follow-up.
Infections were reported in 35/68 (51%) patients during the acute phase of WKS: 
meningitis (1), pneumonia (14), urinary tract infections (9), acute abdominal infections 
(4), septicemia (5) and/ or empyema (1), and infection ‘of unknown origin’ (4).
The neuropsychological test results showed significant lower scores on the Cambridge 
Cognitive Examination (CAMCOG) non-memory section with increasing white blood cell 
counts and on the ‘Key search test’ of the Behavioral Assessment of the Dysexecutive 
Syndrome (BADS) with increasing absolute neutrophil counts. We concluded that infec-
tions may be a presenting manifestation of thiamine deficiency. Wernicke-Korsakoff 
patients who suffered from an infection during the acute phase are at risk of worse neu-
ropsychological outcomes on follow-up. These results should, however, be interpreted 
with caution as the effect estimates were based on a relatively small study population 
with incomplete data regarding relevant parameters of infection and inflammatory 
processes.
chapter 7 − other causes of impaired mobility: review of muscle weakness in 
alcoholism
Myopathy refers to a muscular disease in which muscle fibers do not function, resulting 
in muscular weakness and wasting. Vitamin D deficiency is a well-recognized cause of 
myopathy, and excessive alcohol consumption is often associated with low or subnormal 
levels of vitamin D. We reviewed articles on alcoholic myopathy and hypovitaminosis 
D myopathy and compared the pathophysiological findings in order to ‘chart’ possible 
pathways of vitamin D action in the development of alcohol-related myopathy. Based on 
these results of a strong interdependency of suboptimal levels of vitamin D, phosphate, 
and magnesium in association with chronic alcohol abuse, we hypothesize that these 
combined deficiencies interfere with membrane and intracellular metabolic processes 
in alcohol-related chronic myopathy, although the exact mechanisms remain unclear. 
While it is possible that vitamin D supplementation may be helpful in prevention and 
treatment of alcohol-related chronic myopathy, further research is needed to determine 
if this can improve muscle function if alcohol consumption ceases, and what dosages of 
vitamin D may be optimal.
chapter 8 − research protocol of a vitamin D supplementation program in 
alcoholism
Decreased bioavailability of vitamins may be due to inadequate dietary sources, lower 
intestinal absorption and/ or liver dysfunction. Muscular weakness and wasting is fre-
quently found in chronic alcoholism and might be related to severe vitamin D hypovi-
taminosis. In this Chapter we describe a study protocol to evaluate the effect of vitamin 
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D supplementation in alcoholic myopathy through intensive outreach in 12 months 
follow-up.
chapter 9 − Supplementary: a hypothesis on neuronal tracts in Korsakoff 
syndrome
We proposed further research on the neuronal connections of the frontal brain and the 
cerebellum in their relation to cognitive disturbances in Wernicke-Korsakoff syndrome.
chapter 10 − Supplementary: information on thiamine therapy
Brief description of thiamine treatment dosages and recommendations on intravenous 
administering of thiamine in Wernicke encephalopathy (in addition to the information 
of Table 4−4 in Chapter 4).
chapter 11 − general discussion
In this thesis, we have tried to examine systematically the relation of delirium to the 
Wernicke-Korsakoff syndrome. The relationship between thiamin deficiency and de-
lirium is complex, as is described in successive paragraphs of this Chapter. Based on 
observations and suggestions regarding the pathophysiological mechanisms of action, 
Wernicke-Korsakoff syndrome can be seen as delirium-related cognitive damage. Fur-
thermore, thiamin deficiency is strongly associated with the occurrence of general in-
fections. In this respect, the Wernicke-Korsakoff syndrome is a multidisciplinary disease 
that requires the collaboration across disciplines − psychiatrists, neurologists, internal 
medicine physicians, emergency physicians, intensive care physicians, and others.
In daily medical practice, the patients’ mental confusion and immobility make the 
physical examination more difficult. However, the observed combination of impaired 
mobility and mental disturbances presents a striking feature of Wernicke-Korsakoff 
disease. In fact, this combination of symptoms may facilitate the early detection of 
Wernicke-Korsakoff syndrome in malnourished alcoholic patients. Alcoholism and 
insufficient dietary intake are also associated with other deficiencies than vitamin B1 
deficiency. We paid attention to vitamin D deficiency, which probably can affect muscle 
mass and muscle strength in chronic alcoholism.
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nEDErlanDSE SaMEnvattIng
Vroegsignalering van mentale en motore verschijnselen bij het syndroom van Wernicke-
Korsakov
1. hEt SynDrooM van WErnIcKE-KorSaKov
Het syndroom van Wernicke-Korsakov is een vorm van verwardheid, dat is de ziekte van 
Wernicke, met daarna vaak een blijvende hersenschade in de vorm van het syndroom 
van Korsakov. Het syndroom van Wernicke-Korsakov wordt veroorzaakt door vitamine 
B1-gebrek.37 Het begint dus met verwardheid. En het eindigt met hersenschade.
Er wordt gezegd dat de ziekte van Wernicke vrij weinig voorkomt en dat het syndroom 
van Korsakov vaak sluipend begint. Maar dat is een misvatting. De verschijnselen van 
het syndroom van Wernicke-Korsakov ontstaan vaak enkele uren tot dagen voor een zie-
kenhuisopname. Het begin is te herkennen aan infecties en vooral aan de aanwezigheid 
van een delier38 bij een alcoholist die niet kan lopen. De infecties zijn ernstig en komen 
bij de helft van de mensen in de Wernickefase voor. Het delier komt meestal niet door 
het stoppen of verminderen van alcoholgebruik, maar wordt door het vitaminegebrek 
zelf veroorzaakt.
Het syndroom van Wernicke-Korsakov kan ontstaan bij alcoholisten die niet of nau-
welijks eten. De medische zorg voor verwarde alcoholisten wordt door hulpverleners 
in het ziekenhuis meestal niet als chique of uitdagend ervaren. Op de afdeling in het 
ziekenhuis wordt dan vaak gezegd dat hij/zij tussen wal en schip is gevallen, werd 
opgenomen met een sociale indicatie of inmiddels is uitbehandeld (Hoofdstuk 1 en 2).
2. KorSaKovcEntruM SlIngEDaEl
Slingedael biedt Korsakovzorg met verblijf, wonen en welzijn (locatie Slingedael) en ob-
servatie, diagnostiek en dagopvang (locatie Tussendael) in Rotterdam. Vanuit Slingedael 
deden we systematisch onderzoek naar het syndroom van Wernicke-Korsakov (vitamine 
B1 gebrek) en:
-Het optreden van het delier (Hoofdstuk 2 t/m 5).
-Het verloop van de loop- en balansstoornissen (Hoofdstuk 4).
37 Een andere naam voor vitamine B1 is thiamine.
38 Het woord ‘delirium’ (of delier) komt van het Latijnse: de  =  vanaf, lira  =  groef, spoor. Dus 
van het spoor af, ontspoord. Het is een vorm van verwardheid. Bijvoorbeeld een delier bij 
koorts = ijlen.
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-Het optreden van ernstige infecties (Hoofdstuk 6).
De bedoeling van dit onderzoek was om een beter beeld te krijgen van het syndroom 
van Wernicke-Korsakov. Dit kan helpen bij een betere herkenning van het syndroom.
Een andere vitamine (vitamine D-gebrek) kan ook van invloed zijn op de balans en 
spierkracht bij alcoholisme. Dit thema wordt apart uitgewerkt in de daarop volgende 
hoofdstukken:
-Vitamine D-gebrek en spierziekte bij alcoholisme (Hoofdstuk 7).
-Een plan voor verder onderzoek met vitamine D (Hoofdstuk 8).
3. antWoorDEn oP DE onDErzoEKSvragEn
De antwoorden op de onderzoeksvragen uit hoofdstuk 1, worden als volgt samengevat:
(I) De ziekte van Wernicke en delier kunnen als synonieme begrippen worden beschouwd 
bij ondervoede alcoholisten.
(II) Het syndroom van Wernicke-Korsakov is een neuropsychiatrische aandoening met 
mentale en motore symptomen die met elkaar gecombineerd optreden.
(III) Ernstige infecties kwamen regelmatig voor tijdens de Wernickefase van Korsakov-
patiënten, die in Korsakovcentrum Slingedael werden opgenomen.
(IV) Infectiewaarden tijdens de Wernickefase zijn mogelijk gekoppeld aan de neuropsy-
chologische testresultaten bij het syndroom van Korsakov.
(V) Een ernstig vitamine D-gebrek is een factor om rekening mee te houden bij spier-
zwakte en alcoholisme.
4. SaMEnvattIng van DE hoofDStuKKEn
hoofdstuk 1 − algemene introductie: het syndroom van Wernicke-Korsakov
Het syndroom van Korsakov is een blijvend geheugenverlies door vitamine B1-gebrek. 
Het syndroom kan ontstaan na een Wernickefase die niet is herkend en niet is behandeld. 
Hoofdstuk 1 beschrijft algemene informatie over het syndroom van Wernicke-Korsakov 
en de onderzoeksvragen van dit proefschrift staan in dit hoofdstuk op een rij.
hoofdstuk 2 − het Wernicke-delier wordt aangezien voor 
alcoholonttrekkingsdelier
De Wernickefase van het syndroom van Wernicke-Korsakov wordt gemakkelijk verward 
met een andere aandoening bij alcoholisten, namelijk een delier door stoppen of min-
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deren van alcoholgebruik. In dit hoofdstuk wordt een begin gemaakt met de introductie 
van het delier en de loopstoornissen die voorkomen in de beginfase van het syndroom 
van Wernicke-Korsakov.
hoofdstuk 3 − beschrijvend onderzoek: begin van het delier en duur van de 
alcoholonttrekking
We beschrijven beginsymptomen, gelijktijdig aanwezige ziekten en eventuele alcohol-
onttrekking bij alcoholisten die daarna een Korsakovsyndroom hadden en bij ons wer-
den aangemeld. Uit de beschikbare gegevens onderzochten we of een delier bij deze 
patiënten overeen zou kunnen komen met een niet-ontdekte Wernicke encefalopathie. 
Bij 25/73 (34%) van de patiënten kwamen de drie klassieke verschijnselen voor van de 
ziekte van Wernicke: oogsymptomen, ataxie en verwardheid. Bij ten minste 6/35 is 17% 
(het 95%-betrouwbaarheidsinterval is 10%−25%) van de delieren vonden we geen an-
dere onderliggende oorzaak, rekening houdend met lichamelijke oorzaken, medicatie 
en een (recente) alcoholonttrekking of alcoholintoxicatie. We houden het erop dat deze 
delieren de ziekte van Wernicke vertegenwoordigden zonder de klassieke verschijnselen 
van een oogspierverlamming, nystagmus en ataxie. Het is van belang deze onvolledige 
presentatie te herkennen en de patiënten te behandelen, zoals bij de volledige presen-
tatie van de ziekte van Wernicke. Een hoog percentage (15%) diabetespatiënten kan een 
aanwijzing zijn dat suikerziekte invloed heeft bij een zich ontwikkelend syndroom van 
Korsakov.
hoofdstuk 4 − casusbeschrijving: mentale verschijnselen en problemen met 
het lopen
Hoe het syndroom van Wernicke-Korsakov bij iemand in de tijd precies verloopt, is niet 
eerder onderzocht. Het tijdsverloop van de loopstoornissen bij de ziekte van Wernicke 
is ook niet onderzocht. We beschrijven hier in detail het verloop van de ziekte van Wer-
nicke bij een patiënt die in het begin nog instabiele ziekteverschijnselen had. We volgen 
de veranderingen van zijn mobiliteit en van zijn mentale situatie die zich wijzigt van een 
globale verwardheid en een gestoord bewustzijn naar een meer afgebakende schade 
van de cognitieve functies.39 Zijn ziekte van Wernicke werd aangeduid als ‘mogelijk’ 
syndroom van Korsakov en was onvoldoende behandeld volgens de multidisciplinaire 
richtlijn ‘Stoornissen in het gebruik van alcohol’ van het Trimbosinstituut.40
Patiënten met een voorgeschiedenis van zelfverwaarlozing en alcoholmisbruik lopen 
het risico aan de ziekte van Wernicke te lijden en moeten zo snel mogelijk worden be-
handeld met de juiste toediening van vitamine B1. Zichzelf verwaarlozende, bedlegerige 
39 Cognitieve functies van de hersenen zijn bijvoorbeeld iets leren, onthouden, inzien en begrij-
pen.
40 De richtlijn is te vinden op www.diliguide.nl/document/1820.
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alcoholisten hebben waarschijnlijk op dat moment een actieve ziekte van Wernicke, wat 
een ernstig ziektebeeld is. Een slechte mobiliteit, een delier of een gestoord bewustzijn 
kunnen bij hen de uiting zijn van de ziekte van Wernicke en moeten als zodanig behan-
deld worden om verdere schade door de neurologische complicaties van het vitamine 
B1-gebrek te voorkomen.
hoofdstuk 5 − Systematisch literatuuronderzoek van mechanismen bij een 
delier
In dit hoofdstuk besteedden we verder aandacht aan de ‘link’ tussen vitamine B1-gebrek 
en een delier. De vroegste biochemische verandering bij het syndroom van Wernicke-
Korsakov is een verlaagde α-KGDH-activiteit in bepaalde hersencellen, de astrocyten. 
Volgens hersenenonderzoek bij mensen die aan de ziekte van Wernicke zijn overleden, 
hadden 82% van hen verschijnselen wat de psychische gesteldheid betreft. Het doel 
van ons onderzoek is om een overzicht te geven van mogelijke onderliggende me-
chanismen die een schakel vormen tussen het syndroom van Wernicke-Korsakov en 
de aanwezigheid van een delier. Er is weinig onderzoek gedaan naar een delier bij het 
syndroom van Wernicke-Korsakov. Daarom kozen we er bij ons literatuuronderzoek 
voor eerst naar mogelijke biomarkers41 van een delier te zoeken, ongeacht de klinische 
omstandigheden. Vervolgens gebruikten we de aldus gevonden kandidaat-biomarkers 
voor een zoektocht binnen de literatuur over het syndroom van Wernicke-Korsakov.
Gebaseerd op verschillende patiëntengroepen kwamen er tien biochemische en/of 
genetische biomarkers naar voren, die een sterk verband vertoonden met het optreden 
van een delier. Wat het syndroom van Wernicke-Korsakov betreft, kwamen we uit op 
drie kandidaat-biomarkers voor een delier, namelijk (uit hersenonderzoek) het aantal 
CD68-positieve cellen als een marker van microglia-activiteit, verder een hoog lac-
taatgehalte (in hersenliquor) en ten slotte MHPG, dat is een stofwisselingsproduct van 
noradrenaline. Microglia zijn cellen die in de hersenen deel uitmaken van het (afweer)
systeem voor het opruimen van schade of lichaamsvreemd materiaal. Een ontspoorde 
microglia-activatie zou een belangrijke schakel kunnen zijn tussen vitamine B1-tekort en 
een delier bij het syndroom van Wernicke-Korsakov. Op grond van de verzamelde litera-
tuur veronderstellen we dat ontregeling van de microglia-activatie een mechanisme is 
waardoor vitamine B1-tekort kan leiden tot een delier en verminderde hersenfunctie bij 
het syndroom van Wernicke-Korsakov.
41 Biomarkers zijn meetbare biologische verschijnselen, bijvoorbeeld bepaalde uitslagen van 
een bloedonderzoek, die gebruikt kunnen worden om de aanwezigheid van een bepaalde 
ziekte vast te stellen, of het verloop van die ziekte (of de effecten van een behandeling) te 
volgen.
SAMENVATTING 145
hoofdstuk 6 − beschrijvende studie: aanwezigheid en gevolgen van infecties
Bij mensen met het syndroom van Korsakov deden we een beschrijvend onderzoek naar 
de aanwezigheid van infecties tijdens de voorafgaande ziekte van Wernicke. We hadden 
het idee dat infecties in het lichaam tijdens de beginfase gekoppeld zouden kunnen zijn 
aan de mate van hersenschade bij patiënten met het syndroom van Wernicke-Korsakov. 
Doel was om na te gaan of ‘markers’ van een infectie in de acute Wernickefase, zoals het 
aantal witte bloedcellen en (voor zover genoteerd) het aantal neutrofiele granulocyten, 
in verband staan met stoornissen in de cognitieve functies bij het syndroom van Korsa-
kov.42
Er werd gekeken naar ontslagbrieven van voorafgaande opnames in een ziekenhuis 
en gezocht naar gegevens over infecties tijdens de acute Wernickefase. De gegevens 
werden gebruikt als uit de ontslagbrief kon worden opgemaakt wanneer het syndroom 
van Wernicke-Korsakov was begonnen. En als tijdens die eerste fase bloedonderzoek was 
gedaan met in ieder geval een bepaling van het aantal witte bloedcellen. Verder hadden 
we van tevoren een keus gemaakt welke neuropsychologische testresultaten we wilden 
hebben. Het gaat om een beperkte set van zes testen (screeningsinstrumenten en 
neuropsychologische testen), waarvan we verwachtten dat één of meer van die testen 
gedaan waren. Infecties waren beschreven bij 35/68 is 51% van de patiënten tijdens de 
beginfase van het syndroom van Wernicke-Korsakov. Bij deze 35 patiënten kwamen de 
volgende infecties voor: hersenvliesontsteking (kwam één keer voor), longontsteking 
(14 keer), urineweginfecties (9), acute buikinfecties, waaronder buikvliesontsteking (4), 
bloedvergiftiging (5) en/of pus in een bestaande lichaamsholte (1) en infecties waarvoor 
geen oorzaak is gevonden (4).
Niet bij alle patiënten waren alle zes neuropsychologische testen gedaan. De wel aan-
wezige neuropsychologische testresultaten lieten significant lagere scores zien op dat 
onderdeel van de ‘Cambridge Cognitive Examination’ (CAMCOG) dat niet het geheugen 
testte: bij toename van de witte bloedcellen werd met de Spearman rangcorrelatie coëf-
ficiënt (Rho) een matig sterk maar significant verband gevonden met lagere uitkomsten 
van deze CAMCOG-score (Rho is -0,34 met een 95%-betrouwbaarheidsinterval van 
-0,57 tot -0,06 in een groep van 44 patiënten). Verder werd op een ander testonder-
deel, namelijk de Sleutelzoektest van de ‘Behavioral Assessment of the Dysexecutive 
Syndrome’ (BADS) een sterk en significant verband gevonden met lagere scores op de 
Sleutelzoektest bij toename van het aantal neutrofiele granulocyten (Rho is -0,85 met 
een 95%-betrouwbaarheidsinterval van -0,97 tot -0,42 bij negen patiënten bij wie deze 
bloedbepaling bekend was).
42 De neutrofiele granulocyt is een type witte bloedcel dat vooral in aantal toeneemt bij een 
infectie door bacteriën. Cognitieve functies van de hersenen zijn, zoals eerder vermeld, bij-
voorbeeld iets leren, onthouden, inzien en begrijpen.
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Infecties kunnen de uiting zijn van vitamine B1-gebrek. Patiënten bij wie zich het 
syndroom van Wernicke-Korsakov ontwikkelt, lopen kans op slechtere neuropsycholo-
gische uitkomsten als er in de beginfase infecties aanwezig waren.
hoofdstuk 7 − Spierzwakte bij chronisch alcoholisme: een literatuuronderzoek
Het woord ‘myopathie’ wordt gebruikt voor spierziekte waarbij spiervezels niet goed 
functioneren, wat zich uit in spierzwakte en verlies van spierweefsel. Een tekort aan 
vitamine D is een bekende oorzaak van myopathie. Omdat overmatig alcoholgebruik 
vaak gepaard gaat met te lage waarden van vitamine D, zochten we naar een verband 
tussen vitamine D-gebrek en de myopathie door alcoholgebruik. We keken naar arti-
kelen over ‘alcoholische myopathie’ en/of ‘myopathie door vitamine D-gebrek’ in the 
PubMed-bibliotheek van januari 1985 tot en met september 2011. We bestudeerden de 
teksten op het gebied van de pathofysiologie met de bedoeling om een aanwijzing te 
vinden voor mogelijke werkingsmechanismen van vitamine D binnen de alcoholische 
myopathie.43
In geval van langdurig alcoholmisbruik vonden we een samenhang tussen verlaagde 
waarden van de volgende drie stoffen: magnesium, fosfaat en vitamine D. We vermoe-
den dat de combinatie van deze tekorten van invloed zou kunnen zijn bij chronische 
alcoholische myopathie. Het precieze werkingsmechanisme is niet duidelijk. Hierbij kan 
gedacht worden aan negatieve effecten van deze tekorten op de stofwisselingsproces-
sen van de spiercellen. Mogelijk kan een behandeling met vitamine D een bijdrage 
leveren bij de preventie en behandeling van chronische alcoholische myopathie.
hoofdstuk 8 − onderzoeksprotocol: vitamine D-verstrekking bij alcoholisme en 
vitamine D-tekort
Ons lichaam kan vitamines tekort komen door onvolwaardige voeding, een verminderde 
opname door de darm en/of een gestoorde leverfunctie. Spierzwakte en verlies van 
spiermassa komen veel voor bij chronisch alcoholisme en zouden gekoppeld kunnen 
zijn aan een ernstig vitamine D-gebrek.
Dit hoofdstuk beschrijft een onderzoeksprotocol van een vitamine D-programma 
gericht op het behandelen van vitamine D-tekorten. Kandidaat-deelnemers aan het 
programma zijn mensen uit de algemene bevolking met bekend alcoholisme en een 
risico op (meerdere) vitaminetekorten. Deelnemers met een vitamine D-deficiëntie 
van < 50 nmol/L serum-25-hydroxyvitamine D (25(OH)D) worden per loting toegewe-
zen aan één van de volgende twee behandelstrategieën: (i) Het ‘Vitamin D Intensive 
Outreach’ (VIDIO)-programma bestaande uit een colecalciferol-oplaaddosering en een 
hoge dosering colecalciferol die tweemaandelijks wordt uitgereikt door de Straatdok-
43 Pathofysiologie, dat is (kennis van) een door ziekte verstoorde lichaamsfunctie.
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ter van de GGD in Rotterdam. En de andere lotinguitkomst is: (ii) ‘Care As Usual’ (CAU) 
bestaande uit een recept voor dagelijks colecalciferol 800 I.E. (in combinatie met 500 
mg calciumcarbonaat) − waarvan de effectiviteit mede afhangt van de medicatietrouw 
van de deelnemer. De VIDIO-interventie is gebaseerd op algemene principes om de 
medicatietrouw ten behoeve van een succesvolle behandeling te vergroten, gevolgen 
van ziekte te voorkomen, en gezondheid te verbeteren, met een laagfrequente medica-
tietoediening in één-op-één patiëntcontacten.
Primaire uitkomstmaten van het onderzoek zijn de 25(OH)D concentraties. Secundaire 
uitkomstmaten zijn krachtmetingen van de quadricepsspier, een oriënterend onderzoek 
van het lopen en staan van de deelnemer, de resultaten van een cognitieve screening en 
een beoordeling van ziekte-gerelateerde kwaliteit van leven. Voor de factoren die van 
invloed zouden kunnen zijn op de vitamine D-inname wordt gekeken naar algemene 
kenmerken van de deelnemer, alcoholgebruik, leverfunctie en andere laboratoriumre-
sultaten en onder andere zelfredzaamheid en sociale steun. Een vergelijking tussen de 
twee strategieën van vitamine D-toediening en serum-25(OH)D-waarden geeft inzicht 
in de effectiviteit van de interventie. Verbetering van spierkracht in de VIDIO-interventie 
geeft een indruk over een effect van vitamine D.
hoofdstuk 9 − Supplement: hypothese over zenuwbanen en het syndroom van 
Korsakov
Op basis van het cognitieve profiel van stoornissen die volgens de literatuur voor kunnen 
komen bij beschadiging van de kleine hersenen, deden we suggesties om de cognitieve 
stoornissen van het syndroom van Wernicke-Korsakov te zoeken in zenuwbanen die de 
voorste hersengebieden en de ‘uitvoerende hersenfuncties’ verbinden met de kleine 
hersenen.
hoofdstuk 10 − Supplement: enige informatie over de behandeling met 
thiamine
Beknopte informatie over de vitamine B1 (thiamine) doseringen bij de behandeling van 
de ziekte van Wernicke en adviezen voor de intraveneuze toediening ter aanvulling op 
de informatie in hoofdstuk 4 (Tabel 4−4).
hoofdstuk 11 − algemene discussie van de inhoud van dit proefschrift
Sommige auteurs hebben zich afgevraagd of onder de symptomen van het Wernicke-
Korsakov syndroom een delier zou schuilgaan (Djelantik et al, 2015) en anderen veron-
derstelden dat de diagnose delirium tremens in sommige studies op een vergissing zou 
kunnen berusten (Cook et al, 1998). In dit proefschrift hebben we getracht systematisch 
na te gaan wat een delier is in relatie tot het syndroom van Wernicke-Korsakov. De 
relatie tussen thiaminegebrek en een delier is complex, wat in meerdere paragrafen in 
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dit hoofdstuk uitvoeriger uiteen wordt gezet. Het syndroom van Wernicke-Korsakov is 
op basis van de observaties en suggesties met betrekking tot het werkingsmechanisme, 
op te vatten als een voorbeeld van delier-gerelateerde cognitieve schade.44 Verder is een 
thiaminegebrek sterk geassocieerd met het optreden van algemene infecties. Hiermee 
wordt het syndroom van Wernicke-Korsakov een multidisciplinaire aandoening voor 
de psychiater, de neuroloog, de internist, de eerstehulparts, de intensivecarearts en 
anderen.
In de dagelijkse medische praktijk is de zichzelf verwaarlozende alcoholist, die 
verward en bedlegerig is geworden, moeilijk te onderzoeken. De koppeling tussen 
verstoorde mobiliteit en mentale stoornissen is echter een opvallend ziektekenmerk. De 
combinatie van het delier en de verstoorde mobiliteit bij een zichzelf verwaarlozende 
alcoholist zou de vroege herkenning van het syndroom van Wernicke-Korsakov kunnen 
vereenvoudigen.
Onvolwaardige voeding bij alcoholisme kan tot meer deficiënties leiden dan vitamine 
B1-gebrek. In dit verband wordt ook aandacht besteed aan vitamine D-tekort, dat van 
invloed zou kunnen zijn op het verlies van spierkracht en dunner worden van spieren bij 
chronisch alcoholisme.
44 Vergelijking met: Schmitt EM, Marcantonio ER, Alsop DC, et al. 2012. Novel risk markers and 
long-term outcomes of delirium: the successful aging after elective surgery (SAGES) study 
design and methods. J Am Med Dir Assoc. 13:818.e1−10.
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achterhersenen. Weinig gebruikte omschrijving van het ‘metencephalon’, een deel van 
de hersenen bestaande uit de pons (Zie Pons) en de kleine hersenen (Figuur 9−2).
ataxie (Grieks). Ongecoördineerd verlopende beweging van armen, romp of benen. 
Stoornissen in de coördinatie komen voor bij stoornissen van de kleine hersenen. Een 
voorbeeld is een dronkemansgang die bij de ziekte van Wernicke ook zonder alcohol 
kan voorkomen. Zie ook: Dysartrie en Nystagmus.
biomarkers. Biomarkers zijn meetbare biologische verschijnselen, bijvoorbeeld 
bepaalde uitslagen van een bloedonderzoek, die gebruikt kunnen worden om de aan-
wezigheid van een bepaalde ziekte vast te stellen, of het verloop van die ziekte (of de 
effecten van een behandeling) te volgen.
cerebellum (Latijn). De kleine hersenen (Zie figuur 9−2).
cerebellar (Engels), cerebellair. Met betrekking tot de kleine hersenen.
cholecalciferol (Engels), colecalciferol (Nederlands). Een vorm van vitamine D afkom-
stig uit de voeding en het lichaam maakt dit zelf aan in de huid onder invloed van 
(ultraviolet) licht.
Colecalciferol wordt door de lever omgezet naar 25-hydroxyvitamine D  =  25(OH)
D, dat door de nier wordt omgezet naar de actieve vorm 1α, 25-dihydroxyvitamine 
D = 1,25(OH)2D.
cognition (Engels), cognitie. Kennende functies van de hersenen, zoals leren, onthou-
den, onderkennen, enz.
coma (Grieks). Toestand van verlaagd bewustzijn. Bewusteloosheid.
Decussating tracts (Engels). Decussatio (Latijn  =  een kruiselings verloop, kruising). 
Kruising van zenuwbanen uit (gelijknamige) linker en rechter hersengebieden. Bijvoor-
beeld: de ‘midden’ in de hersenstam gelegen overkruising van de zenuwvezels komend 
uit de linker en rechter rode kern.
Delirium, delier (Latijn: de = vanaf, lira = groef, spoor). Van het spoor af, ontspoord. Een 
vorm van verwardheid. Bijvoorbeeld: een delier bij koorts = ijlen.
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Delirium tremens is alcoholonthoudingsdelier, alcoholonttrekkingsdelier. Delier na 
het staken of na een vermindering van voorheen fors en/of langdurig alcoholgebruik; is 
afgezien van de oorzaak klinisch niet goed te onderscheiden van een delier door andere 
oorzaken (Tabel 3−1 en Van den Brink & Jansen, 2009, blz. 248).
Dementie (Latijn: de = naar beneden, mens = geest). Afbrokkeling, aftakeling van de 
geestelijke vermogens.
Diaschisis (Grieks). Verstoorde functie van een hersengebied door beschadigde 
verbindingen met andere hersengebieden.
Dysartrie (Grieks). Ongecoördineerd verlopende spraak die moeilijk is te verstaan door 
verstoorde articulatie.
Empyeem (Grieks). Pusophoping (etter) in een bestaande lichaamsholte, bijvoorbeeld 
de borstkas, galblaas, urineblaas.
Encephalopathy (Engels), encephalopathie, encefalopathie (Grieks: en  =  in, 
cep(h)  =  ‘kop’, -pathie  =  aandoening of aandoenlijk). Dus een omschrijving voor: 
hersen aandoening.
Korsakoff (Engels), Korsakov, Korsakow. Russische neuroloog in de 19e eeuw.
Korsakoff’s (Engels). Bedoeld is syndroom van Korsakov (Zie tabel 3−1).
Mentale, mentaal (Latijn: mens = geest), verschillende betekenissen. Hier: met betrek-
king tot de geestesgesteldheid.
Mental symptoms (Engels). Psychische klachten of verschijnselen.
Microglia (Grieks). Microglia zijn cellen die in de hersenen deel uitmaken van het (af-
weer)systeem voor het opruimen van schade of lichaamsvreemd materiaal.
Motor (Engels), motoor, motorisch (Nederlands). Op beweging betrekking hebbend.
Myopathy (Engels), myopathie (Grieks: myos  =  spier). Dus een omschrijving voor: 
spierziekte.
nucleus ruber (Latijn), rode kern. Een groep zenuwcellen (links en rechts) in de hersen-
stam, met een kleur die zou komen door ijzerpigmenten.
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nystagmus (Grieks). Ongecoördineerd (schokkend) verlopende oogbewegingen.
ophthalmoplegie (Grieks), op verschillende manieren gespeld: ph = f, th = t. Ophthal-
moplegie is zwakte of verlamming van de oogbewegingen. Ophthalmoplegie kan zich 
uiten in dubbelzien.
Pathogenese (Grieks). De wijze waarop een ziekte ontstaat.
Pons (Latijn) = brug. Deel van de hersenstam dat een verbinding vormt met de kleine 
hersenen.
quadriceps (Latijn), voluit: ‘musculus quadriceps femoris’. Bovenbeenspier; deze strekt 
de knie. Voorbeelden van de functie van de quadricepsspier zijn: opstaan, lopen, traplo-
pen.
Sepsis (Grieks). ‘Bloedvergiftiging’. Een levensbedreigend ziektebeeld door aan-
wezigheid en vermeerdering van bacteriën in het bloed.
Somnolentie (Latijn). Sufheid, slaperigheid.
Syndrome (Engels), syndroom. Samenstel van ziekteverschijselen die als eenheid 
(ziekte) worden opgevat. Bijvoorbeeld: syndroom van Korsakov.
thiamine is vitamine B1.
Wernicke. Duitse neuroloog in de 19e eeuw. Zijn naam is ondermeer verbonden aan het 
ziektebeeld Wernicke encefalopthie (Zie Tabel 3−1), een levensbedreigende hersenaan-
doening door vitamine B1 gebrek.
Wernicke-Korsakoff syndrome (Engels), is de combinatie van de twee ziektebeelden: 
1. De ziekte van Wernicke (is Wernicke encefalopathie) en 2. Het syndroom van Korsakov.
ziekte van Wernicke is Wernicke encefalopathie.
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